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ABSTRACT 
 
Both feeding and cell culture studies were conducted to test the hypothesis that 
branched-chain amino acids (BCAA) can enhance milk synthesis by porcine mammary 
epithelial cells (PMEC). In the first in vivo feeding trial, ten multiparous lactating sows 
were fed corn-soybean meal-based diets supplemented with 0%, 1.535%, or 3.07% 
BCAA for 29 d. The number of piglets was standardized to 9 per sow. On d 3,15 and 29 
of lactation, body weights of sows and their piglets, as well as milk consumption of 
piglets were determined. Blood samples were obtained from sows and piglets at 2 and 1 
h after feeding, respectively. The second feeding experiment was conducted with dietary 
supplements containing 0%, 1% or 2% monosodium glutamate (MSG). Data were 
analyzed by two-way ANOVA. In both feeding trials, plasma concentrations of aspartate, 
glutamine, citrulline, arginine, and BCAA were higher, compared to the control. Dietary 
supplementation with 1.535% and 3.07% BCAA increased: 1) concentrations of free and 
protein-bound glutamate plus glutamine in milk; 2) milk intake of piglets by 14% and 
21%; and 3) daily weight gains of piglets by 19% and 28%. Dietary supplementation 
with 1% and 2% MSG increased: 1) concentrations of free and protein-bound glutamate 
plus glutamine in milk; 2) milk intake of piglets by 14% and 25%; and 3) daily weight 
gains of piglets by 23% and 44%. These results indicated that dietary supplementation 
with up to 3.07% BCAA or 2% MSG was safe and enhanced lactation in sows. To 
elucidate the mechanisms responsible for the effects of BCAA on milk production, 
PMEC were cultured in customized medium containing 0.1, 0.25, 0.5, 1 or 2 mM L-
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leucine, L-isoleucine, or L-valine, or a mixture of those three BCAA. Elevating 
extracellular concentrations of BCAA from 0.1 to 2 mM increased the phosphorylation 
of proteins in the mechanistic target of rapamycin pathway, the rate of protein synthesis 
and cell proliferation, while decreasing the abundance of proteasome and ubiquitinated 
protein, and the rate of protein degradation in PMEC. The findings not only advance 
understanding of nutritional regulation of lactation but also provide a new strategy to 
improve milk production by livestock, women, and other mammals. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
BACKGROUND 
An increase in production unit size results from increasing economic pressure on 
the swine industry (Foxcroft et al., 2006). The economic profitability of a swine 
production unit is primarily determined by both the number and size of piglets produced 
per year per sow (Quiniou et al., 2002). However, increased litter size results in lower 
birth weights for individual piglets (Fix et al., 2010). The greatest proportion of 
mortality in commercial swine production occurs prior to weaning. Reviews of piglet 
survival during lactation indicate that pre-weaning mortality ranges between 10 and 20% 
of live-born pigs (Alonso-Spilsbury et al., 2007; Wu et al., 2006). Similarly, pre-
weaning mortality was estimated at about 12.8% in U.S. commercial swine herds during 
2008 (PIGCHAMP, 2008).  
A variety of causes lead to pre-weaning mortality and poor performance, such as 
low birth weight of individual piglets (Alonso-Spilsbury et al., 2007), as well as 
inadequate provision of milk (Wolter et al., 2002). Milk is the sole source of nutrients 
for suckling piglets, and their maximal growth performance and survival largely depend 
on sufficient production of milk by sows (Wu et al., 2006). In turn, the weight achieved 
by the time of weaning determines adaptability of piglets to the nursery and how rapidly 
they reach market weight (Harrell et al., 1993). Indeed, secretion of milk by the 
mammary gland is the main determinant of neonatal growth rate; therefore, it is 
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important that milk output by high-producing sows is adequate to allow maximum 
neonatal growth (Boyd et al., 1995). For instance, arginine (Arg, a nutritionally essential 
AA for neonatal pigs) is deficient in sow’s milk which limits growth performance of 
piglets (Wu et al., 2010). In addition, the amount of milk produced does not match 
energy and protein requirements of neonatal piglets in a litter. Previous results showed 
that milk from high-producing, primiparous females does not satisfy the energy 
requirements of piglets (9 to10 pigs/litter) after d 8 of lactation. This gap gradually 
increases throughout lactation so that maternal milk output is approximately 50% of 
neonatal needs at 21 d of age (Boyd et al., 1995).  
It has been estimated that a sow must produce 18-20 kg milk/d to supply a litter 
of 9 piglets with enough energy to grow at a rate comparable to artificially-reared piglets 
of the same age (Harrell et al., 1993). In pigs, average growth rates of at least 450 g/d to 
21 d of age (vs 230 g/d) are achievable with an adequate supply of nutrients (Harrell et 
al., 1993). The biological basis for this apparent limitation in milk secretion is unclear. It 
may result from an inadequate supply of nutrients to mammary tissue, a deficit in 
endocrine stimulation of milk synthesis, and (or) coordination of metabolism in extra-
mammary tissues (e.g., adipose, muscle) to spare nutrients for use in milk synthesis. 
Sows have a high capacity to utilize nutrients from the arterial circulation for 
milk production (Kim et al., 2000). However, due to inadequate feed intake by lactating 
sows, they do not meet physiological requirements for maximum milk production, 
thereby leading to a catabolic state in which their body reserves are mobilized to provide 
nutrients and energy for milk production during lactation (Boyd et al., 1995). Traditional 
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feeding strategies for sows currently practiced in swine enterprises are unable to support 
sufficient milk production for optimal growth and survival of neonatal pigs (Wu et al., 
2010). Many studies have shown that high neonatal mortality and poor growth of pre-
weaning pigs are highly correlated with insufficient milk production by sows.  Most of 
the studies have focused on hormonal regulation of lactation; however, little attention 
has been paid to the development of nutritional strategies that enhance lactogenesis in 
sows or growth of suckling piglets. 
Amino acids are building blocks of proteins that regulate metabolic pathways for 
whole body homeostasis (Wu, 2009). Sows require large amounts of amino acids to 
support tissue growth and milk synthesis by the mammary glands during lactation (Guan 
et al., 2002). Of the dietary essential amino acids whose carbon skeletons cannot be 
synthesized endogenously, branched chain amino acids (BCAA), including leucine, 
isoleucine and valine, have received much attention in recent years (Lei et al., 2012ab).  
BCAA are major components of milk proteins, and their uptake by the sow’s mammary 
glands is much higher than their secretion into milk (Li et al., 2009; Trottier et al., 1997). 
This means that BCAA are catabolized extensively in lactating mammary tissue to 
provide amino groups for biosynthesis of other amino acids, such as glutamate and 
glutamine, which are necessary for piglet growth and digestive tract maturation (Lei et 
al., 2012ab). High levels of BCAA can also reduce degradation of arginine by arginase 
in mammary tissue, thereby increasing the bioavailability of arginine for synthesis of 
milk proteins (Kim et al., 2008). Recent studies have shown the important roles of 
BCAA in the regulation of mammary gland metabolism. For example, leucine increases 
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protein synthesis in mammary epithelial cells through activation of the mechanistic 
target of rapamycin (mTOR) cell signaling pathway (Wu, 2009). There is great potential 
for BCAA to increase milk synthesis in mammary tissue, thereby improving neonatal 
growth, development and survival.  
The requirement of the lactating sow for BCAA involves more than just 
synthesis of milk proteins. Recommendations for appropriate amino acid requirements 
for optimal milk production by lactating sows relies on a better understanding of the 
utilization and metabolic fates of BCAA during lactation. Therefore, the objectives of 
this study are to: 1) evaluate survival and growth performance of piglets from sows 
receiving BCAA as a dietary -supplement; 2) determine regulatory roles of BCAA in 
protein synthesis by porcine mammary epithelial cells; and 3) elucidate biochemical and 
molecular mechanisms whereby BCAA increases milk synthesis. 
INTRODUCTION 
Milk is the secretory product of the mammary gland, compound, tubulo-alveolar 
structure with a merocrine/apocrine mode of secretion. Fats, proteins, and some amino 
acids are synthesized and secreted by epithelial cells of alveoli. The alveoli are 
connected to a duct system through which the secreted milk flows into the teat canal 
from which it can be removed by suckling or milking.  Thus, the mammary gland is a 
highly organized organ which serves as a medium to supply nutrients from the mother to 
the neonate through suckling (Akers, 2002). 
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THE STRUCTURE OF THE MAMMARY GLAND 
The classification of the mammary gland 
One of the main distinctive adaptations in mammals is highly evolved secreting 
glands developed in the skin (e.g., hair follicles) and mammary glands. A gland is a 
secretory organ whose products can be secreted into a cavity or directly into the blood in 
order to be distributed to tissues. The structure of glands can be simple (e.g., coiled 
tubular or branched alveolar), or compound (e.g., branched tubulo-alveolar). The 
mammary gland is an example of compound, branched tubuloalveolar gland (Blackburn 
et al., 1989). Glands can be categorized based on their mode of action: 1) apocrine, 
products are synthesized by the cells of the gland without causing disintegration of the 
cell; 2) exocrine, a fluid is secreted and cells are not lost as part of the secretory process; 
3) holocrine, secretion results from disintegrated of cells of the gland; and 4) merocrine, 
the gland is repeatedly functional and cells are not destroyed during the secretory 
process. The secretions from the mammary gland occur via both merocrine and apocrine 
modes (Cardiff and Allison, 2012).  
Tissues of the mammary gland 
In the lactating mammary gland, the parenchymal tissue is composed of 
epithelial structures (e.g., alveoli and ducts) and the associated stromal connective tissue. 
The stroma of a lactating gland is composed of connective tissue surrounding the 
epithelial structures (Cardiff and Allison, 2012). The cellular components of the 
connective tissue include fibroblasts, endothelial cells associated with blood vessels, and 
leukocytes, while non-cellular components include collagen and other connective-tissue 
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proteins. In addition, an extensive white adipose tissue exists as part of the stroma of the 
developing gland. This fat pad is considered as extra-parenchymal tissue and is 
noticeably larger during the early phases of fetal development and the decreases in mass 
through the remainder of pregnancy. Thus, the fat pad of a lactating mammary gland is 
smaller than during pregnancy (Cardiff and Allison, 2012). 
Mammary glands are also considered accessory reproductive organs. As noted 
previously, they are compound, tubulo-alveolar skin glands which are located on the 
ventral surface of the mammal. The alveolus is the basic milk secreting structure which 
consists of a single layer of secretory epithelial cells surrounding a lumen. The epithelial 
layer is surrounded by a layer of contractile myoepithelial cells which play an important 
role in milk ejection. The alveolus is then surrounded by a basement membrane 
(Frandson et al., 2013).  
Upon stimulation of mechanoreceptors in the teat skin, these receptors induce 
cholinergic nerve impulses which travel via segmental pathways in the central nervous 
system (CNS) to the paraventricular (PVN), and supraoptic nuclei (SON) in the 
hypothalamus resulting in release of oxytocin from the posterior pituitary gland. 
Oxytocin is a nonapeptide consisting of nine amino acids and is produced in the SON 
and PVN of the hypothalamus. Oxytocin is transported by carrier proteins (neurophysin 
I) from the cell bodies of PVN and SON through the pituitary stalk. From the pituitary, 
oxytocin is released from neurophysin and enters the blood for transport to the mammary 
gland where it binds to its receptors on the myoepithelial cells surrounding the alveoli. 
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This causes myoepithelial cells to contract and force milk from the alveoli into the teat 
canal from which it is expelled via nursing or milking (Crowley and Armstrong, 1992).  
In pigs, the number of mammary glands varies from 6 to 20 (3-10 pairs). The 
arrangement of glands is in two parallel rows on either side of the ventral median line 
and extending from the pectoral to the inguinal region. Each gland is separate and 
independent of secretory tissue from adjacent glands. The heritability of teat number is 
rather low (0.10 to 0.20). Thus, it is difficult to select for high teat number in sows 
(Hartmann and Holmes, 1989). 
Innervation in the mammary gland 
As the mammary gland is a skin-derived structure that contains external 
innervation in the skin covering the gland. There are few internal innervations which 
control the blood vessels in the mammary gland. Innervation inside the gland is sparse 
compared with other tissues. Sympathetic nerves are present in the mammary gland and 
are associated with the arteries, but not the alveoli. Sensory nerves found in the teat and 
skin are critical for initiating the afferent pathway (neural pathway) of the milk ejection 
reflex. There is no parasympathetic innervation of the mammary gland. This is similar to 
other skin glands. There is no innervation of the secretory system. Myoepithelial cells 
are not innervated and do not contract in response to direct innervation, but rather 
contract in response to the blood-borne hormone, oxytocin (Frandson et al., 2013). 
Blood and lymphatic vessels in the mammary gland 
The blood supply to the mammary gland must leave and return to the body cavity 
through points where blood vessels exit the body cavity to reach the ventral portions of 
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the skin, such as the thoracic and inguinal canal (Cardiff and Allison, 2012). In pigs, 
blood supply to the mammary glands arises from two branches of the arterial system, the 
common carotid artery supplies the anterior glands and a branch of the abdominal aorta 
supplies the posterior glands. There is an anastomosis of the anterior and posterior 
mammary arteries and veins between the second and fourth inguinal glands so that the 
blood supplying the inguinal glands may pass forward through the anastomosis, whereas 
the blood supplying anterior glands may pass posteriorly through the anastomosis 
(Frandson et al, 2013).  
The extracellular fluids are drained from the mammary tissue and conducted 
back to the circulatory system via the lymphatic network. Also, the lymphatics contain 
concentrated areas of leukocytes (particularly lymphocytes and macrophages) in lymph 
nodes; these leukocytes can mount an immune response to bacteria and foreign material. 
The lymphatic network serves to transport some nutrients such as vitamin K and lipids 
absorbed in the intestine. The lymphatic network originates in tissue spaces as very thin, 
closed endothelial tubes (lymphatic capillaries). These are analogous to blood 
capillaries, but are much more permeable, with little resistance to passage. They have no 
basement membrane. Lymph capillaries converge to form larger vessels. Lymph flow is 
unidirectional from the tissues through lymphatic vessels, eventually draining into the 
vena cava (Frandson et al., 2013). 
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DEVELOPMENT OF THE MAMMARY GLAND 
Mammogenesis 
The mammary gland is one of a few tissues in mammals which can undergo 
repeated cycles of growth, functional differentiation, and regression. The development of 
mammary gland structures is referred as mammogenesis. Mammogenesis begins during 
early fetal development and proceeds beyond initiation of lactation. Most 
mammogenesis occurs during pregnancy, and some pregnancy hormones such as 
estrogen and progesterone are responsible for mammary growth. In fact, high 
concentrations of such hormones mark the primary physiological mediators of 
mammogenesis during pregnancy (Knight et al., 1986; 1998). 
Differences among species in how lactation fits into the overall reproductive 
cycle is one of many interesting aspects of lactation biology. For example, a sow 
typically is bred to farrow for the first time at about 12 months of age (gestation is about 
114 days). The majority of mammary development occurs during this 114 day period. 
Lactation begins at farrowing. Usually, the piglets are weaned at 21 days, at which time 
the mammary gland of the sow undergoes involution and milk secretion ceases (King, 
1993; 2000).  
Many mammalian species experience lactational anestrus, that is, they do not 
experience estrous cycles during early lactation.  The length of lactational anestrus varies 
among species. For example, in the sow, gestation is 114 days and the piglets suckle the 
sow for several weeks (generally 2 – 4 weeks) before weaning. Lactation in the sow 
inhibits normal reproductive cycling and the next estrus occurs several days after the 
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piglets are weaned. In fact, this management approach is used to synchronize estrus and, 
therefore, the time of the next farrowing (parturition). In this case the swine producer 
uses the normal relationships between reproductive function and lactation to optimize 
sow productivity. Lactation in swine, under modern management procedures, accounts 
for only one part of the total reproductive process, but is nevertheless a critical period for 
survival and growth of the newborn piglet (Brooks and Burke, 1998). 
Lactation and reproductive processes are closely intertwined in mammals. 
Mammary development occurs only slightly during estrous cycles, while substantial 
development occurs while the female is pregnant and preparing to provide extra-uterine 
maternal nutritional support after birth of the piglet. Some factors involved in control of 
pregnancy are the same factors involved in regulating mammary development during 
pregnancy. For example, key pregnancy hormones, estrogen and progesterone, are the 
primary stimulators of growth of the mammary tissue. In addition, growth hormone, 
prolactin and glucocorticoids (mainly cortisol) also contribute to mammary gland 
development. Similarly, important hormone changes that occur in association with 
parturition are critical to the initiation of milk synthesis and secretion by the mammary 
tissue at birth (Akers, 2002; King, 1989).   
During pregnancy, the interrelationships between mother and offspring occur in 
utero. After birth, the metabolic interrelationships occur outside of the uterus via 
production of milk by the mammary gland. During lactation, the mother undergoes 
substantial changes in metabolism to account for the increased demands of milk 
synthesis. From this perspective, the mammary gland replaces functions of the placental-
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uterine unit in providing nutrients and protective factors for development of the 
offspring (Hughes and Varley, 1980). With the subsequent evolution of the placenta 
resulting in a much more extensive intrauterine development of the conceptus, the ability 
to lactate after expulsion of the offspring from the uterus becomes a critical part of the 
reproductive strategy of mammalian species that give birth to live young (Hughes and 
Varley, 1980).  
Most of our understanding of the physiology of lactation (including structural 
development of mammary and control of nutrient supply to the mammary gland) has 
been acquired from studies of the dairy cow. That is because of the combined 
importance of efficient milk production and the consumption of milk as a major human 
nutritional component. Another reason is the relative ease of using the bovine model 
compared with the pig with regard to handling and milking as well as the availability of 
equipment that allows for precise and easy measurement of total milk output in the cow 
to assess mammary gland metabolism (Trottier et al., 1997).  
Structural development of the mammary gland generally occurs in five phases. 
These phases are development during the fetal period, the prepubertal period, the 
postpubertal period, pregnancy, and lactation (Akers, 2000). These morphological 
changes are distinct and have been well characterized in cows and mice. Here, we will 
next review hormonal regulation of the development of the mammary gland.  
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Hormonal regulation of mammary gland development 
During the fetal period 
Testosterone injection into the pregnant mouse on d 8, 9, or 10 of pregnancy 
leads to masculinization of the mammary gland of female fetuses. The female fetuses are 
born without nipples. The mammary bud becomes exteriorized and is separated from the 
epidermis, as observed by d 14 or 15. Mammary development in male fetuses is not 
further affected by the testosterone treatment of the mother. Gonadectomy of male 
fetuses results in the female pattern of mammary development in male fetuses. 
Gonadectomy resulted from localized irradiation on d 13 of pregnancy of the region 
where the gonads form in the mouse fetus. This functionally castrates the fetus. By d 18 
of pregnancy, mammary development in male mice includes formation of normal 
primary mammary cords. Gonadectomy of the female fetus by irradiation does not alter 
normal mammary development (Bocchinfuso and Korach, 1997). Administration of high 
doses of estrogen to female fetuses or to the mother results in a number of abnormalities 
of mammary development. These abnormalities include total suppression of 
development of the mammary bud, leaving only a nipple with no internal structures; 
partial inhibition of the mammary bud; formation of a cavity at the site of the mammary 
bud; abnormally shaped mammary buds; formation of multiple primary mammary cords; 
and excessive formation of the mesenchyme around the primary mammary duct (Cheng 
et al., 2004). Likewise, administration of growth hormone into the mouse fetus increases 
the size of the developing mammary gland in both male and female fetuses, suggesting 
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that this hormone is also involved in development of the mammary gland of the fetus 
(Etherton and Bauman, 1998). 
During the pre-pubertal period 
Daily injections of somatotropin (growth hormone) to heifers from 8 to 15.6 
months of age resulted in increased mammary parenchyma and decreased 
extraparenchymal tissue compared to controls (Sejrsen et al., 1999). Growth hormone 
stimulates mammary growth through increasing the hepatic synthesis of insulin-like 
growth factor-1 (IGF-1), which is a potent mitogen for mammary cells. Therefore, 
growth hormone may be a major factor controlling mammary development during the 
prepartum period. However, administration of growth hormone during the prepubertal 
period does not increase milk yield during the first lactation (Blackburn et al., 1989). 
Leptin, which is produced by white adipocytes, is another protein that influences 
mammary development indirectly and this may explain why excessive fattening impairs 
mammary development.  For example, results from both in vitro and in vivo studies 
indicate that leptin decreases IGF-1-induced proliferation of bovine mammary epithelial 
cells. However, leptin could not mediate the effects of a high-plane of nutrition on 
mammary epithelial cells in prepubertal heifers due to the paucity of leptin receptors on 
those cells. It appears that leptin exerts its effects on mammogenesis through inhibition 
of IGF-1 mediated cell signaling in mammary epithelial cells that is linked to activation 
of macrophages in the mammary gland. Upon stimulation with leptin, macrophages 
increase their phagocytic activity and production of cytokines such as TNFβ and IL-6, 
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which are associated with inhibition of IGF-1-induced proliferation of many cell types 
(Shennan and Peaker, 2000). 
During the post-pubertal period 
The growth of mammary tissue during estrus is related to ovarian steroid 
hormones. Estrogen receptors and progesterone receptors both appear in cells of the 
gland around the time of puberty. However, the exact roles of estrogen and progesterone 
are not completely understood. Mammogenic hormones establish the conditions for 
specific growth patterns in mammary tissue. For example, concurrently elevated 
concentrations of estrogen and progesterone in blood in late gestation result in an 
exponential increase in parenchymal growth and in formation of alveoli. In contrast, the 
cyclic changes in those hormones associated with estrous cycles result primarily in duct 
elongation and formation of some lobular tissue, but not in formation of alveoli. 
Mammary development is usually driven by a complex of hormones acting in 
concert. Effects of many mammogenic hormones are thought to be mediated through 
stromal cell-derived growth factors which act in a paracrine manner by eliciting 
mitogenic responses in the adjacent epithelial cells. Much of our current understanding 
of how mammogenic hormones and growth factors function arises from research in 
rodents. However, similarities are being noted in other animals and knowledge of 
hormone action in rodents can help in understanding similar processes in other animals 
(Akers, 2002). Estrogen is an important mammogenic factor, particularly in the 
postpubertal female. Estrogen receptors (particularly estrogen receptor α) appear in the 
gland around the time of puberty, coinciding with the period when the gland becomes 
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exposed to cyclic increases in concentrations of estrogens in blood. In rodents, estrogen 
acts via its receptors in the stromal tissue to stimulate production of growth factors, 
which in turn stimulate ductal development. The evidence available from studies of 
cattle also indicates that estrogen’s action on mammary development may be mediated 
through the stroma (Ellis et al., 2000). Progesterone is another ovarian steroid hormone 
which plays a key role in mammary development. While progesterone receptors have 
been difficult to identify in the mammary fat pad, administration of progesterone 
stimulates proliferation of stromal cells under some physiological conditions. The 
stimulatory effect of progesterone on DNA synthesis in ductal epithelium is probably 
mediated indirectly through its effects on stromal cells. The major mammogenic effect 
of progesterone is mediated through binding to its receptors in epithelial cells and 
stimulating ductal side branching or alveolar bud formation, which are the hallmarks of 
postpubertal mammary development. Estrogen stimulation of progesterone receptor 
expression in epithelial cells is required for progesterone to exert its effects. 
Progesterone, therefore, has a major role in alveolar morphogenesis and a lesser 
role in ductal morphogenesis. During estrous cycles, duct elongation and expansion of 
the parenchymal tissue into the fat pad occur in limited bursts associated with the 
periods when circulating concentrations of estrogen are high. During the luteal phase 
when concentrations of progesterone are greatest, relatively little growth of the 
mammary gland occurs in ruminants, but formation and maintenance of lobular 
structures in the mammary gland may be stimulated by progesterone, with little 
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regression of the mammary ductal system occurring between estrous cycles (Akers, 
1990). 
Synergy between estrogen and progesterone is observed during pregnancy when 
both hormones are present in high concentrations. Elevated concentrations of estrogen 
and progesterone in blood establish the conditions required for exponential growth of the 
mammary gland during pregnancy (Haslam and Shyamala, 1979). Lobuloalveolar 
development represents the greatest increase in mammary gland tissue mass during 
pregnancy. In the cow, circulating concentrations of progesterone are elevated 
throughout gestation, while circulating concentrations of unconjugated estrogens are 
greatest during the later stages of gestation when there is the greatest increase in 
mammary tissue mass. Estrogen and progesterone have direct effects on the mammary 
gland, probably mediated via autocrine and paracrine factors produced locally in the 
tissue. In addition, steroid hormones may have indirect effects via their impact on the 
secretion of prolactin by the anterior pituitary gland lactotrophs (Mepham, 1987).  
Prolactin often is associated with initiation of lactation and galactopoeisis, but it 
also has mammogenic effects. Prolactin receptors are present in the mammary fat pad 
and the mammary epithelium. Prolactin may act on both epithelial and stromal 
components of the growing mammary tissue. Inhibition of prolactin secretion inhibits 
mammary gland development in pregnant goats, pigs and other species (Farmer and 
Palin, 2005).   
Concentrations of prolactin are normally low during pregnancy. Mammary 
development during pregnancy may not be limited by low concentrations of prolactin in 
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blood (Farmer and Petitclerc, 2003), especially when the action of prolactin may be 
regulated by estrogen-induced changes in expression of receptors for prolactin in 
mammary tissue (Young et al., 1989).  
Administration of growth hormone (somatotropin) to cattle is known to stimulate 
milk production during lactation. This effect is indirect in that growth hormone 
stimulates secretion of insulin-like growth factor-I (IGF-I) from the liver, which in turn 
mediates many of the galactopoeitic effects of growth hormone during lactation 
(Bauman and Vernon, 1993). Growth hormone also acts as a mammogenic hormone and 
can stimulate mammary growth at all stages of development. Direct effects of growth 
hormone on mammary tissue require the presence of growth hormone receptors on 
mammary cells. While this remains a point of controversy, there is evidence for growth 
hormone receptors in mammary epithelial or stromal cells in various species. Several 
lines of evidence indicate that growth hormone may act on mammary tissue in ruminants 
by stimulating stromal production of IGF-I which is mitogenic for mammary epithelial 
cells. The highest level of IGF-I expression in mammary tissue occurs in the fat pad and 
is greatest during the prepubertal allometric growth phase and during late pregnancy. 
Mammary expression of IGF-I is regulated by growth hormone, estrogen and 
positive feedback stimulation from proliferating epithelial cells. The function of IGF-II 
in mammary growth is less clear than for IGF-I. Stromal cells probably produce IGF-II, 
which is regulated by stage of mammary development and hormonal stimulation (Akers, 
2002).  
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Placental lactogens are secreted by the placenta and may have prolactin- or 
growth hormone-like activities, depending upon the species. In pregnant goats, 
concentrations of placental lactogen in maternal blood is closely correlated with the 
number of fetuses present and, therefore, placental mass. This graded concentrations of 
placental lactogen, in combination with other mammogenic hormones, may regulate the 
extent of mammary development during late pregnancy. In the dairy cow, there is a 
relationship between placental mass and subsequent milk production. However, the 
concentration of placental lactogen in maternal blood of the dairy cow is low and the 
effect of placental mass may result from other placental hormones, including estrogen 
(Schams et al., 1984). Other hormones also are required for mammary growth, including 
glucocorticoids, thyroid hormones and insulin (Tucker, 2000). Severely diabetic mice 
given estrogen and progesterone will develop extensive lobuloalveolar structures. Of 
note, insulin synergizes with estrogen and progesterone to increase mammary 
development. Normal concentrations of insulin in blood is not limiting for normal 
mammary development (Tucker, 2000).  
During pregnancy 
Optimal mammary growth requires both estrogen and progesterone. During 
pregnancy, both sromal and epithelial cells of the mammary gland express estrogen 
receptor alpha and progesterone receptors. During lactation, the epithelial cells of the 
mammary gland express estrogen receptor alpha, but there is no expression of 
progesterone receptors. In fact, progesterone receptor levels are inversely proportional to 
the secretory activity of the gland. Concurrently, changes in circulating concentrations of 
  19 
estrogen and progesterone during pregnancy establish conditions for geometric cell 
multiplication of epithelial cells and lobuloalveolar growth, which is characteristic of 
mammary tissue development during pregnancy. In pigs, on d 30 of pregnancy, elevated 
estrogen levels signal to increase DNA concentrations in mammary glands. The 
mammary continues to grow throughout pregnancy but the peak in growth is between d 
75 and 90 (Kensinger et al., 1982).  In the cow, progesterone is elevated throughout 
gestation (required for maintenance of pregnancy), while estrogen is particularly 
elevated during the second half of gestation. Consequently, most mammary growth 
during the first half of gestation is ductal growth and lobular formation. In the second 
half of gestation, ductal growth continues, but most growth is lobuloalveolar (Tyler and 
Ensminger, 2006).  
In hypophysectomized-ovariectomized goats, administration of estradiol (E2), 
progesterone (P4), prolactin (PRL), growth hormone (GH1), adrenocorticotrophic 
hormone (ACTH) and glucocorticoids, particularly cortisol, are required for 
lobuloalveolar development comparable to that in mid-pregnancy. This suggests that all 
of these hormones are involved in mammary development during pregnancy (Brisken, 
2002). The roles of some of these and other hormones are discussed below. 
Prolactin (PRL) and Growth Hormone (GH1) In virgin rats, transplantation of the 
pituitary to the kidney capsule releases the anterior pituitary lactotrophs from inhibition 
of secretion of PRL by dopamine and this results in marked stimulation of growth of the 
mammary gland. However, circulating levels of both PRL and GH are normally 
suppressed during gestation in most species (Barber et al., 1992).  Although both PRL 
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and GH are required for mammary development, their concentrations in blood are not 
normally limiting. GH is implicated in mammary growth during the fetal stages and 
prepubertal stage of mammary development (Buskirk et al., 1997).  
Placental lactogens (CSH1) are synthesized and secreted from the chorion of the 
placenta. Generally they have both PRL- and GH-like activities. However, there is great 
variation among species. Pigs and rabbits do not have placental lactogen (Neville, 2002). 
In the rat, during the first half of pregnancy, PRL and GH are the primary hormones 
involved in mammary development. Significant amounts of CSH1 are not secreted until 
d 12 of gestation in rats.  
Hypophysectomy of the rat at d 12 of pregnancy or later, does not affect 
mammary cell numbers or maintenance of pregnancy (Barber et al., 1992). In goats, the 
concentration of placental lactogen in maternal blood is closely correlated with the 
number of fetuses (Hayden et al., 1980).  One interpretation of this observation is that 
the level of total lactogenic hormone activity in maternal blood (PRL plus CSH1 or other 
hormones) regulates the extent of mammary development during late pregnancy. 
However, in the cow, concentrations of placental lactogen in maternal blood are very 
low (Capuco et al., 2001). Placental lactogen probably synergizes with E2, P4, PRL and 
GH1 in mammary development (Byatt et al., 1992). It must be borne in mind that the 
placenta also secretes estrogens and progesterone in a highly species-dependent manner 
(Tucker, 1994). 
Relaxin is a hormone secreted during pregnancy in some species. Its role is 
usually associated with preparing the late pregnant reproductive tract for parturition. For 
  21 
example, it is involved in softening of the cervix prior to parturition. Most effects of 
relaxin require the estrogen stimulation (Hurley et al., 1991). Relaxin also has a major 
mammogenic role in the sow. Removal of the ovary from late pregnant gilts (at d 80 or d 
100 of pregnancy in association with administration of exogenous progesterone to 
maintain pregnancy) removes the source of relaxin in the pregnant pig. This led to 
substantially reduced mammary development during the last weeks of pregnancy 
(Hurley et al., 1991). Relaxin also stimulates mammary development in virgin gilts 
(Winn et al., 1994). It is interesting that, while the pig does not express a placental 
lactogen, the corpora lutea do secrete relaxin as a major mammogenic factor during 
pregnancy. The concentration of relaxin in the mother's blood is correlated with the 
number of corpora lutea on the ovaries in pigs. Additionally, the number of corpora lutea 
is directly related to the number of ovulated oocytes and the number of fetuses. Thus, 
even in the pig, there is a relationship between the number of fetuses and the level of 
mammogenic stimulus on development of the mammary gland (Hurley, 2001; Zaleski et 
al., 1996)).   
Insulin is required to maintain normal mammary tissue function. Mammary cells 
are resistant to insulin before conception, and thereafter they become sensitive to insulin 
during gestation and lactation, and become insensitive again during involution of the 
mammary gland. Insulin stimulates mitosis of mammary cells in vitro, but is not 
absolutely essential in vivo (Spinka et al., 1999). Severely diabetic mice given estrogen 
and progesterone develop extensive lobuloalveolar structures. Still, insulin synergizes 
with estrogen and progesterone to increase mammary development. Concentrations of 
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insulin in blood decrease during gestation as do concentrations of prolactin and growth 
hormone; therefore; it can be surmised that insulin is not a major factor directly affecting 
mammary development (Richert et al., 2000).  
Thyroid hormones (T3 and T4) are involved in overall metabolic rate and oxygen 
consumption by cells of the body. Their effect on mammary development is probably 
indirect or via the normal requirements of cell maintenance. Hypothyroidism retards 
ductal and lobuloalveolar growth in rat mammary tissue and administration of thyroid 
hormones restores the normal developmental pattern (Tucker, 1994).  
During lactation 
The number of cells in the lactating mammary gland is critical for milk 
production and they continue to increase after parturition. Mammary tissue weights and 
total DNA content continue to increase in early lactation. The impact of this increased 
mass of mammary tissue on milk production can be substantial in some species. For 
example, the total amount of DNA in mammary glands of rats during lactation is highly 
correlated with litter weight gain (Tucker, 2000). In rats, total mammary DNA can 
increase by over 100% during lactation, depending upon litter size (Tucker, 2000). In the 
sow, mammary gland weight and total mammary DNA increase by 55% and 100%, 
respectively, between d 5 and 21 of lactation when the sow nurses 9 or 10 piglets (Kim 
et al., 1999). In cows, mammary DNA increases by 65% from d 10 prepartum to d 10 
postpartum, although how much of this increase occurred pre- and postpartum was not 
determined (Akers, 2002). So far there are no reports of cell numbers in the cow 
mammary gland throughout the lactating period (Tyler and Ensminger, 2006).  
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Litter size in some species (e.g., the rat or pig) is directly related to nursing 
intensity (a combination of number of nursing young and the intensity with which they 
nurse). Nursing intensity and parity have major effects on the extent of mammary 
growth during lactation (Hurley et al., 2001).  There is considerable evidence that the 
mammary growth is enhanced by nursing (Farmer et al., 2012) and that mammary tissue 
of the lactating sows has substantial growth potential (Kim et al., 2000).  
AUTOCRINE AND PARACRINE REGULATION OF MAMMARY GROWTH 
Autocrine and paracrine factors (local growth factors) play a major role in 
growth of the mammary glands. Many effects of steroid hormones on growth of the 
mammary gland are mediated by local growth factors and those effects include an 
interaction between the developing mammary gland epithelial structures and the 
mammary fat pad. Mammary epithelial cells will only grow and organize when 
transplanted into the fat pad. The interaction may involve specific fatty acids from the fat 
pad which induce changes in proliferation and differentiation of epithelial cells (Hovey 
et al., 1999).  
Stromal cells in the region of the terminal end buds (TEB) or terminal ductule 
lobular unit (TDLU) of mammary glands may be involved in dissolving collagen so that 
structures can expand. The enlarging ducts may promote mesenchymal growth and 
angiogenesis. Epithelial cells in the TDLU and developing ducts are probably interacting 
with each other to induce synthesis and assembly of the basement membrane (Talhouk et 
al., 1993; Akers, 2002).  
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Besides IGF-1, as noted previously, a number of other growth factors have 
positive or negative effects on mammary gland development. Local production of 
transforming growth factor-ß (TGFB) inhibits mammary growth, such as during the 
prepubertal period and between estrous cycles. Epidermal growth factor (EGF) and 
TGF-alpha (TGFA) produced in the mammary tissue stimulate mammary cell 
proliferation. Both EGF and TGFA bind to EGF receptors. The mammogenic action of 
estrogen and progesterone occurs in part by decreasing local production of the inhibitory 
TGFB, while increasing local production of TGFA and increasing EGF receptors in the 
epithelial cells. EGF receptors in stromal cells also are necessary for normal ductal 
growth (Plath-Gabler et al., 2001).  
Other growth factors produced by stromal cells are known epithelial cell 
mitogens and may be involved in mediating effects of mammogenic hormones. These 
include hepatocyte growth factor (HGF), and members of the fibroblast growth factor 
(FGF) family such as acidic FGF and FGF7. Basic-FGF is also an epithelial cell 
mitogen, although the origin of this growth factor in mammary tissue is uncertain 
(Akers, 2002).  
Fatty acids, particularly unsaturated fatty acids, stimulate growth of mammary 
epithelial cells and enhance in vitro effects of other growth factors such as IGF-I and 
EGF. Mammary stromal cells also are involved in dissolving collagen so that the 
epithelial structures can continue to grow. Several proteases are involved in tissue 
remodeling and growth of parenchymal tissue derived from stromal tissue. Extracellular 
matrix components (e.g. proteoglycans, hyaluronan, fibronectin, laminin and so forth), 
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which are important for mammary tissue growth and function, are produced by both 
epithelial cells and stromal cells (Neville et al., 1998).  
LACTATION IN MAMMALS 
Lactation is a critical component of the reproductive strategy of mammals and 
the physiology of lactation is intimately intertwined with the physiology of reproductive 
processes. Lactation is defined as the combined processes of milk secretion and milk 
removal. Milk secretion is the synthesis of milk by epithelial cells and passage of that 
milk from the epithelial cell into the lumen of the alveoli of the mammary gland. Milk 
removal is the passive removal from the cisterns and the ejection of milk from the lumen 
of the alveoli lumen (Akers, 2002). 
Cycles of lactation 
Mammals reproduce more than once, and therefore, lactate more than once. The 
mammary gland is one of the relatively few structures of the body which undergoes 
repeated cycles of structural development, functional differentiation, and regression 
(Mepham, 1983).   The cycle includes the following events: 
(1) the mammary gland undergoes mammogenesis, the most dramatic change in the 
structural development of the mammary gland that occurs during pregnancy; (2) milk 
synthesis and secretion begin after parturition (lactogenesis) and begins   with  synthesis 
and secretion of colostrum and then lactation lasting  for weeks or months; (3) 
maintenance of milk secretion (galactopoiesis) until the young no longer need milk or 
milk is no longer removed from the gland; and (4) involution of the mammary gland  
  26 
following cessation of milk secretion and the cycle can start again with stimulatory 
effects of hormones of a new pregnancy and peri-parturient events. 
These phases of mammary development are at the heart of lactation biology 
(Akers, 2002). In essence, they include onset, maintenance and termination of lactation.  
These physiological processes are described in the following sections. 
Onset of lactation 
The onset of lactation can be divided into two stages: Stage 1 and Stage 2 
lactogenesis. In pigs, Stage 1 lactogenesis occurs between d 90 and d 105 of pregnancy, 
and Stage 2 lactogenesis is between d 112 of pregnancy and early lactation which is 
concomitant with copious secretion of milk. By d 4 of lactation, mammary epithelial 
cells are fully differentiated (Kensinger et al., 1986).  
Lactogenesis consists of a series of events in the differentiation process whereby 
cells are converted from a nonsecretory to a secretory state. Stage 1 consists of cytologic 
and enzymatic differentiation of alveolar cells and coincides with limited milk secretion 
before parturition. The prelactating alveolar epithelial cells have an irregular shaped 
nucleus, minimal RER, a small inconspicuous Golgi, few microvilli at the apical surface, 
few mitochondria, and perhaps 1 or 2 fat droplets. Immediately before and during 
parturition, there is dramatic hypertrophy of the RER, hypertrophy of the Golgi, 
appearance of large vesicles containing casein micelles, release of granular material 
(casein micelles) into the lumen, an increase in the number of cytoplasmic fat droplets 
and their release into the lumen, an increase in the number of microvilli at the apical cell 
membrane, and an increase in the number of mitochondria per cell. Cell polarity 
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becomes evident: the RER is primarily on the basal half of the cell, the nucleus is shifted 
to the basal portion of the cell, and the Golgi is apical to the nucleus (Kensinger et al., 
1986).  
Enzymatic changes include increased synthesis of acetyl CoA carboxylase, fatty 
acid synthetase, and other enzymes associated with lactation, as well as increases in the 
activities of transport systems for amino acids, glucose, and other substrates for milk 
synthesis. Synthesis of Alpha-lactalbumin, and therefore, lactose, does not begin until 
Stage 2 of lactogenesis. The mammary glands enter Stage 1 lactogenesis days or weeks 
(e.g., five weeks in pigs) prior to farrowing. This stage may be detected by measureable 
amounts of colostral proteins in plasma of blood. Colostrum production takes place 
during Stage 1 lactogenesis, whereas milk is not produced at that time because of high 
levels of progesterone in the plasma which inhibits lactation (Akers, 2002).  
At farrowing, concentrations of progesterone in plasma decrease rapidly which 
relieves inhibition of milk synthesis, while increasing concentrations of prolactin in the 
plasma stimulate synthesis of milk components (e.g. Alpha-lactalbumin and lactose) and 
growth of the mammary gland (Hurley et al., 1991; Hartmann et al., 1984a). These 
changes are probably the main driving forces for the mammary gland entering Stage 2 
lactogenesis characterized by the initiation of copious milk production, which begins 0 
to 4 days before parturition and extends through a few days postpartum in swine. Other 
hormones such as estrogen, oxytocin and relaxin are also involved (Ford et al., 2003). 
Suckling of the mammary gland by piglets is an additional factor in initiating the onset 
of Stage 2 lactogenesis. This is different than other species such as cows and humans 
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where milk production is initiated irrespective to whether the glands are being suckled or 
not (Hartmann et al., 1984b).  
Maintenance of lactation 
In Stage 2 lactogenesis, milk removal is necessary to maintain milk production 
by individual mammary glands. If milk removal ceases, such as when a piglet dies, that 
mammary gland undergoes rapid involution. Involution is induced if milk stasis occurs 
for an extended period of time, often less than one day. Milk production cannot be 
restored in individual glands after the involution process reaches a “point of no return” 
after 40-60 h of milk stasis (Theil et al., 2005).  
However, during the next reproductive cycle, all glands start to re-develop and 
they will again produce milk if suckled after parturition. Development of mammary 
glands and their synthesis of milk are regulated at the gland level by interactions 
between systemic factors (e.g., circulating hormones and nutrients) and local factors 
(e.g., hormone receptors in the membranes of mammary epithelial cells). Immediately 
after milk removal, systemic factors, of which prolactin is the most important, are 
responsible for stimulating milk production and the rate of milk synthesis is high during 
the first 30-35 min after a suckling bout. As filling of the gland progresses, the rate of 
synthesis of milk is inhibited by local factors (e.g. hormone receptors and transcription 
factors) controlled by milk stasis (Kim et al., 2001).   
When the mammary gland is emptied once again at the next suckling, the 
inhibition of milk synthesis due to milk stasis is relieved and milk synthesis resumes at 
the maximum rate (Hurley, 2001). A lactogenic complex consisting of insulin, 
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glucocorticoids and prolactin is responsible for maintenance of lactation in many 
species. In pigs, in contrast to the onset of lactation, maintenance of lactation seems to 
be dependent on piglet suckling and prolactin (Lucy, 2008).  Suckling by piglets induces 
release of prolactin from lactotrophs in the anterior pituitary gland into the blood, and 
upon binding to receptors in the mammary glands, prolactin elicits signals to stimulate 
milk production and mammary tissue growth (Akers, 2002).  
The importance of prolactin for milk production by sows was elucidated by 
Farmer et al (2009).  When sows were given bromocriptine to inhibit prolactin release, 
there was a marked reduction in milk yield, whereas milk production increased again 
when the bromocriptine treatment ceased. However, prolactin is normally not the 
limiting factor for milk production, and improvements in milk yield of sows using 
exogenous prolactin treatment has been attempted without success. No other hormones 
are known to be involved directly in maintaining lactation (Hurley, 2001). The hormone 
oxytocin is clearly necessary for milk letdown, but there is no knowledge of its direct 
role in maintaining milk synthesis (Akers, 2002). In contrast, growth hormone has a well 
described lactogenic effect in dairy cows, but administration of porcine growth hormone 
to lactating sows did not influence milk yield or maintenance of lactation (Lucy, 2008). 
Termination of lactation 
Mammary glands begin to involute rapidly if not suckled. This occurs in early 
lactation for mammary glands not suckled after piglets develop a teat preference or 
anytime throughout lactation if a piglet dies and the associated mammary gland is not 
suckled (Accorsi et al., 2002). Involution of the mammary gland occurs immediately 
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follows weaning and is characterized by apoptosis or loss of the alveolar epithelial cells 
and proteolytic degradation (Accorsi et al., 2002).  
Rates of epithelial cell apoptosis vary with species (Akers, 2002). Apoptosis, 
usually caused by DNA fragmentation, is thought to be correlated with decreases in 
circulating concentrations of prolactin, GH1, and IGF1 (Accorsi et al., 2002). There is 
no fundamental difference between involution of individual mammary glands during 
lactation or after weaning (Kim et al., 2001). If milk stasis remains in one or more glands 
for one-half day, expression of prolactin receptors in the mammary gland decrease, 
thereby uncoupling the stimulatory effects of prolactin on milk synthesis (Theil et al., 
2006).  Furthermore, milk stasis induces a mechanism that leads to programmed cell 
death or apoptosis. Once started, apoptosis has severe consequences on the mammary 
gland. If milk stasis is relieved after 24 h, milk yield is reduced by approximately 25% 
throughout the remaining period of lactation. If milk stasis is not relieved within 50-60 
h, the gland will become totally involuted and unfunctional (Theil et al., 2006). 
SIGNIFICANCE OF MOTHER'S MILK TO NEONATES 
Mammals have a highly developed brain and complex body systems. It usually 
takes a prolonged period of time for mammalian neonates to fully develop 
physiologically and anatomically. This developmental process occurs in utero during 
gestation and after birth. Prior to birth, the fetus is nurtured in a sterile, protected, moist, 
and warm environment of the uterus. The fetus is provided with all necessary nutrients 
and oxygen required for growth and development. At birth, the neonate is suddenly  
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exposed to an environment with many potentially adverse situations, and it also 
experiences a dramatic switch from primarily parenteral nutrition to exclusively enteral 
nutrition. This is associated with rapid changes in nutrient metabolism (Mepham, 1983). 
Because a newborn mammal has an underdeveloped ability to digest solid foods, it is 
greatly dependent on the mother’s liquid milk for nutritional support (Akers, 2002).  
Milk (colostrum or mature milk) contains water, lactose, fat, proteins, minerals, 
and vitamins (Noblet and Ettiene, 1989). Milk composition varies among species, strains 
or breeds within a species, stage of lactation, and different milking intervals (Table A-1).  
Colostrum is the first secretion from the mammary gland immediately and within a few 
days after parturition. Colostrum is characterized by high concentrations of 
immunoglobulins necessary for conferring passive immunity in support of the 
underdeveloped immune system of the newborn (Klobasa et al., 1987). In addition, milk 
is the only source of water, organic nutrients, and minerals for the suckling newborn and 
it has a high energy value to meet needs of the neonate. Besides immunoglobulins, 
colostrum and mature milk also contain nonnutrient substances (e.g., osteopontin, 
insulin-like growth factor I, and other bioactive factors) that are crucial for growth, 
development, health, and survival of the neonate (Klaver et al., 1981). Thus, milk is of 
supreme importance to survival, proper development, and dynamic growth of the 
neonate (Fox and McSweeney, 1998).  
Lactation is an integral component of the highly successful reproductive strategy 
of mammalian species. Mammals reproduce multiple times in their lives. This means 
that the requirement to provide the newborn offspring with nutrients occurs repetitively. 
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A mammary gland that lactates continually is not energetically favorable, whereas a 
mammary gland that develops and functions in concert with the reproductive cycle of the 
animal is much more efficient. In fact, development of the mammary gland is closely 
linked to the reproductive cycle of all mammalian species (Mepham, 1983; Manjarin et 
al., 2014). 
PROTECTIVE FACTORS IN MOTHER’S MILK 
Analyses of the composition of milk revealed a variety of protective factors 
including antimicrobial lipids and proteins in milk. Most of the protective factors are not 
specifically produced by the mammary gland itself, but instead they are directly taken up 
from the mother’s blood and transferred into milk. These proteins include lactoferrin 
which binds iron to prevent growth of microorganisms, lysozyme that hydrolyzes 
bacterial cell walls, lactoperoxidase which oxidizes bacterial components, and secretory 
immunoglobulins, IgA and IgM, in colostrum. These secretory factors are effectively 
involved in protecting the gastrointestinal tract from damage induced by environmental 
insults.  The levels and activities of these factors are species specific. For instance, 
bovine milk contains low levels of taurine, lactoferrin, lysozyme, and IgA, but high 
levels of lactoperoxidase. In contrast, human milk has higher levels of taurine, 
lactoferrin, lysozymes, IgA, and antimicrobial activity, but lower amounts of 
lactoperoxidase than bovine milk (Akers, 2002). 
MACRONUTRIENTS IN MILK AND THEIR CHARACTERISTICS 
As noted previously, milk is a complex mixture of a wide range of compounds 
important to the neonate.  This nutritious food is an emulsion of fat globules and a 
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suspension of casein micelles (casein, calcium, and phosphorous) in an aqueous phase 
that contains solubilized lactose, whey proteins, and minerals. The mother’s blood is the 
sources of all nutrients needed for milk synthesis by epithelial cells of the mammary 
gland. Specifically, the precursors of milk components leave the blood and enter the 
extracellular fluid among capillaries and epithelial cells.  These substances are taken up 
from the extracellular fluid through the basolateral membrane of the epithelial cell. Once 
inside the cell, they enter the appropriate synthetic pathways. In addition, some pre-
formed proteins (e.g., immunoglobulins) and amino acids (e.g., BCAA and taurine), are 
transported intact across the mammary epithelial cells and incorporated into milk 
(Mepham, 1983).  
Synthesis of proteins  
Amino acids are absorbed through the basal membrane of mammary epithelial 
cells by specific amino acid transport systems. Once inside the cell, amino acids are 
covalently bound together to form proteins in the poly-ribosomes on the rough 
endoplasmic reticulum (RER). Proteins that are synthesized at the RER are either 
secreted proteins (e.g., casein, Beta-lactoglobulin, and Alpha-lactalbumin), membrane-
bound proteins (e.g., extra-cellular matrix proteins involved in cell-cell contacts and 
membrane-bound enzymes), or intracellular proteins. Newly synthesized proteins are 
transferred from the RER to the Golgi apparatus where they are processed for transport 
out of the cell. Casein is secreted as a micelle, which is formed in the Golgi from casein, 
calcium and phosphorous. Caseins and other proteins undergo post-translational 
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processing in the Golgi. Proteins that remain in the cell include cellular enzymes, 
structural proteins (e.g., keratin), and fatty acid-binding proteins (Akers, 2002). 
Milk proteins and lactose are transported to the apical area of the cell via 
secretory vesicles that bud off of the Golgi. These secretory vesicles are bounded by a 
lipid bilayer membrane and make their way to the apical membrane via a mechanism 
involving microtubules made of polymerized tubulin. Tubulin is one of several 
cytoskeletal proteins which form the cellular scaffolding, providing the cell with 
structure.  Keratin is another cytoskeletal protein. The secretory vesicles do not transfer 
to the basolateral membrane if the epithelial cell is polarized. The apical membrane of 
the epithelial cell and the membrane of the secretory vesicle fuse resulting in an opening 
through which the vesicle contents are discharged into the lumen of the alveoli 
(Mepham, 1983). 
Synthesis of lactose 
Glucose enters the cell through the basolateral membrane via a specific transport 
mechanism (predominantly via GLUT1). Some glucose is converted to galactose. Both 
glucose and galactose enter the Golgi to form lactose via a series of enzyme-catalyzed 
reactions. The formation of lactose in the Golgi results in drawing water into the 
cytoplasm and then into the Golgi where it ultimately becomes a component of milk. 
The Golgi apparatus is involved in processing of milk proteins, synthesis of lactose, and 
osmotic gradients for transport of water and, therefore, very important in the synthesis of 
milk components. Lactose and much of the associated water in milk is released from 
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secretory vesicles along with the milk proteins into the lumen of the alveoli (Mepham, 
1983). 
Synthesis of fat 
Precursors for synthesis of milk fats, including acetate, ß-hydroxybutyrate, 
preformed fatty acids, glycerol, and monoacylglycerides, are taken up by mammary 
epithelial cells at the basolateral membrane. The ketone bodies are important precursors 
of fatty acid synthesis in epithelial cells of the mammary gland in ruminants. All of those 
components enter the pathway for synthesis of triglycerides in the smooth endoplasmic 
reticulum (SER), leading to the formation of small lipid droplets. Numerous small lipid 
droplets fuse to yield larger droplets, which move toward the apical membrane. At the 
apical membrane, the large lipid droplet is exported out of the mammary epithelial cell 
through its apical membrane into the lumen of alveoli and duct system of the mammary 
gland (Mather and Keenan, 1998).  
TRANSPORT OF MILK COMPONENTS NOT SYNTHESIZED IN MAMMARY 
EPITHELIAL CELLS 
A number of components in maternal plasma are transported across the 
mammary epithelial cell into the duct system essentially unchanged. These substances 
include immunoglobulins which bind to specific receptors on the basolateral surface of 
the cells and are taken "into" the cell through the apical side of the cell via endocytic 
vesicles (or transport vesicles). In this process, the membrane of the transport vesicles 
fuses with the inner surface of the apical membrane of the cell and releases the 
immunoglobulin into the lumen of the alveolus. As the transport vesicles traverse the 
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cell, they do not seem to interact with the Golgi, secretory vesicles, or lipid droplets. 
Serum albumin may be transported across the mammary epithelial cells by this 
mechanism. Because there is no serum albumin receptor, serum albumin molecules are 
probably internalized into the cell along with the immunoglobulins in transport vesicles 
(Mepham, 1987). 
Paracellular pathway for nutrient transport 
Because of the tight junctions between epithelial cells, there is little or no flow of 
macromolecules between the cells, except perhaps water and ions. Passing of substances 
between the cells through the tight junction is known as paracellular transport. When the 
gland is inflamed, such as during mastitis or involution, or when oxytocin is causing 
milk ejection, the tight junctions open to allow lactose and potassium to move from the 
lumen into the extracellular space and for sodium and chlorine to move into the lumen 
from the extracellular space. This results in a change in electrical conductivity by the 
mammary epithelial cell, as well as increases concentrations of lactose and other milk-
specific components in blood. For instance, lactose can be measured in the urine of a 
cow during the periparturient period. Milk proteins can be detected in the cow's blood 
during lactation and early involution (Akers, 2002). 
Other components that can enter the lumen without passing through the epithelial 
cells include leukocytes. The leukocytes comprise the vast majority of somatic cells in 
milk. These cells pass between the epithelial cells via the paracellular pathway to enter 
the lumen of alveoli of the mammary gland (Akers, 2002). Sodium, potassium and 
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located on the basal and lateral membranes, but not the apical membranes, of mammary 
secretory cells. Ca
++
 is also actively transported but the mechanism is still poorly 
understood. Other macronutrients such as Iron, Zink, Cupper, Selenium, Iodine, 
Fluoride, Manganese and so forth are also actively transported to cells via their 
respective transporters on mammary epithelial cell membranes (Shennan and Peaker, 
2000).  
MAJOR MILK PROTEINS 
All of the major milk proteins (except serum albumin and immunoglobulins) are 
synthesized and secreted by epithelial cells in the mammary gland from amino acids. 
The amino acids required for protein synthesis are either taken up from the blood 
(Klobasa et al., 1987) or synthesized from numerous precursors in mammary epithelial 
cells (Kim and Wu, 2009). 
Caseins 
Caseins are present in milk in the form of a micelle. The phosphate groups 
covalently bound to the casein molecules bind calcium via ionic bonds. After caseins are 
phosphorylated, Ca
2+
 binds the phosphate to initiate polymerization of the micelle 
particles. This structure is essential for micelle formation. The casein micelle (140 
nanometers in diameter) functions as a source of nutrients for the neonate, supplying 
amino acids, calcium and phosphate. They are composed of alpha, beta, gamma, and 
kappa caseins. Alpha-caseins are in multi phosphorylated forms (s2, s3, s4, s5, and s6). 
Beta-casein is the major casein in the sow’s milk. Kappa-casein (a glycoprotein) is 
distributed throughout the casein micelle and acts to stabilize the micelle. Gamma-
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caseins are C-terminal fragments of ß-casein which are released after proteolytic 
degradation by plasmin when this milk is within the alveoli of the mammary gland. 
Destabilization of the casein micelle by proteases is part of the mechanism involved in 
digestion of milk proteins in the stomach and intestine of neonates (Mather, 2000). 
Major whey proteins 
Beta-lactoglobulin  
This protein comprises of approximately 50 % of the total whey proteins in milk 
and it is the major whey protein in milk from ruminants and pigs.  Beta-lactoglobulin is 
not found in the milk of many species. The function of Beta-Lactoglobulin is unknown, 
but it may be a fatty acid or lipid binding protein. Beta-lactoglobulin does have sequence 
similarities to retinol-binding proteins. Generally, Beta-Lactoglobulin is found in the 
milk of species which transport high levels of immunoglobulins during colostrum 
formation; however, the specific relationship between the presence of Beta-
Lactoglobulin and immunoglobulin transport remains unclear (Mather, 2000). 
Alpha-lactoglobulin  
This protein accounts for about 25 % of the total whey proteins in milk. It is the 
B protein of the lactose synthase enzyme complex. Therefore, Alpha-lactoglobulin plays 
a role in the control of milk production and secretion. Alpha-lactoglobulin may have 




) to affect the integrity of milk fat 
membranes (Mather, 2000). 
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Minor whey proteins 
Serum albumin  
Serum albumin in milk is derived from maternal serum and is not synthesized in 
the mammary gland. There are suggestions that this protein enters the milk via the 
paracellular pathway, or taken up along with other components such as 
immunoglobulins. There does not seem to be a specific mechanism for transport of 
serum albumin. Increases in the concentration of serum albumin in milk occur especially 
during mastitis and during involution of the mammary gland. The function of serum 
albumin in milk is unknown, but this protein can bind to fatty acids and some small 
molecules (Mepham, 1987). 
Immunoglobulins (Ig)  
These proteins include IgG1, IgG2, IgA, and IgM. Immunoglobulins are present 
in very high concentrations in colostrum, but in much lower concentrations in milk. 
Immunoglobulins provide passive immunity to offspring by being transported from the 
mother’s colostrum to the general circulation of the neonate.  They also serve as part of 
the immune system of the mammary gland. Secretory component (SC) is the part of the 
IgA receptor which is hydrolyzed by a protease, and remains attached to IgA during the 
process of secretion from the cell (Mepham, 1987). 
Other milk proteins 
Lactoferrin (LF) 
Lactoferin is an iron-binding protein with antibacterial properties. LF is present 
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at relatively low concentrations in milk from cows during lactation, but at relatively high 
concentrations when cows experience mastitis or involution of the mammary gland. 
Lactoferrin may also be an immunomodulatory protein, as it is the major nonspecific 
disease resistance factor found in the mammary gland (Meisel, 1997).  
Lactoperoxidase  
Lactoperoxidase is a member of the heme peroxidase family of enzymes that 
break down hydrogen peroxide into water. This protein also has antibacterial and anti-
oxidant properties (Meisel, 1997).  
Lysozyme  
Lysozyme is an enzyme that cleaves the carbohydrate polymers of the bacterial 
cell wall to act as a bactericidal protein. This enzyme has a high activity in the human 
milk and possibly horse milk, but its activity is low in cow’s milk (Mepham, 1987). 
Beta2-microglobulin  
Beta2-Microglobulin was initially discovered as a crystalline precipitate in 
resuspended casein and was first called lactolin. It is part of major histocompatability 
complex II (MHC II). While the function of Beta2-microglobulin in milk is not known, 
this protein is present in the epithelial cell in association with a protein that binds 
immunoglobulin G. Beta 2-microglobulin may be involved in function of the IgG 
receptor or in transport of IgG during colostrum formation (Meisel, 1997). 
Milk has numerous other enzymes, including proteases, protease activators, 
nucleases, glycosidases, and D-amino acid oxidases (Klobasa et al., 1987). They can 
degrade proteins, amino acids, carbohydrates, and nucleotides present in milk.  
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MILK PROTEIN SYNTHESIS AND THE ROLE OF mTOR 
The major role of mechanistic target of rapamycin (mTOR), particularly 
mTORC1, in the regulation of protein synthesis in animal cells has been well defined 
(Wang and Proud, 2006). Protein synthesis is inhibited by the association of the 
nonphosphorylated eukaryotic translation initiation factor 4E binding protein 1 (4EBP1) 
with the eukaryotic translation initiation factor 4E (eIF4E), preventing the formation of 
the translation initiation complex. Insulin increases phosphorylation of mTOR, which in 
turn phosphorylates 4EBP1 at multiple sites and subsequently causes the release of 
eIF4E from the 4EBP1-eIF4E complex. Once released from this complex, eIF4E forms 
the active translation initiation complex with other translation initiation factors. The 
complete translation initiation complex then binds the 40S ribosomal subunit, generating 
the 43S pre-initiation complex which initiates translation of mRNA into protein 
(Kimball and Jefferson, 2006).  
The activated mTOR complex enhances mRNA translation by additional 
mechanisms: (1) increased activation of the 40S ribosomal subunit through 
phosphorylation of the ribosomal protein S6 kinase (S6K1); (2) phosphorylation of the 
eukaryotic elongation factor-2 kinase (EEF2K); and (3) enhanced ATP production 
(Kimball and Jefferson, 2006).  Specifically, activated mTOR phosphorylates ribosomal 
protein S6 (RPS6, a component of the 40S ribosomal subunit), resulting in the initiation 
of polypeptide synthesis. Because active, non-phosphorylated EEF2K inhibits translation 
by hindering the activity of the elongation factor 2 (eEF2), inhibition of EEF2K by 
mTOR frees eEF2, thereby increasing mRNA translation. Moreover, activation of 
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mTOR stimulates expression of glucose transporter 1 and amino acid transporters in 
epithelial cells of the mammary gland (Schieke et al., 2006). These nutrients can be used 
for mitochondrial ATP synthesis, which drives the translation processes (Proud, 2007).  
The mTOR complex is activated by certain amino acids, particularly leucine (a 
branched-chain AA) (Wu, 2010).  Additionally, leucine enhances overall protein 
synthesis by serving as a precursor for the synthesis of glutamate, glutamine, aspartate, 
asparagine, and protein (Lei et al. 2012).  
The activation of transcription for milk protein synthesis by Jak2-Stat5 cell 
signaling has also been reported where binding of prolactin and insulin to their receptors 
induces the phosphorylation of STAT5. Upon phosphorylation, STAT5 dimers 
translocate to the nucleus and induce transcription of several genes, including ELF5 and 
genes coding for milk proteins. ELF5 protein enhances the activity of STAT5, thereby 
increasing transcription of genes encoding milk proteins (Rosen, 1999).   
AMINO ACID METABOLISM IN THE MAMMARY GLAND AND THEIR 
ROLES IN LACTATION 
Amino acid utilization by mammary tissue is greatly affected by: a) 
concentrations of amino acids in plasma; b) mechanisms of amino acid uptake into 
mammary cells;, and c) intracellular metabolism of the amino acid. Each of these control 
systems is further influenced by a variety of factors. Concentrations of amino acids in 
plasma are affected by diet and physiological state of the animal. There are multiple 
mechanisms responsible for amino acid transport by mammary epithelial cells. In 
addition, intracellular metabolism of amino acids involves many competing biochemical 
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pathways. Thus, uptake and intracellular metabolism of amino acids by the mammary 
gland are more complex than simply being incorporated into milk proteins (Oddy et al., 
1988).  For example, uptake of “nutritionally nonessential amino acids” varies 
considerably with stage of lactation, generally exhibiting a deficit in uptake relative to 
their amounts in milk proteins. Some “nutritionally essential amino acids” are taken up 
stoichiometrically (e.g., Lys, Met, Phe, Tyr, and Trp) in relation to milk protein output, 
while others, including BCAA and arginine, are taken up by the mammary gland in 
amounts greater than rates of milk protein production (Trottier et al., 1997). Some of 
these amino acids are extensively used by the mammary tissue either as a potential 
energy source or as a source of carbon and nitrogen for synthesis of other nonessential 
amino acids, such as glutamine and glutamate (Wu, 2010).  
Amino acids are not only building blocks for protein, but they are also key 
regulators of metabolic pathways that are vital for whole body homeostasis (Jobgen et al. 
2006; Wu and Meininger 2000) as well as lactogenesis (Bequette et al., 1998).  In 
primiparous sows, limited food intake and decreased blood flow to lactating mammary 
glands lead to reduced provision of nutrients (including amino acids) to mammary 
tissues for their own growth and milk synthesis (Kim et al., 1999). Of note, arginine is 
the common substrate for the generation of nitric oxide (NO; a major vasodilator and 
angiogenic factor) and polyamines (key regulators of protein synthesis and lactogenesis) 
(Wu and Morris, 1998). Compelling evidence shows that endogenous synthesis of 
arginine alone cannot meet the need for maximal milk production by lactating sows and 
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arginine is also deficient in sow’s milk with respect to supporting maximum growth of 
suckling piglets (Mateo et al., 2008; Wu et al., 2004).  
  The BCAA are actively involved in regulation of cell-cycle progression, cell 
differentiation (Kimura and Ogihara, 2005), cell apoptosis (D’Anona et al., 2010), and 
milk protein synthesis (Toerien et al., 2010). Lactating sows have high requirements for 
BCAA to support milk production (Wu, 2009). The uptake of BCAA by porcine 
mammary glands (76 g/d on d 13–20 of lactation) is much greater than their output in 
milk protein (46 g/d) (Wu, 2010). Thus, the lactating porcine mammary gland 
catabolizes about 30 g BCAA/d (40% of the BCAA taken up from arterial plasma) (Lei 
et al., 2012). In contrast, sow’s milk contains high concentrations of free and peptide-
bound glutamine plus glutamate (Mateo et al., 2008), which are crucial for growth, 
development, and normal function of the neonatal small intestine (Kim and Wu, 2009). 
On d 10 of lactation, the lactating porcine mammary gland takes up 16 g/d glutamine 
from the arterial circulation (Trottier et al., 1997), but produces more than twice (36 g/d) 
that amount of glutamine in milk (Haynes et al., 2009). Therefore, extraction of 
glutamine by the lactating mammary gland is much less than its output in milk and a 
large amount of glutamine (20 g/d) must be synthesized by mammary tissue to support 
the production of milk proteins (Li et al., 2009). Mammary tissue does not contain 
pyrroline-5-carboxylate dehydrogenase or proline oxidase activity; therefore, it cannot 
convert arginine, ornithine, or proline into glutamate or glutamine (O’Quinn et al., 
2002). Instead, BCAA are utilized for glutamine synthesis in the lactating mammary 
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gland through BCAA transaminase and glutamine synthetase, asreported for skeletal 
muscle (Wu et al., 1989) and placentae (Self et al., 2004). 
Catabolism of BCAA in mammary tissue 
The overall pathway of BCAA catabolism in the lactating mammary gland of 
sows is depicted in Figure B-1. The catabolism of BCAA by the mammary gland and 
mammary epithelial cells is initiated by BCAA transaminase in the presence of α- 
ketoglutarate to form branched-chain Alpha-ketoacids (BCKA) and glutamate (Li et al., 
2009). Thus, concentrations of BCKA in milk may be relatively high, and milk-born 
BCKA may serve as energy substrates for the small intestine of suckling neonates. In 
support of this view, there is evidence that substantial amounts of BCKA are utilized by 
enterocytes of the small intestine (Wu, 2009) and the splanchnic bed of animals (Wu, 
1998).  The BCAA transaminase exists as mitochondrial and cytosolic isoforms. Both 
isoforms are expressed in mammary epithelial cells (Desantiago et al., 1998). BCAA 
transaminase is activated by octanoate, a medium-chain fatty acid.  
The BCAA-derived BCKA undergoes oxidative decarboxylation by the 
mitochondrial BCKA dehydrogenase complex (BCKAD). This enzyme complex 
consists of BCKA decarboxylase (E1 which requires thiamine pyrophosphate as a 
cofactor), dihydrolipoamide acyltransferase (E2 which requires lipoate and coenzyme A 
as cofactors), and dihydrolipoamide dehydrogenase [E3 which requires flavine adenine 
dinucleotide (FAD) and nicotinamide adenine dinucleotide (NAD) as cofactors] 
(Brosnan and Brosnan, 2006). The BCKAD E1 has two subunits: E1a and E1b. BCKAD 
is regulated by phosphorylation and dephosphorylation in cells. Protein levels for BCAT 
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and BCKAD E1α, as well as dephosphorylation of BCKAD E1α are enhanced by 
leucine. Increasing concentrations of leucine from 0.5 to 2 mM increased protein levels 
for mitochondrial BCAA transaminase and total BCKAD E1α by 39% and 42%, 
respectively, while decreasing the abundance of phosphorylated BCKAD E1α by 33% 
(Lei et al., 2012). As a result, the ratio of phosphorylated BCKAD E1α to total BCKAD 
E1α (PE1α/ total E1α value) is reduced by 51% (Lei et al., 2012). Lactation increases 
mammary tissue BCAT activity by a factor of ten and sustains the BCKAD complex in 
the fully activated state (Desantiago et al., 1998). For comparison, only 20% of BCKAD 
exists in an active state in mammary tissue of non-lactating cows (Brosnan and Brosnan, 
2006). Thus, the mammary gland is a quantitatively significant site for BCAA 
catabolism during lactation (Wu, 2009). 
The BCAA transaminase catalyzes the transamination of BCAA with α- 
ketoglutarate to form glutamate and BCKA in mammary epithelial cells. The BCAA-
derived glutamate is either amidated to form glutamine or transaminated with pyruvate 
(or oxaloacetate) to produce alanine (or aspartate) (Li et al., 2009). Rates of synthesis of 
alanine, aspartate, asparagine, glutamate, and glutamine from BCAA increase as the 
concentrations of leucine increase from 0 to 5 mM, with the values being the highest for 
glutamine, followed by glutamate, aspartate, alanine, and asparagine in descending order 
(Lei et al., 2012). Glutamine synthetase and phosphate-dependent glutaminase are the 
two key enzymes involved in glutamine synthesis and degradation, respectively in most 
animal cells (Wu et al., 2011). Interestingly, glutaminase activity is absent from tissues 
of the lactating mammary gland; therefore, the epithelial cells maximize production and 
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release of glutamine (Li et al., 2009). The de novo synthesis of glutamate and glutamine 
helps to explain the high abundance of these two amino acids in both free and peptide-
bound forms in milk (Wu and Knabe, 1994). Accordingly, BCAA likely play an 
important role in milk synthesis by mammary epithelial cells of lactating mammals (Lei 
et al., 2012). Approximately 30 g/d BCAA must be degraded to form 20 g/d glutamine 
in the mammary glands of lactating sows (Lei et al., 2012). 
DIETARY REQUIREMENTS OF AMINO ACIDS BY NEONATES 
Protein deposition in the body of neonates is affected by both the quality and the 
quantity of dietary protein. Relatively high intakes of protein and energy are required by 
young animals for supporting their rapid growth rates. The energy density of the diet 
could influence the voluntary feed intake of animals. To meet the requirement for 
energy, feed intake generally increases when dietary energy is low.  Similarly, when 
diets contain suboptimal levels of protein, food intake also increases to minimize 
deficiencies in amino acids.  These studies have been performed extensively with young 
pigs.  
The capacity of the gut of neonatal pigs limits their feed intake. Thus, piglets 
may not be able to consume sufficient amounts of a diet with low energy density to 
maintain their optimal growth rate. Many amino acids cannot be synthesized by piglets 
and must be provided in the diet. Therefore, an adequate supply of all amino acids must 
be taken into consideration when recommending requirements of dietary protein (Wu, 
2010). The composition of amino acids in milk and rates of milk consumption by 
suckling piglets can be used to estimate dietary requirements piglets weighing 1 to 5 kg. 
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Their maximum growth rates may be achieved by increasing dietary provisions of 
glutamine, glycine, arginine, and proline beyond that provided in milk (Wang et al. 
2013, 2014; Wu et al. 2014).  Current growth models cannot be used to accurately 
estimate energy or amino acid requirements for neonatal pigs (< 20 kg body weight) 
because there is not sufficient information on their energy or amino acid metabolism. 
Experimental data on optimal dietary requirements of other amino acids by neonatal pigs 
between birth and weaning are not available. Thus, NRC-recommended intakes of 
dietary amino acids for swine (NRC, 2012) may not be ideal for piglets. This is 
exemplified by the dietary requirements for arginine by young pigs (see discussion 
below). Rather, reductions in dietary lysine requirements for piglets between 5 and 20 kg 
body weight have been proposed based on results from biochemical and nutritional 
studies (Wu, 2014). Specifically, optimal amounts of dietary lysine (based on true ileal 
digestible amounts) are 1.19% and 1.01% for 5-10 and 10-20 kg pigs, respectively, 
which is consistent with a progressive decrease in the fractional rate of skeletal-muscle 
protein synthesis (Wu, 2013).  
Sow’s milk is thought to provide adequate amino acids for growth of neonatal 
pigs. However, the amount of milk produced by sows during lactation does not provide 
adequate amounts of all amino acids for maximum growth of piglets (Rezaei et al., 
2011). Hodge (1974) and Boyd et al. (1995) demonstrated that artificially reared 
neonatal pigs grow at a rate that is at least 50% greater than that of sow-reared piglets.  
Beginning at eight days of age, piglets exhibit sub-maximal growth, which may have 
resulted from inadequate intake of protein or energy from sow’s milk (Boyd et al., 
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1995). Furthermore, arginine is a nutritionally essential amino acid for maximum rates 
of growth of young mammals (Wu et al., 2004). There are low levels of arginine in 
sow’s milk (Wu and Knabe 1994); therefore, neonatal pigs must synthesize substantial 
amounts of arginine to achieve maximum growth rates. Compelling evidence shows that 
endogenous synthesis of arginine in young pigs is inadequate for their maximum growth. 
Recently, Wu (2014) proposed that an ideal, highly digestible diet for 5-10 and 10-20 kg 
piglets contain 1.19% and 1.01% arginine based on true digestible amounts in the ilium. 
Importance of glutamine, glutamate and aspartate in neonates  
Glutamine is used extensively in the rat small intestine (Windmueller and Spaeth, 
1974). Additionally, in vivo studies have shown that glutamate and aspartate are actively 
oxidized to CO2 via the Krebs cycle in the intestinal mucosa (Stoll et al., 1999; Wu et 
al., 1995). Based on these findings, dietary glutamine, glutamate and aspartate are now 
regarded as essential for the maintenance and function of the small intestine (Xi et al., 
2011).  
Dietary glutamate is a preferential substrate for glutathione (a major antioxidant) 
synthesis in the gut mucosa (Reeds et al., 1997), and glutamine serves as the nitrogen 
moiety for the syntheses of purines, pyrimidines, and amino sugars (e.g., N-
acetylglycosamine and N-acetylglactosamine) (Wu et al., 2011). Purines and 
pyrimidines are necessary for the synthesis of DNA, whereas amino sugars are required 
for the production of mucosal mucin and, therefore, the maintenance of intestinal-
mucosal integrity (Reeds and Burrin, 2001).  
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As noted previously, the catabolism of glutamine and glutamate in enterocytes is 
of supreme importance for the synthesis of ornithine, citrulline, and arginine in most of 
mammalian neonates, including human infants and young pigs (Wu, 2009). The 
endogenous synthesis of arginine from its precursors compensates for a marked 
deficiency of arginine in the milk of most species, including humans, cows, sheep, and 
pigs (Kim and Wu, 2004; Geng et al., 2011). Arginine stimulates protein synthesis in 
muscle, maintains an active hepatic urea cycle for ammonia detoxification, and regulates 
the uptake and utilization of nutrients by tissues (Wu et al., 2009).  
Physiological levels of glutamine enhance intestinal expression of genes that are 
related to: i) antioxidative responses (Wang et al., 2008); ii) proliferation and survival of 
mucosal cells (Weiss et al., 1999); c) expression of tight-junction proteins (Wang et al. 
2014) and mucosal integrity (Roads and Wu, 2009); and iii) prevention of inflammation 
and apoptosis (Roads and Wu, 2009). Glutamine can also modulate the transport of 
many nutrients (including amino acids, small peptides, fatty acids, glucose, vitamins and 
minerals) by enterocytes at transcriptional and translational levels (Wu, 2010). Also, 
through activation of the mechanistic target of rapamycin (mTOR) signaling pathway, 
glutamine stimulates protein synthesis and inhibits protein degradation in enterocytes, 
thereby promoting cell growth (Xi et al., 2011) and migration (Roads and Wu, 2009). 
Studies using the swine model demonstrate that milk-borne glutamine is insufficient for 
maximal growth of neonates (Haynes et al., 2009). Sow’s milk contains 4.3-10.8 g/L 
glutamine which increases as lactation advances. Based on milk consumption, piglets 
with a normal birth-weight obtain 2.9- 3.5 g/day glutamine from milk during the 
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suckling period (Lei et al., 2012). Due to extensive catabolism of glutamine in the small 
intestine, less than 36% of milk-derived glutamine (i.e., 1.14 g) is accreted in the body of 
the piglet. As a consequence, the rate of endogenous synthesis of glutamine in the 
suckling piglet is relatively high (≥ 0.88 g/kg body weight per day) to sustain maximum 
growth (Wu, 2009). Another milk-derived amino acid closely related to glutamine is 
glutamate, which can spare glutamine oxidation by the intestine (Wu et al., 1995) and 
maintain gut function (Rezaei et al., 2013).  
A suckling piglet can obtain 3.3-3.8 g/L glutamate from milk, but more than 95% 
of that amount is removed by the portal-drained viscera (Stoll et al., 1999). Thus, 
glutamate in milk is virtually not available for protein synthesis in extra-intestinal tissues 
(Lei et al., 2012). Although a young pig can obtain 6-7 g of glutamine plus glutamate 
from milk daily, oral administration of glutamine (1 g/kg body weight per day) can 
enhance daily weight gains and anti-inflammatory responses in the animal (Wu et al., 
2011). The beneficial effects of glutamate have also been reported for older pigs, as 
supplementation of up to 4% mono-sodium glutamate significantly increased growth in 
postweaning pigs (Rezaei et al., 2013). Therefore, it seems logical to provide lactating 
dams with an abundant supply of BCAA for the synthesis of glutamine and glutamate in 
mammary tissue which can be secreted in milk (Lei et al., 2012). These amino acids 
promote the growth, development and health of neonates (Wu, 2009).  
BCAA AND LACTATION 
Effects of BCAA on growth and proliferation of mammary epithelial cells 
BCAA modulates cell metabolism through the synthesis of macromolecules 
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(DNA and protein), that regulate growth and proliferation of a variety of cell types, 
including pancreatic cells (Xu et al., 1998), hepatocytes (Kimura and Ogihara, 2005), 
fibroblasts (Gonçalves and Marcondes, 2010), embryonic kidney cells (Kim et al., 
2002), and mammary epithelial cells (Kim et al., 2009). This indicates that BCAA are 
not only building blocks for synthesis of proteins, but also nutrient signals that regulate 
mechanism affecting cell proliferation including the cell cycle, DNA synthesis, and 
protein synthesis (Lei et al., 2012).  
The cell cycle consists of interphase and mitosis phases with a series of 
sequential rapid and highly complex events leading to cell growth and division. During 
the interphase step of the cell cycle, the synthesis of cellular macromolecules, 
particularly proteins, is the primary event that initiates the cell cycle (Fingar et al., 2002, 
2004). Based on the stage of cell division, the interphase is divided into three sequential 
phases [Gap 1 (G1), DNA synthesis (S), and Gap 2 (G2)] and is the longest period of the 
cell cycle compared with the mitotic (M) phase. During the three phases of interphase, 
the cell grows by synthesizing proteins and cytoplasmic organelles and duplication of its 
chromosomes during S and G2 phases, followed by cell mitosis (Blow and Tanaka, 
2005). At the M stage of the cell cycle, nuclear and cytoplasmic division occurs. Thus, 
an increase in cell size through synthesis of macromolecules (particularly protein) is 
necessary for cell division. At the end of each cell cycle, two daughter cells are produced 
by mitosis. The process of cell differentiation, which is critically influenced by 
intracellular levels of polyamines, requires activation of the necessary biochemical 
machinery (Wu et al., 2011; Wu et al., 2010).  
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During lactation, extensive constitutive proteins are synthesized by cells of the 
mammary gland that account for 40 to 70% of total mammary protein synthesis that 
includes synthesis of constitutive tissue proteins and milk proteins) (Bequette et al., 
1998). In lactating sows, the synthetic rate for mammary constitutive proteins increases 
to a peak level on Day 14 of lactation (7.8 g/kg wet tissue/day), and then decreases to 2.7 
g/kg wet tissue/day on Day 21 and to 0.5 g/kg wet tissue/day on Day 28 of lactation 
(Bequette et al., 1998). Consistent with protein synthesis, the net rate of DNA synthesis 
changes in a similar manner during lactation (Kim et al., 1999). Interestingly, the highest 
rate of milk production by sows occurs around Day 14 of lactation, as estimated by the 
weigh-suckle-weigh (Rezaei et al., 2011) and deuterium oxide dilution (Thodberg and 
Sørensen, 2006) methods. It is likely that the synthesis of constitutive proteins in 
mammary tissue is proportionally correlated with the number of functional mammary 
epithelial cells, which is a consequence of cell proliferation. As mentioned earlier, the 
physiological process of increased proliferation of epithelia cells of the mammary gland 
can be up-regulated by BCAA (Kim et al., 2009) although the underlying mechanisms 
remain unknown. 
Effects of BCAA on the functional differentiation of mammary epithelial cells 
Mature secretory cells must possess the proper biochemical pathways for 
synthesis and secretion of milk (Kim and Wu, 2009; Kim et al., 2009). These metabolic 
pathways develop during the process of cell differentiation and have important 
implications for epigenetic regulation of lactogenesis (Wang et al., 2012). The mTOR 
cell signaling pathway plays an important role in regulation of cellular differentiation in 
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response to certain nutrients, including BCAA (Jankiewicz et al., 2006). Branched-chain 
amino acids, especially leucine and its metabolites, stimulate secretion of insulin by 
pancreatic β- cells (Li et al., 2007) partly through phosphorylation of molecules 
downstream of mTOR, particularly p70 S6K and 4E-BP1. Results from both in vitro and 
in vivo studies show that unlike differentiating mammary epithelial cells, 
undifferentiated and predifferentiated cells have low levels of phosphorylated mTOR. 
Also, treatment with rapamycin abrogates development of mammary alveoli, β-casein 
secretion and olume of the mammary gland (Jankiewicz et al., 2006).  Further, mTOR-
mediated expression of the Id2 protein (inhibitor of DNA-binding protein) is a 
prerequisite for cell differentiation (Jankiewicz et al., 2006). These results indicate that 
mTOR is necessary for functional differentiation of mammary secretory cells and normal 
development of the mammary gland. Such a mechanism explains the stimulatory effects 
of BCAA on protein synthesis and secretion by mammary epithelial cells (Lei et al., 
2012). 
Effects of BCAA on the longevity of mammary epithelial cells 
Mammary involution is a dramatic cellular remodeling process associated with 
cell aging and apoptosis (Appuhamy et al., 2012). An increase in mitochondrial 
biogenesis occurs in response to the onset of lactation to meet the need for ATP in 
biosynthetic pathways. For example, in lactating mice, the density of mitochondrial 
inner membranes in mammary epithelial cells increases 7-fold and the activity of 
mammary cytochrome C oxidase increases 4- to 5-fold (Rosano et al., 1976). These 
results demonstrate increases in the number and activity of mitochondria in the 
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mammary gland during lactation. However, increased rates of mitochondrial respiration 
are required for the mammary gland to support ATP provision, but high metabolic needs 
can be deleterious because endogenous free radicals are also produced concurrently to 
adversely affect normal cellular functions (Dai et al. 2013). More specifically, 
accumulation of free-radical results in oxidative damage of cellular lipids, proteins and 
DNA, which further leads to cell aging and impaired synthetic capacity of the mammary 
epithelial cells (Appuhamy et al., 2012). Thus, controlling mitochondrial respiration and 
optimizing the defense system against generation of reactive oxygen species are crucial 
for prolonging mammary cell survival and milk production. Through activating the 
mTOR signaling pathway to promote the synthesis of anti-oxidative proteins, BCAA 
may beneficially increase the life span of mammary epithelial cells. The anti-aging role 
of BCAA is associated with the enhanced growth of new mitochondria (Alvers et al., 
2009). In support of this view, leucine, isoleucine and valine can extend the 
chronological longevity of Saccharomyces cerevisiae, implicating that these nutrients are 
capable of promoting eukaryotic cell survival (Alvers et al., 2009). Similarly, provision 
of BCAA to cardiac and skeletal myocytes increases mitochondrial DNA concentration 
and expression of major genes related to activation of mitochondrial biogenesis and 
reductions in production of ROS (D’Anona et al., 2010). These genes include 
peroxisome proliferator-activated receptor γ coactivator-1α and sirtuin 1. The result is 
prevention of oxidative damage, and possibly apoptosis, in metabolically active cells 
which extends their survival in the face of increased mitochondrial respiration for 
generation of ATP (Lei et al., 2012). 
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Effects of BCAA on milk synthesis process in mammary epithelial cells 
Intracellular protein synthesis 
Production of milk proteins depends on the balance between rates of intracellular 
protein synthesis and proteolysis (Kim and Wu, 2009). The mammary gland has a high 
capacity for protein synthesis during lactation. Large amounts of milk proteins and a 
variety of constitutive proteins (e.g., structural proteins and enzymes) are synthesized 
endogenously by the lactating mammary gland (Grinari et al., 1997). The mammary 
glands of sows and cows produce 420 and 950 g milk protein, respectively, each day at 
the peak of lactation (Lei et al., 2012). However, the efficiency of converting dietary 
protein into milk protein is less than 30% and 10% in sows and cows, respectively (Bell 
and Bauman, 2006; Wu et al. 2014). The factors that regulate this process in the 
mammary gland include: a) entry of dietary amino acids into the portal circulation; b) 
uptake of amino acids and peptides; c) concentrations of lactogenic hormones and 
nutrients that regulate metabolism of amino acids and peptides; and d) activation of 
signaling pathways that regulate syntheses of proteins, lipids and lactose (Boyd et al., 
1995). Because the metabolic capacity of the mammary gland for milk protein synthesis 
is much higher than now achieved under current feeding systems and management (Kim 
and Wu, 2009), there is great potential for enhancing milk production in animals and 
humans. The regulatory roles of hormones in controlling the synthesis of milk proteins 
are well studied (Rhoads and Grudzien-Nogalska, 2007). However, the functions of 
amino acids in this regard are largely unknown. Previous studies showed that BCAA 
promotes milk protein production (Richert et al., 1997), but inconsistent results have 
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been reported by the same laboratory (see Wu et al. 2014 for discussion).  It is unclear 
whether those nutrients simply serve as building blocks of peptides and proteins or 
function as signaling molecules in the control of metabolic pathways for lactogenesis 
(Lei et al., 2012). Dairy cows that received intragastric infusion of casein (a BCAA-rich 
protein) as a source of amino acids had 10% higher production of milk protein (Bell and 
Bauman, 2006). Interestingly, this effect of casein was amplified (28% increase in the 
production of milk protein compared with the control group) by intragastric 
administration of casein together and intravenous infusion of insulin, which indicates a 
synergistic action of amino acids and insulin on milk protein synthesis (Bell and 
Bauman, 2006). Intravenous infusion of either total essential amino acids or leucine 
activates the mTOR signaling pathway, but infusion of methionine plus lysine or 
histidine had no effect (Toerien et al., 2010). In contrast, either a lack of all amino acids 
or selective deprivation of leucine inhibited phosphorylation of the mTOR substrates, 
4E-BP1 and p70 S6K1, thereby decreasing the synthesis of total and cell-specific 
proteins (e.g., Beta-lactoglobulins) in both bovine and murine mammary epithelial cell 
lines (Moshel et al., 2006). Addition of either complete amino acids or leucine to the 
amino acid-free basal medium restored protein synthesis in the cells, but such effects 
were blocked by rapamycin or LY294002 (a phosphatidylinositol 3-kinase inhibitor) in a 
dose dependent manner (Moshel et al., 2006). Collectively, these results indicate that 
leucine (and/or BCAA) is signaling molecules in the translational machinery that 
controls milk protein synthesis, in addition to serving as a substrate for synthesis of 
polypeptides. This is consistent with findings from both in vitro and in vivo studies 
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which indicate that BCAA (particularly leucine) have anabolic effects on protein 
synthesis in skeletal muscle and other tissues (Gringari et al., 1997; Bell and Bauman, 
2006; Richert et al., 1997; Tischler et al., 1982; Garlick and Grant, 1988; Mitch and 
Clark, 1984). 
Intracellular protein degradation 
The control of intracellular protein degradation in the lactating mammary gland 
is very important to maximize the production of milk proteins. However, the rates or 
regulation of protein degradation in mammary epithelial cells are poorly understood. 
Nonetheless, there is an inhibitory effect of BCAA on proteolysis in skeletal muscle and 
whole body under catabolic conditions (Wang et al., 2012; Tischler et al., 1982; Tayek et 
al., 1986). α-Ketoisocaproate (a product of leucine transamination) and 4-methyl-2-
oxopentanoate (a metabolite of α-ketoisocaproate) also suppress proteolysis in muscle 
tissue (Tischler et al., 1982; Mitch and Clark, 1984); however, the underlying 
mechanisms are unknown. High concentrations of α-ketoisocaproate and 4-methyl-2-
oxopentanoate (> 0.25 mmol/L) are required for inhibiting muscle protein degradation 
(Tischler et al., 1982; Mitch and Clark, 1984), but it is not known whether they mediate 
this effect in the presence of physiological levels of leucine in muscle cells. 
  Multiple proteolytic mechanisms are known to be responsible for the catabolism 
of proteins, including: a) the calcium-activated pathway; b) the ATP- and ubiquitin-
dependent proteasome pathway; and c) the lysosomal pathway (Ciechanover, 2012). The 
calcium-activated pathway plays a major role in degrading myofibrillar protein. In 
contrast, most of the intracellular proteins are hydrolyzed by the proteasomal pathway, 
  59 
which is enhanced by a variety of catabolic conditions, including trauma, sepsis, cancer, 
and starvation. The lysosomal system is mostly responsible for the degradation of 
engulfed particles that enter lysosomes via a process known as autophagy (Meijer et al. 
2014). The short-term effect of BCAA on proteolysis has been associated with decreased 
activities of lysosomal proteases whereas the long-term effect of these amino acids 
might be mediated through the proteasome pathway (Busquets et al., 2000). In addition, 
activation of the mTOR signaling pathway results in inhibition of intracellular 
proteolysis in enterocytes (Yao et al., 2011), but this effect has not been reported for 
mammary epithelial cells. Based on the aforementioned evidence, BCAA may inhibit 
protein degradation in mammary epithelial cells via activation of the mTOR signaling 
pathway (Lei et al., 2012). However, there is a need for experiments to test this 
hypothesis. 
Effect of dietary supplementation of BCAA on lactation and the growth 
performance of neonates 
Limitation of glutamine and glutamate supply in lactating animals 
Glutamate and glutamine are preferred sources of energy for cells of the small 
intestineand large amounts are required for maturation of the neonatal gut (Wu, 2009). 
Although regular diets for animals contain relatively high levels of glutamine and 
glutamate (Li et al., 2011; Hou et al., 2010; Wu et al., 2010), dietary supplementation 
with 1% glutamine to lactating sows significantly increased milk production (Wu et al., 
2011). The underlying mechanisms may involve the cooperation of several organs, 
including the small intestine, skeletal muscle and lactating mammary gland (Lei et al., 
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2012). At present, little is known about efficacy of dietary supplementation with 
glutamine versus BCAA to sustain high levels of glutamate and glutamine in milk. 
Studies with rats have shown that glutamine catabolism in the small intestine increases 
during lactation compared with virgin and nonlactating animals (Ardawi et al., 1988). 
Likewise, Okine et al. (1995) reported that enterocytes from cows in early stages of 
lactation oxidize more glutamine than cells from cows at either the mid- or late-stage of 
lactation. Consequently, the small intestine of lactating dams degrades approximately 
70% of dietary glutamine (Wu et al., 2011) and only a small percentage is available for 
the lactating mammary gland (Doepel et al., 2007). This explains the need to increase 
glutamine and glutamate availability in milk. Supplementing BCAA to the diet of 
lactating dams may provide an efficient and effective strategy to overcome the problem 
of suboptimal milk production in lactating mammals (Li et al., 2009). 
Effects of dietary BCAA supplementation on production of milk in lactating animals 
The amount and quality of nutrients secreted by the mammary gland is the major 
determinant of growth and survival of piglets (Boyd et al., 1995). Lei et al. (2012) 
suggested that BCAA stimulates secretion of milk and modifies its nutrient composition. 
The mammary glands of lactating sows produce 125% more glutamine in milk 
than is taken up from arterial plasma (Li et al., 2009), while the uptake of glutamate by 
the mammary gland is almost equal by the amount of glutamate present in milk 
(Shennan and Peaker, 2000). The extra glutamine could not be derived from proline 
because porcine mammary tissue lacks proline oxidase (O’Quinn et al., 2002). The 
synthesis of aspartate and asparagine has important implications since the uptake of 
  61 
these two amino acids by the mammary gland of lactating sows accounts for only 50% 
of their output in milk (Trottier et al., 1997). Aspartate and asparagine are the third most 
abundant nonessential amino acids in porcine milk proteins (Wu and Knabe, 1994; Davis 
et al., 1994). As a result, BCAA substantially supports protein synthesis in lactating 
mammary tissue through stimulating the synthesis of nutritionally nonessential amino 
acids. As summarized in Table A-2, many studies have used BCAA supplementation as 
a strategy to improve lactation and litter performance in pigs, but the results are 
inconsistent. Several studies showed that supplementing BCAA to the diets of lactating 
sows enhances milk yield and neonatal growth. First, Richert et al. (1997a) found that 
weaning weights and weight gains of litters of high-producing lactating sows increased 
as dietary valine increased from 0.85 to 1.15%. Subsequently, they confirmed that 
increasing dietary valine (0.64-1.44%) to lactating sows nursing 10 or more piglets 
increased weaning weights and weight gains of litters (Richert et al., 1997b). This effect 
of dietary valine on lactation was also confirmed by Moser et al. (2000). Furthermore, 
Paulicks et al. (2003) observed that dietary supplementation of valine (0.85- 1.45%) to 
lactating sows increased milk production and milk protein content, in comparison with 
the control group (0.55% valine). Similarly, increasing dietary intake of valine, 
isoleucine, or total branched-chain amino acids by lactating sows increased milk 
synthesis, composition and growth performance of piglets (Richert et al., 1997). 
Consistent with the findings from swine, duodenal infusion of leucine to lactating 
cows increased concentrations of casein, whey proteins, and total proteins in milk 
(Rulquin and Pisulewski, 2006). These results from animal studies have important 
  62 
implications for enhancing milk production in women who have impaired lactogenesis 
under various stressful conditions (e.g., premature birth, maternal complications, and 
high or low ambient temperatures) and in response to low intake of dietary protein 
(Dewey, 2001). 
CONCLUDING REMARKS 
The synthetic capacity of the mammary gland depends largely on the number and 
efficiency of functional mammary epithelial cells and it directly correlates with 
subsequent growth of suckling neonates. In the lactating mammary gland, BCAA are 
extensively transaminated with α-ketoglutarate to produce glutamate and BCKA, with 
glutamate being an essential substrate for synthesis of other NEAA such as glutamine, 
alanine, aspartate and asparagine. Moreover, some of the BCAA carbons are either 
oxidized to provide ATP in mitochondria or utilized for lipid synthesis in cytoplasm. 
BCAA enhance secretion of insulin by β-cells of the pancreas (Li et al., 2007) 
and also stimulate the mTOR cell signaling pathway to initiate synthesis of 
polypeptidesand inhibit protein degradation (Suryawan, and Davis, 2011). At present, 
little is known about hormonal or nutritional regulation of BCAA catabolism in 
mammary tissue. Emerging evidence from animal studies indicate that dietary 
supplementation with valine, isoleucine or a mixture of BCAA stimulates milk synthesis 
and lactation in sows (Richert et al., 1997a and 1997b; Moser et al., 2002; Paulicks et al., 
2003). Interestingly, in contrast to enteral provision (Rulquin and Pisulewski, 2006), 
intravenous administration of BCAA was not found to affect milk protein synthesis or 
milk production by lactating cows. Thus, the route of supplementation with BCAA or 
  63 
dietary composition of amino acids may be a critical factor influencing physiological 
responses. It is possible that BCAA inhibits catabolism of amino acids by both mucosal 
cells and luminal microorganisms of the small intestine (Dai et al., 2010; Dai et al., 
2011; Hou et al., 2011), thereby increasing the entry of dietary amino acids to the portal 
circulation for utilization by extra-intestinal cells and tissues. One of the beneficial 
outcomes would be to increase the availability of arginine for synthesis of nitric oxide 
(Meininger and Wu, 2002), a major vasodilator (Wu and Meininger, 2009), to increase 
blood flow and associated increases in the uptake of nutrients by the lactating mammary 
gland. 
Collectively, the findings on BCAA metabolism and nutrition in mammary tissue 
have not only advanced our knowledge of the biology of lactation, but they also have 
practical implications for improving milk production by female animals and women in 
both developed and developing countries. Furthermore, it is important to define optimal 
requirements for BCAA by lactating livestock and other mammals. Basic research on the 
biology of lactation is essential to achieve the biological potential for neonatal growth 
and survival, improve the efficiency of livestock production, and sustain animal 
agriculture worldwide. 
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CHAPTER II 
DIETARY SUPPLEMENTATION WITH BRANCHED-CHAIN 
AMINO ACIDS ENHANCES MILK PRODUCTION BY 
LACTATING SOWS AND GROWTH OF SUCKLING PIGLETS 
SYNOPSIS 
The growth rate of suckling pig is critically dependent on milk yield and the 
concentration of nutrients in milk. In lactating sows, large amounts of amino acids are 
mobilized from the body for milk synthesis. Under current dietary regimens, milk 
secretion is insufficient to sustain the maximal growth of neonatal pigs. This study tested 
the hypothesis that dietary supplementation of branched-chain amino acids (BCAA; L-
leucine, L-isoleucine and L-valine) to lactating sows enhanced their production of milk 
and the growth performance of their suckling piglets. Thirty multiparous sows (Landrace 
x Large White) were assigned randomly into one of three groups: 1) control (a corn- and 
soybean meal-based diet), 2) basal diet + 1.535% BCAA; and 3) basal diet + 3.07% 
BCAA. Diets were made isonitrogenous by addition of appropriate amounts of L-
alanine. Lactating sows had free access to drinking water and their respective diets. The 
number of live-born piglets was normalized to 9 per sow at d 0 of lactation (the day of 
parturition). On d 3, 15 and 29 of lactation, body weights and milk consumption of 
piglets were measured and blood samples obtained from sows and piglets at 2h after 
feeding. Data were analyzed by 2-way ANOVA. Feed intake did not differ among the 
three groups of sows. Concentrations of aspartate, glutamine, citrulline, arginine, and 
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BCAA were higher (P < 0.05) in the plasma of BCAA-supplemented sows and their 
piglets than those in the control group. Compared with the control, dietary 
supplementation with 1.535% and 3.07% BCAA increased (P < 0.05): 1) concentrations 
of free and protein-bound BCAA, glutamate and glutamine in milk (P < 0.01); 2) milk 
production by 14% and 21%, 3) daily weight gains of piglets by 19% and 28%, 
respectively; and 4) reduced the rate of preweaning mortality by 50% and 70%, 
respectively. These results indicate that dietary supplementation with up to 3.07% 
BCAA enhanced milk production in lactating sows which improved growth and survival 
of their piglets.  
INTRODUCTION 
The major goal of the swine industry is to minimize neonatal mortality and 
improve weaning weights of neonatal pigs as their adaptability to weaning and rates of 
growth to market weight are positively affected by weaning weight (Boyd et al., 1995). 
The total net profit of a swine production unit is primarily determined by both the 
number and size of piglets produced per year per sow (Quiniou et al., 2002). Recent 
attempts to increase litter size have led to increased prevalence of low birth weight 
piglets (Fix et al., 2010), which results in a higher rate of mortality and a longer period 
of time to reach an optimum market weight, when compared with normal-birth-weight 
piglets (Rezaei et al., 2011; Wu et al. 2006). Pork quality is also affected by birth weight 
to a large extent (Fix et al., 2010). The greatest proportion of mortality in commercial 
swine production occurs prior to weaning and ranges between 10 and 20% of live-born 
pigs (Wu et al., 2006). For example, pre-weaning mortality was estimated at 13% in U.S. 
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commercial swine herds during 2008 (PIGCHAMP, 2008) due to poor performance of 
piglets, including low birth weight and inadequate provision of milk (Boyd et al., 1995; 
Wolter et al., 2002). 
Insufficient intake of dietary amino acids limits milk production by lactating 
sows. For example, increasing the content of crude protein (23% vs 16.2%) and all 
amino acids, including leucine plus isoleucine plus valine (e.g., 4.61% vs 2.28%), in the 
diet of lactating sows enhances milk yield and piglet growth (Dunshea et al, 2005). It is 
unknown whether this effect is due to specific amino acids (e.g., BCAA) or simply total 
amino-acid nitrogen. Results from several studies indicate that dietary supplementation 
with valine (Richert et al. 1996, 1997a; Moser et al. 2000; Paulicks et al. 2003) or 
isoleucine (Richert et al. 1997b), but not leucine (Moser et al. 2000), increase litter 
weight of suckling piglets. BCAA are major AA components of milk protein (Davis et 
al., 1994; Wu et al., 1994), and also provide the amino group for synthesis of glutamate, 
glutamine, aspartate and asparagine all of which are abundant amino acids in milk (Li et 
al., 2009).  To date, dietary supplementation with a single BCAA to sows has yielded 
inconsistent results on milk production (Richert et al., 1997ab; Moser et al., 2000) 
possibly due to a dietary imbalance of the three BCAA (Wu et al., 2014). For example, 
dietary supplementation of lactating sows with 0.4% isoleucine enhanced growth of 
suckling piglets when the ratio of isoleucine to leucine in the complete diet was 0.88 
(Richert et al., 1997a), but isoleucine failed to exert a beneficial effect when the ratio of 
isoleucine to leucine in the complete diet was 0.55 (Moser et al., 2000).  Little is known 
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about effects of dietary supplementation with leucine plus isoleucine plus valine on 
lactation performance in any mammal, including sows.  
L-Leucine activates the mechanistic target of rapamycin (mTOR) cell signaling 
pathway to stimulate protein synthesis in skeletal muscle (Dennis et al., 2011; Suryawan 
and Davis, 2011; Suryawan et al., 2012) and mammary epithelial cells (Lei et al., 
2012b). We hypothesized that BCAA would increase milk synthesis in mammary tissue 
of lactating sows, thereby improving neonatal growth, development and survival. The 
present study tested this hypothesis by determining effects of BCAA supplementation to 
lactating sows on: 1) growth performance of neonates; 2) yield, composition and nutrient 
composition of milk; 3) biochemical metabolites in milk as well as plasma from sows 
and piglets. To prevent an imbalance among BCAA, we supplemented the diet of 
lactating sows with a mixture of L-leucine, L-isoleucine and L-valine in proportion to 
their physiological ratios in the lumen of their small intestine. 
MATERIALS AND METHODS 
Animals housing and management for feeding trials 
The experimental protocol for this study was approved by the Texas A&M 
University Institutional Animal Care and Use Committee. Thirty multiparous sows 
(Yorkshire × Landrace; parity = 2 and 3) were housed individually in 1.8 × 2.5 m pens 
with plastic coated perforated flooring. During the entire gestation, they were fed 2 kg/d 
a corn- and soybean meal-based diet containing 12.0% crude protein and 12.9 MJ/kg 
metabolizable energy (Li et al., 2010).  Immediately after farrowing, the sows were 
assigned randomly to one of three groups, and fed a corn- and soybean meal-based diet 
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(Table A-3) supplemented with 0% (control), 1.535% (0.32% L-isoleucine plus 0.82% 
L-leucine plus 0.395% L-valine), or 3.07% BCAA (0.64% L-isoleucine plus 1.64% L-
leucine plus 0.79% L-valine). Diets were provided to sows twice a day (3 kg/meal) and 
they had free access to their respective diets. These supplemental doses of BCAA were 
based on the following rationale. First, the ratios of isoleucine:leucine:valine in the 
lumen of the small intestine of lactating sows were determined to be 1.00:2.56:1.23 (R. 
Rezaei and G. Wu, unpublished results). Second, the content of leucine in the basal diet 
was 1.64%. Thus, the supplemental doses of 0.82% and 1.64% leucine amounted to 50% 
and 100% of the leucine content in the basal diet. There were 10 sows per group. Diets 
were made isonitrogenous and isoenergetic by addition of appropriate amounts of L-
alanine at the expense of corn starch (Table A-4). Supplemental AA were obtained from 
Ajinomoto Co., Inc. (Tokyo, Japan). Before feeding sows, complete diets were mixed 
thoroughly using a Hobart feed mixer. On the day of farrowing (d = 0), cross fostering of 
newborn pigs was performed to minimize within-litter variation, and the number of 
piglets per sow was standardized to nine, yielding a total of 270 piglets for this 
experiment. The number of male and female piglets per treatment group was the same. 
The ambient temperature in the farrowing facility was maintained at 26°C throughout 
the trial. Heat lamps were used to provide heat to neonatal pigs in each pen. Lactating 
sows had free access to drinking water and their respective diets. Feed intake of the sows 
was recorded daily. Teeth of piglets were clipped and their tails docked at d 3 of age. At 
this age, each piglet was also ear notched for identification and given an intramuscular 
iron dextran injection (200 mg per piglet). On d 3, 15 and 29 of lactation, all sows and 
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piglets were weighed. During the entire experiment, piglets had no access to the feed 
provided to sows and were not provided with any creep feed. The growth performance 
and survival rates of piglets were determined. 
Collection of blood samples from sows and piglets 
Heparinized tubes were used to draw blood from sows and piglets on d 3, 15, and 
29 of lactation. Specifically, blood samples (10 ml) were obtained from all sows via the 
caudal auricular vein in the ear 2h post-feeding, and blood samples (2 ml) were obtained 
via the jugular vein 1 h after nursing from two randomly selected piglets in each litter.  
Blood samples were immediately centrifuged at 10,000 x g for 1 min, and the 
supernatant fluid (plasma) stored at -80°C for subsequent analyses.  
Collection of milk from sows  
To obtain milk samples, 20 IU oxytocin was administered via the ear vein of 
sows to induce milk letdown into the teat canal and milk was expressed manually (Wu 
and Knabe, 1994). Milk samples (50 ml/gland) were collected from three different 
mammary glands (front, middle, and rear). Equal volumes of milk (10 ml) from each 
gland of a sow were mixed, and the samples stored at -80
o
 C for subsequent analyses.  
Milk consumption of piglets 
Milk consumption of piglets was determined using the weigh-suckle-weigh 
method as previously described (Kim and Wu, 2004). Briefly, on d 3, 15, and 29 of 
lactation, after blood sampling, piglets were separated from their mothers for 1.5 h and 
then returned to the sows for nursing. Piglets were weighed before and after nursing to 
calculate milk intake.  This procedure was repeated four times.     
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Analysis of milk composition  
The frozen whole-milk samples were thawed at 4°C, and then used for 
determination of total milk fat, lactose, crude protein, DM and ash according to AOAC 
(Association of Official Analytical Chemists, Washington DC 1990) procedures. 
Additionally, protein was determined by the modified Lowry procedure using purified 
porcine IgG as the standard (Wu and Knabe, 1994). Milk lactose was determined using 
the colorimetric method of Marier and Boulet (1959) that involved the reaction with 
phenol and sulfuric acid and then reading against the blank at 490 nm. Total milk lipids 
were extracted using a mixture of isopropylalcohol:heptane:1N H2SO4 (Dole, 1956).  
Analysis of free amino acids in plasma  
Plasma samples (0.5 mL) were deproteinized with an equal volume of 1.5 M 
HClO4 and neutralized with 0.25 mL of 2 M K2CO3. The neutralized samples were 
analyzed for free AA by HPLC methods involving precolumn derivatization with o-
phthal-dialdehyde (Wu et al., 1997).  
Analysis of free and protein-bound amino acids in milk 
For analysis of free AA, milk samples (0.5 mL) were deproteinized with an equal 
volume of 1.5 M HClO4 and neutralized with 0.25 mL of 2 M K2CO3. The neutralized 
samples were analyzed for free AA, as described above. Composition of protein-bound 
AA in milk was determined as described by Dai et al. (2014).  
Analysis of glucose, ammonia, urea, lactate, pyruvate and ketone bodies in plasma 
and milk 
Deproteinized and neutralized plasma or milk samples were analyzed for 
  71 
glucose, ammonia, urea, lactate, pyruvate, and ketone bodies by enzymatic methods 
(Tekwe et al., 2013).  The enzymes were hexokinase,glucose-6-phosphate 
dehydrogenase, glutamate dehydrogenase, urease, lactate dehydrogenase, and β-
hydroxybutyrate dehydrogenase for the assays of glucose, ammonia plus urea, lactate 
plus pyruvate, acetoacetate plus β-hydroxybutyrate, respectively. We also measured 
cholesterol, triglycerides, free fatty acids and glycerol in sows and piglet’s plasma and 
milk colorimetrically according to manufacturer’s manual. 
Determination of plasma thiobarbituric acid reactive substances (TBARS) 
To evaluate the oxidative status of sows and piglets, their plasma was analyzed 
for TBARS. Thiobarbituric acid forms a reaction with malondialdehyde (a naturally 
occurring product of lipid peroxidation) under high temperature and acidic conditions 
and can be measured colorimetrically. The technical procedure was performed as 
recommended by the manufacturer (Cayman Chemical, Ann Arbor MI). Briefly, 100 µL 
of thawed plasma was placed into a labeled glass tube and mixed with the reagents of the 
commercial kit (Cayman Chemical, Cat # 10009055). Each tube was capped and 
incubated at 95°C for 60 min. The tubes were then cooled in an ice bath for 10 min. 
Thereafter, the tubes were centrifuged at 1,100 × g for 15 min and the supernatant fluid 
was obtained for the measurement absorbance at 530-540 nm (Draper et al., 1993). 
STATISTICAL ANALYSIS 
Results are expressed as means ± pooled SEM. Data were analyzed statistically 
using two-way ANOVA software available online at 
https://housseinassaad.shinyapps.io/TwoWayANOVA/. Data on rates of piglet mortality 
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were analyzed by X
2
-analysis. Values of P ≤0.05 indicated statistical significance. All 
statistical analyses were performed by using the 64-bit version of the R 3.1.0 software on 
Linux. 
RESULTS 
Feed intake and body weights of lactating sows  
There were no differences in feed intake by sows among groups which was 
approximately 32 g/kg BW per day throughout the 29-d period of lactation (Table A-6).  
With advanced lactation, sows mobilized body reserves to provide nutrients for milk 
production. On the day of farrowing, body weights of sows did not differ among the 
three treatment groups (Table A-7). However, on d 29 of lactation, sows in the 3.07% 
BCAA group were heavier (P < 0.05) than those in the control and 1.535% BCAA 
groups (Table A-7). Overall, sows in the control and 1.535% BCAA groups lost (P < 
0.05) 26 and 16 kg body weight between d 0 and 29 of lactation, respectively, whereas 
there was no difference in the body weights of sows in the 3.07% BCAA group during 
the same period (Table A-8). Most (approximately 60%) of the weight losses in sows 
occurred during the fourth week of lactation. 
Milk intake, growth and mortality of sow-reared piglets 
Milk intake of piglets was 16.5% and 20.5% higher in the 1.535% and 3.07% 
BCAA groups, respectively, compared with control piglets (Table A-6). Piglet BW at d 
0 of lactation did not differ among treatment groups (Table A-7). However, the BW of 
piglets nursed by sows fed the BCAA-supplemented diets during lactation were greater 
(P < 0.01) at d 15 and 29 of lactation, compared with piglets from control-fed sows. 
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Average daily weight gains of piglets from sows fed the BCAA-supplemented diets 
during lactation were consistently greater (P < 0.01) throughout the 29-d lactation 
compared with piglets from control-fed sows (Table A-8). Piglets in the 3.07% BCAA 
group had a greater weight gain (P < 0.01) than piglets in the 1.535% BCAA group. Of 
note, rates of preweaning mortality of piglets in the 1.535% and 3.07% BCAA groups 
were 50% and 33% (P < 0.05) of the value for the control group, respectively (Table A-
9). 
Milk composition 
Concentrations of DM, CP, fat and carbohydrate were higher (P < 0.01) in milk 
from BCAA-supplemented sows as compared to control sows (Table A-10). Lactose 
accounted for 89.3% to 89.8% of total carbohydrate in each group. Composition of milk 
did not differ between the 1.535% and 3.07% groups. Concentrations of DM, fat and CP 
in milk were higher on d 3 than on d 15 or d 29 of lactation (P < 0.05), but did not differ 
between d 15 and 29 of lactation. There was no treatment × day interaction effect on 
milk composition (Table A-10). 
Concentrations of AA in the plasma of piglets and sows 
Concentrations of AA in plasma of sows and piglets at d 3, 15 and 29 of lactation 
are summarized in Tables A-11 and A-12, respectively. BCAA supplementation to sows 
resulted in greater (P < 0.001) concentrations of Pro, BCAA, citrulline, Arg, Asn, Glu 
and Gln in plasma, compared with values for sows in the control group.  Except for Asn, 
b-Ala and Lys, concentrations of all other AA in the plasma from sows were greater (P < 
0.05) for the 3.07% BCAA group than the 1.535% BCAA group (Table A-11). The 
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effect of day of lactation was significant for all AA in plasma from sows except for Cys, 
Glu, Gln, Gly, Lys, Met, Pro and Tau. However, no treatment × day effect was detected 
for any AA except Asn in plasma of sows. Similar results were obtained for 
concentrations of AA in plasma from piglets (Table A-12).  
Concentrations of protein-bound and free AA in milk 
Concentrations of most free AA, including Ala, Arg, Asp, Asn, Cit, Glu, Gln, 
BCAA and Pro, were greater  (P < 0.05) in milk from BCAA-supplemented, as 
compared with the control sows (Table A-13).  Except for Ala and Trp, the abundance of 
all free AA was greatest in milk from sows in the 3.07% BCAA group (Table A-13). 
There was a significant effect of day on concentrations of all free AA in milk, but a 
treatment × day interaction effect was detected only for Ser (Table A-13). 
Concentrations of all protein-bound AA were higher (P < 0.01) in milk of BCAA-
supplemented sows, compared with control sows. Concentrations of all protein-bound 
AA were affected by day of lactation. There was no treatment × Day effect for any AA 
in milk protein (Table A-14).  
Metabolites in the plasma of sows and piglets and in milk 
Effects of BCAA supplementation on concentrations of ammonia, urea, glucose, 
lactate and pyruvate in the plasma of sows and piglets and in sow’s milk are summarized 
in Table A-15. Concentrations of glucose were higher in plasma from BCAA-
supplemented sows (P=0.018) and piglets nursed by those sows (P < 0.001) than sows 
and piglets in the control group. No differences in concentrations of glucose in milk 
were detected among the three groups of sows. BCAA supplementation did not affect 
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concentrations of ammonia, urea, lactate or pyruvate in the plasma of sows or piglets or 
in sow’s milk. Concentrations of lactate in plasma and milk from sows increased as 
lactation advanced, but there were no changes in other measured metabolites. No 
treatment × day of lactation interaction had an effect on concentrations of ammonia, 
urea, lactate or pyruvate in plasma from sows and piglets or in milk from d 3, 15 or 29 of 
lactation. Acetoacetate and β-hydroxybutyrate were not detected in plasma of sows and 
piglets or in milk on the same days of lactation (detection limit = 25 μM). 
Concentrations of lipids in plasma and milk are summarized in Table A-16. 
Plasma TBARS concentrations in sows and piglets 
Concentrations TBARS in the plasma of sows increased (P < 0.001) as lactation 
progressed, but the opposite changes were detected in plasma from piglets (Table A-17). 
BCAA supplementation reduced (P= 0.004) the concentrations of TBARS in plasma 
from sows compared with control sows (Table A-17). Concentrations of TBARS in 
plasma from piglets did not differ among the three treatment groups.  
DISCUSSION 
The mammary gland undergoes metabolic and histological changes during 
lactation (Kensinger et al., 1982; Shennan and Peaker, 2000). During lactation, sows are 
capable of utilizing nutrients from the arterial circulation for milk production (Guan et 
al., 2004; Kim et al., 2000). However, due to reduced feed intake of lactating sows, they 
cannot meet the nutritional requirements for milk production, thereby leading to a 
catabolic state in which their body reserves are mobilized to provide precursors and 
energy for milk production (Boyd et al., 1995). This results in substantial weight loss for 
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lactating sows, which can negatively affect their subsequent reproductive performance 
(Hughes and Varley, 1980). Results of the present study demonstrate that supplementing 
1.535% and 3.07% BCAA to the typical corn- and soybean meal-based diet of 
multiparous sows during the entire 29d lactation period reduced their weight loss, while 
increasing milk yield as well as concentrations of total AA, lipids and lactose in milk, 
and improved piglet growth performance. Therefore, findings of the present study 
provide a new and effective strategy for nutritional management of lactating sows. To 
our knowledge, this is the first study demonstrating effects of dietary supplementation 
with a mixture of BCAA (without increasing dietary protein levels) on lactational 
performance of lactating sows and associated effects on growth and survival of piglets.   
 Lactating mammals extensively degrade BCAA (Wholt et al., 1977; Viña and 
Williamson, 1981); therefore, the requirements for dietary BCAA by lactating sows to 
support milk synthesis are great (Wu, 2014). There are reports that supplementing L-
valine to the diets of lactating sows enhances milk yield and piglet growth. For example, 
Richert et al. (1997a) found that litter weaning weight and litter weight gain in high-
producing lactating sows increased as total content of valine and isoleucine in the diet 
increased from 0.72% to 1.42% and from 0.50% to 1.2%, respectively.  Also, they 
showed that increasing total valine content from 0.61% to 1.15% in the diet for lactating 
sows nursing 10 or more piglets increased litter preweaning weights (Richert et al., 
1997b). This beneficial effect of dietary valine (an increase from 0.75% to 1.15% valine) 
on lactation was confirmed by Moser et al. (2000). Furthermore, Paulicks et al. (2003) 
observed that supplementing up to 1% valine to a basal diet containing 0.45% valine for 
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lactating sows increased milk production and total milk protein content, in comparison 
with the control group. Of note, supplementing either 0.4% leucine to a basal diet 
containing 1.57% leucine or 0.4% isoleucine to a basal diet containing 0.68% isoleucine 
for lactating sows did not affect milk production or piglet growth (Moser et al., 2000).  
In contrast, duodenal infusion of leucine to lactating cows increased concentrations of 
casein, whey proteins, and total proteins in milk (Rulquin and Pisulewski, 2006).  Ratios 
of leucine, isoleucine and valine in the complete diet may affect lactational performance. 
To prevent a BCAA imbalance resulting from the addition of one single BCAA to the 
ration, dietary supplementation with all three BCAA provides a more effective strategy 
to improve milk production in sows and perhaps other mammals. 
Voluntary feed intake of sows was not affected by dietary supplementation with 
up to 3.07% BCAA (Table A-6). As reported previously (Kim et al., 2009), the body 
weight of sows is markedly reduced with advanced lactation (Table A-7). Interestingly, 
dietary supplementation with 1.535% BCAA and 3.07% BCAA reduced weight loss of 
sows in a dose-dependent manner (Table A-8) which may be attributed to effects of 
BCAA (mainly leucine) to stimulate muscle protein synthesis and inhibit muscle 
proteolysis during catabolic conditions (Donato et al., 2007; Biolo et al., 1997) and those 
effects may enhance subsequent reproductive performance. In the present study, we did 
not measure the component of weight loss in lactating sows, but the loss likely occurred 
primarily in white adipose tissue and secondarily in skeletal muscle (Kim et al., 2009). It 
is likely that by activating the MTOR cell signaling pathway, BCAA supplementation 
improves the efficiency of utilization of dietary nutrients for milk production. 
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 Approximately 40% to 45% of dietary BCAA are utilized by the small intestine 
of sows in the first pass (Wu et al., 2014). Because degradation of BCAA in the liver is 
limited due to its low BCAA transaminase activity, most of the BCAA that enters the 
portal circulation bypasses this organ to become available for utilization by other tissues, 
including skeletal muscle and mammary glands (Tover et al., 2001). Skeletal muscle of 
lactating mammals actively transports extracellular BCAA and converts them into 
BCKA and glutamate (Harper et al., 1984). Glutamate is subsequently amidated to form 
glutamine and undergoes transamination with pyruvate and oxaloacetate to yield alanine 
and aspartate, respectively (Li et al., 2009; Yin et al., 2010). This explains why dietary 
BCAA supplementation increased concentrations of glutamate, glutamine, alanine and 
aspartate in the plasma of lactating sows. Utilization of arterial glutamine by the small 
intestine of lactating sows is expected to promote intestinal synthesis of citrulline (the 
precursor of arginine), thereby contributing to an increase in the concentrations of both 
citrulline and arginine in maternal blood (Table A-11).  
 Besides skeletal muscle and small intestine, the mammary gland of sows takes up 
and catabolizes large amounts of extracellular BCAA (Li et al., 2009; Manjarin et al., 
2012). For example, during lactation, 76-80 g/d BCAA are utilized by the mammary 
gland, with 46-53 g/d BCAA being secreted in milk (Trottier et al., 1997; Nielsen et al., 
2002). Thus, approximately 30 g/d BCAA is metabolized in the mammary gland. We 
reported that BCAA are nitrogenous precursors for synthesis of glutamate, glutamine, 
aspartate, and alanine in the lactating gland, which contains BCAA transaminase, BCKA 
dehydrogenase, glutamine synthetase, glutamate-oxaloacetate aminotransferase, 
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glutamate-pyruvate aminotransferase, and asparagine synthetase (Li et al., 2009; 
Conway and Hutson, 2000). Similarly, Matsumoto et al. (2013) found that dietary 
supplementation with leucine increased concentrations of glutamate and glutamine in 
milk of rats. The BCKA produced can be either oxidized to provide ATP or utilized for 
fat synthesis. Of note, dietary supplementation with 2 g/d β-hydroxy-β-methyl butyrate 
(a leucine metabolite) enhances fat content in colostrum by 41% and body weight of 
suckling pigs by 7% on d 21 of lactation (Nissen et al., 1994). Furthermore, BCAA 
stimulate protein synthesis in mammary epithelial cells through the mTOR pathway (Lei 
et al., 2012b). The results of the present study advance understanding of these new and 
important findings that dietary BCAA supplementation increases concentrations of free 
and peptide-bound glutamate, glutamine, aspartate, and alanine, as well as 
concentrations of protein and fat in sow's milk.  
 As noted previously, inadequate provision of dietary protein and some amino 
acids (e.g., arginine, glutamine, glutamate, glycine, leucine, and proline) limits maximal 
growth of young pigs (Manjarin et al., 2014; Wang et al. 2014ab; Wu et al., 2014).  An 
increase in the provision of these amino acids from sow's milk enhances their 
concentrations in plasma of suckling piglets, thereby improving growth of suckling 
piglets.  The underlying mechanisms may involve the supply of substrates for protein 
synthesis as well as activation of the mTOR cell signaling pathway to increase protein 
synthesis and inhibit protein degradation (Columbus et al., 2014; Suryawan and Davis, 
2014). In support of this view, arginine and glycine are known to be severely deficient in 
sow’s milk relative to their requirements for piglet growth (Davis et al., 1994; Wang et 
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al., 2013; Wu and Knabe, 1994). Additionally, approximately 70% and 95% of 
glutamine and glutamate in sow’s milk are utilized via catabolic and synthetic pathways 
in the small intestine of piglets and, therefore, do not enter the portal circulation (Reeds 
and Burrin, 2001; Stoll et al., 1999; Wu et al., 2011). Thus, endogenous synthesis of 
these two amino acids, which are highly abundant in tissue protein, is necessary for 
piglet growth (Rezaei et al., 2013; Wu et al., 2014). Furthermore, arginine, glutamine, 
glycine, and leucine stimulate the phosphorylation of mTOR, S6K1, and 4EBP1 proteins 
in porcine tissues, including mammary tissue (Appuhamy et al., 2012), skeletal muscle 
(Escobar et al., 2006; Suryawan and Davis, 2011; Yao et al., 2008), and the small 
intestine (Wang et al., 2014b; Xi et al., 2011). Taken together, these functional amino 
acids are expected to play an important role in improving the growth of neonatal pigs 
and the efficiency of milk utilization (Wu, 2013). 
In summary, supplementing a mixture of BCAA to the diet for lactating sows 
increases concentrations of amino acids in plasma and milk of sows, and plasma of 
piglets, while reducing oxidative stress in both sows and piglets. BCAA supplementation 
does not affect feed intake by sows or milk consumption by piglets (per kilogram body 
weight), but enhances the growth of suckling piglets likely through stimulating tissue 
protein synthesis. Dietary supplementation with appropriate proportions of leucine, 
isoleucine and valine can prevent an imbalance among BCAA in the diet and provide an 
effective means to improve milk synthesis by lactating sows and, in turn, growth and 
survival of piglets.
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CHAPTER III 
DIETARY SUPPLEMENTATION WITH MONOSODIUM 
GLUTAMATE ENHANCES MILK PRODUCTION BY LACTATING 
SOWS AND GROWTH OF SUCKLING PIGLETS 
SYNOPSIS 
L-Glutamate is a predominant product of extensive catabolism of branched-chain 
amino acids (BCAA) in the lactating mammary gland and a major nutrient in the milk of 
all mammals. Results provided in Chapter II indicate that dietary supplementation with 
BCAA enhances glutamate provision and lactational performance in sows. Although 
glutamate has been traditionally regarded to be a nutritionally nonessential amino acid 
for mammals, emerging evidence shows that a typical corn- and soybean meal-based diet 
may not provide sufficient glutamate to support maximum protein synthesis in growing 
swine. Therefore, the present study was conducted to test the hypothesis that increasing 
dietary content of glutamate through addition of monosodium glutamate (MSG) 
enhances milk production by lactating sows and the growth of their offspring.  Thirty 
multiparous sows (Landrace x Large White) were assigned randomly into one of three 
dietary groups: 1) control (a corn- and soybean meal-based diet), 2) basal diet + 1 % 
MSG; and 3) basal diet + 2 % MSG. Diets were made isonitrogenous by addition of 
appropriate amounts of L-alanine. Lactating sows had free access to drinking water and 
their respective diets. The number of live-born piglets was normalized to 9 per sow at d 
0 of lactation (the day of farrowing). On d 3, 15 and 29 of lactation, body weight and 
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milk consumption of piglets were measured, and blood samples obtained from sows and 
piglets at 2h and 1h after feeding, respectively. Data were analyzed by 2-way ANOVA. 
Feed intake of sows did not differ among the three groups of sows (P > 0.05). 
Concentrations of aspartate, glutamine, citrulline, arginine, and glutamate were higher (P 
< 0.05) in plasma of MSG-supplemented sows and their piglets than for controls. 
Compared with the control, dietary supplementation with 1% and 2 % MSG increased (P 
< 0.05): 1) concentrations of free and protein bound glutamate plus glutamine in milk (P 
< 0.01); 2) milk intake of piglets by 14-25% (P < 0.001); and 3) daily weight gains of 
piglets by 23% and 44%, respectively. These results indicate that dietary 
supplementation with up to 2% MSG enhances milk production to support growth of 
piglets nursing lactating sows.  
INTRODUCTION 
Amino acids are not only building blocks for protein, but are also key regulators 
of metabolic pathways that are vital for whole body homeostasis (Jobgen et al., 2006; 
Wu and Meininger, 2000) and lactogenesis (Bequette et al., 1998).  In primiparous sows, 
limited food intake and inadequate blood flow to lactating mammary glands result in 
reduced provision of nutrients (including AA) to the mammary gland for synthesis of 
components of milk (Kim et al., 1999; Kim and Wu, 2009). Sow’s milk contains high 
concentrations of free and peptide-bound glutamine plus glutamate (Wu et al., 2011) 
which are crucial for growth, development, and normal function of the small intestine of 
neonates (Kim and Wu, 2009). On d 10 of lactation, the lactating porcine mammary 
gland takes up 16 g/d glutamine from the arterial circulation (Trottier et al., 1997), but 
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produces 36 g/d glutamine in milk (Haynes et al., 2009). Therefore, extraction of 
glutamine by the lactating mammary gland is much less than its output in milk and a 
large amount of glutamine (20 g/d) must be synthesized by mammary tissue to support 
the production of milk proteins (Li et al., 2009). Mammary tissue does not contain 
pyrroline-5-carboxylate dehydrogenase or proline oxidase activity; therefore, it cannot 
convert arginine, ornithine, or proline into glutamate or glutamine (O’Quinn et al., 
2002). Instead, BCAA are utilized for glutamate and glutamine synthesis in the 
mammary gland through BCAA transaminase and glutamine synthetase (Li et al., 2009). 
The de novo synthesis of glutamate and glutamine helps to explain the high abundance 
of these two amino acids in both free and peptide-bound forms in milk (Wu and Knabe, 
1994).  
 Sow’s milk is thought to provide adequate amino acids needed for the growth of 
neonatal pigs. However, it has been shown that the amount of milk produced by sows 
during lactation does not provide adequate amounts of all amino acids for maximal 
growth of piglets (Rezaei et al., 2011). For example, Hodge (1974) and Boyd et al. 
(1995) demonstrated that artificially reared neonatal pigs grow at a rate that is at least 
50% greater than that of sow-reared piglets.  Beginning at 8 d of age, piglets exhibit sub-
maximal growth, which may have resulted from inadequate intake of protein or energy 
from sow’s milk (Boyd et al., 1995). Whether the suboptimal growth of piglets results 
from inadequate provision of all or some individual amino acids in diet remain 
unknown. However, increasing the provision of L-arginine (Wu et al., 2004), glycine 
(Wang et al., 2014), L-glutamine (Haynes et al., 2009) and branched-chain amino acids 
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(BCAA; see Chapter II) in sow’s milk enhances growth of the piglets. L-Glutamate is a 
major metabolic fuel, a substrate for synthesis of citrulline and arginine, and an inhibitor 
of glutamine degradation in the small intestine (Boutry et al., 2011; Reeds and Burrin, 
2001; Wu, 2009). At present, little is known about effects of glutamate on milk 
production by any lactating mammal. Although glutamate has been traditionally 
regarded as a nutritionally nonessential amino acid for mammals, emerging evidence 
shows that a typical corn- and soybean meal-based diet may not provide sufficient 
glutamate to support maximum protein synthesis in growing swine (Rezaei et al., 2013). 
The current study was conducted to test the hypothesis that increasing dietary provision 
of glutamate through addition of monosodium glutamate (MSG) enhances milk 
production by lactating sows and the growth of their suckling piglets. 
MATERIALS AND METHODS 
Animals housing and management for feeding trials 
The experimental protocol for this study was approved by the Texas A&M 
University Institutional Animal Care and Use Committee. Thirty multiparous sows 
(Yorkshire × Landrace; parity = 2 and 3) were housed individually in 1.8 × 2.5 m pens 
with plastic coated perforated flooring. During the entire gestation, they were fed 2 kg/d 
a corn- and soybean meal-based diet containing 12.0% crude protein and 12.9 MJ/kg 
metabolizable energy (Li et al., 2010).  Immediately after farrowing, the sows were 
assigned randomly to be fed a corn- and soybean meal-based diet (Table A-3) 
supplemented with either 0% (control), 1%, or 2% MSG. Diets were provided to sows 
twice a day (3 kg/meal) and they had free access to their respective diets. There were 10 
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sows per group. Diets were made isonitrogenous and isocaloric by addition of 
appropriate amounts of L-alanine at the expense of cornstarch (Table A-18). The content 
of sodium in the three diets was made the same through the addition of appropriate 
amounts of NaCl (Table A-18). Supplemental AA were obtained from Ajinomoto Co., 
Inc. (Tokyo, Japan). Before being fed to sows, complete diets were mixed thoroughly 
using a Hobart mixer. On the day of farrowing (d = 0), cross fostering of newborn pigs 
was performed to minimize within-litter variation, and the number of piglets per sow 
was standardized to nine, yielding a total of 270 piglets for this experiment. The number 
of male and female piglets per treatment group was the same. The ambient temperature 
in the farrowing facility was maintained at 26°C throughout the trial. Heat lamps were 
used to provide warmth for neonatal pigs in each pen. Lactating sows had free access to 
drinking water and their respective diets. Feed intake of the sows was recorded daily. 
Teeth of piglets were clipped and their tails docked at d 3 of age. At this age, each piglet 
was also ear notched for identification and received an intramuscular iron dextran 
injection (200 mg per piglet). On d 3, 15 and 29 of lactation, all sows and piglets were 
weighed. During the entire experiment, piglets had no access to the feed provided to 
sows and piglets were not provided with any creep feed. The growth performance and 
survival rates of piglets were determined. 
Collection of blood samples from sows and piglets 
Heparinized tubes were used to draw blood from sows and piglets on d 3, 15, and 
29 of lactation. Specifically, blood samples (10 ml) were obtained from all sows via the
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caudal auricular vein in the ear 2h post-feeding, and blood samples (2 ml) were obtained 
from the jugular vein of two randomly selected piglets in each litter 1 h after nursing.  
Blood samples were immediately centrifuged at 10,000 x g for 1 min, and the 
supernatant fluid (plasma) was stored at -80°C for subsequent analyses.  
Collection of milk from sows  
To obtain milk samples, 20 IU oxytocin was administered via the ear vein of 
sows to induce letdown of milk into the teat canal from which it was expressed manually 
(Wu and Knabe, 1994). Milk samples (50 ml/gland) were collected from three different 
mammary glands (front, middle, and rear). Equal volumes of milk (10 ml) from each 
gland of a sow were mixed, and thereafter the samples were stored at -80
o
C for 
subsequent analyses.  
Milk consumption of piglets 
Milk consumption of piglets was determined using the weigh-suckle-weigh 
method as previously described (Kim and Wu, 2004). Briefly, on d 3, 15, and 29 of 
lactation, after blood sampling, piglets were separated from their mothers for 1.5 h and 
then returned to the sows for nursing. Piglets were weighed before and after nursing to 
calculate their milk intake and this procedure was repeated four times.     
Analysis of milk composition 
The frozen whole-milk samples were thawed at 4°C, and then used for 
determination of total milk fat, lactose, crude protein, DM and ash according to AOAC 
(1990) procedures. Additionally, protein was determined by the modified Lowry 
procedure using purified porcine IgG as the standard (Wu and Knabe, 1994). Milk 
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lactose was determined by the colorimetric method of Marier and Boulet (1959) that 
involved the reaction with phenol and sulfuric acid and then reading against the blank at 
490 nm. Total milk lipids were extracted by using a mixture of 
isopropylalcohol:heptane:1N H2SO4 (Dole, 1956).  
Analysis of free amino acids in plasma 
Plasma samples (0.5 mL) were deproteinized with an equal volume of 1.5 M 
HClO4 and neutralized with 0.25 mL of 2 M K2CO3. The neutralized samples were 
analyzed for free AA by HPLC methods involving precolumn derivatization with o-
phthal-dialdehyde (Wu et al., 1997).  
Analysis of free and protein-bound amino acids in milk 
For analysis of free AA, milk samples (0.5 mL) were deproteinized with an equal 
volume of 1.5 M HClO4 and neutralized with 0.25 mL of 2 M K2CO3. The neutralized 
samples were analyzed for free AA, as described above. Composition of protein-bound 
AA in milk was determined as described by Dai et al. (2014).  
Analysis of glucose, ammonia, urea, lactate, pyruvate and ketone bodies in plasma 
and milk 
Deproteinized and neutralized plasma or milk samples were analyzed for 
glucose, ammonia, urea, lactate, pyruvate, and ketone bodies by enzymatic methods 
(Tekwe et al., 2013).  The enzymes hexokinase, glucose-6-phosphate dehydrogenase, 
glutamate dehydrogenase, urease, lactate dehydrogenase, and β-hydroxybutyrate 
dehydrogenase were used for assays of glucose, ammonia plus urea, lactate plus 
pyruvate, and acetoacetate plus β-hydroxybutyrate, respectively. We also measured 
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cholesterol, triglycerides, free fatty acids and glycerol in sows and piglet’s plasma and 
milk colorimetrically according to manufacturer’s manual. 
Determination of plasma thiobarbituric acid reactive substances (TBARS) 
To evaluate the oxidative status of sows and piglets, their plasma was analyzed 
for TBARS. Thiobarbituric acid forms a reaction with malondialdehyde (a naturally 
occurring product of lipid peroxidation) under high temperature and acidic conditions 
and can be measured colorimetrically. The technical procedure was performed as 
recommended by the manufacturer (Cayman Chemical, Ann Arbor MI). Briefly, 100 µL 
of thawed plasma was placed into a labeled glass tube and mixed with the reagents of the 
commercial kit (Cayman Chemical, Cat # 10009055). Each tube was capped and 
incubated at 95°C for 60 min. The tubes were then cooled in an ice bath for 10 min. 
Thereafter, the tubes were centrifuged at 1,100 × g for 15 min and the supernatant fluid 
was obtained for the measurement of absorbance at 530-540 nm (Draper et al., 1993). 
STATISTICAL ANALYSIS 
Results are expressed as means ± pooled SEM. Data were statistically analyzed 
using two-way ANOVA software available online at 
https://housseinassaad.shinyapps.io/TwoWayANOVA/. Data on rates of piglet mortality 
were analyzed by X
2
-analysis. Values of P ≤0.05 are taken to indicate statistical 
significance. All statistical analyses were performed using the 64-bit version of the R 
3.1.0 software on Linux.
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RESULTS 
Feed intake and body weights of lactating sows  
There was no difference in feed intake by sows among groups which was 
approximately 32 g/kg BW per day throughout the 29 d period of lactation (Table A-20).  
With advanced lactation, sows mobilized body reserves to provide nutrients for milk 
production. On the day of farrowing, body weights of sows did not differ among the 
three treatment groups (Table A-21). However, on d 29 of lactation, sows in the 1% and 
2% MSG groups were heavier (P < 0.05) than those in the control group (Table A-21). 
Overall, sows in the control, 1% MSG, and 2% MSG groups lost (P < 0.05) 21.3, 17.3 
and 13.4 kg between d 0 and d 29 of lactation, respectively (Table A-22). Most 
(approximately 60%) of the weight losses in sows occurred in the fourth week of 
lactation. The sows used in this study did not exhibit any adverse response to MSG 
supplementation.  
Milk intake, growth and mortality of sow-reared piglets  
Milk intake of piglets was 14% and 25% higher in the 1% and 2% MSG groups, 
respectively, compared with the control sows (Table A-21). Piglet BW at d 0 of lactation 
did not differ among treatment groups (Table A-22). However, the BW of piglets nursed 
by sows fed the MSG-supplemented diets were greater (P < 0.01) at d 15 and 29 of 
lactation, compared with piglets from control-fed sows. Average daily weight gains of 
piglets from sows fed the MSG-supplemented diet were greater (P < 0.01) throughout 
the 29 d lactation, compared with piglets from control-fed sows (Table A-22). Piglets in 
the 1% and 2% MSG groups had 27% and 42% greater weight gains (P < 0.01) than 
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piglets in the control group. Of note, rates of preweaning mortality for piglets in 1% and 
2% MSG groups were 4.4% and 3.3%, respectively, which were lower (P < 0.05) than 
the 16.7% preweaning mortality for piglets nursed by control sows (Table A-23). 
Milk composition   
Concentrations of DM, CP, fat and carbohydrate were higher (P < 0.01) in milk 
from MSG-supplemented sows, as compared to control sows (Table A-24). Lactose 
accounted for 89.3% to 89.8% of total carbohydrate in each treatment group. 
Composition of milk did not differ among treatment groups. Concentrations of DM, fat 
and CP in milk were higher on d 3 than on d 15 or d 29 of lactation (P < 0.05), but did 
not differ between d 15 and 29 of lactation. There was no treatment x day interaction 
effect for milk composition (Table A-24). 
Concentrations of free AA in the plasma of sows and piglets  
Concentrations of AA in plasma of sows and piglets at d 3, 15 and 29 of lactation 
are summarized in Tables 8 and 9, respectively. MSG supplementation to sows during 
lactation increased (P < 0.001) concentrations of BCAA, Pro, Arg, Asn, Glu and Gln, in 
plasma compared with values for control sows. Concentrations of Cys, Gly, His, and Lys 
in maternal plasma was not affected by treatment (Table A-25). The effect of day of 
lactation was significant (P < 0.05) for all AA in plasma of sows except for Cys, Glu, 
Gln, Gly, Lys, Met, Pro and Tau. Similar results were observed for concentrations of free 
AA in plasma from control and MSG-supplemented piglets, except that significant 
treatment x day effects were detected for beta-Ala, Tau, and Trp (Table A-26). 
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Concentrations of protein-bound and free AA in milk  
Concentrations of many free AA in sow’s milk, including Ala, Arg, Asp, Asn, Cit, 
Glu, Gln, BCAA and Pro, were higher (P < 0.05) in MSG-supplemented sows, compared 
with the control group, with values being highest for the 2% MSG group (Table A-27). 
There was a significant effect of day for all free AA in milk. However, treatment × day 
interaction effects (P < 0.05) were detected only for Gln and Ser (Table A-27). All 
protein-bound AA, including Arg, Cit, Asp plus Asn, and Glu plus Gln, were higher (P < 
0.05) in milk of MSG-supplemented as compared to control sows. Concentrations of all 
protein-bound AA were affected by day of lactation, but there was no treatment × Day 
effect for any AA (Table A-28). 
Metabolites in the plasma of sows and piglets and in milk  
Effects of MSG supplementation on concentrations of ammonia, urea, glucose, 
lactate and pyruvate in the plasma of sows and piglets and in sow’s milk are summarized 
in Table A-29. Concentrations of glucose in plasma of MSG-supplemented sows were 
higher (P < 0.05) than those for control sows. No effect of treatment on concentrations of 
glucose in sow’s milk or plasma of piglets was detected. MSG supplementation did not 
affect concentrations of ammonia, urea, lactate or pyruvate in the plasma of sows or 
piglets or in sow’s milk. Only concentrations of lactate in plasma and milk of sows 
increased as lactation advanced. No treatment × day of lactation interactions were 
detected for concentrations of ammonia, urea, lactate and pyruvate plasma and milk of 
sows and plasma of piglets on d 3, 15 or 29 of lactation. Acetoacetate and β-
hydroxybutyrate were not detected in plasma or milk of sows and plasma of piglets 
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during lactation (detection limit = 25 μM). Concentrations of lipids in plasma and milk 
are summarized in Table A-30. 
Plasma TBARS concentrations in sows and piglets  
Concentrations of TBARS in plasma of sows increased (P < 0.001) as lactation 
progressed, but the opposite changes occurred in plasma from piglets (Table A-31). MSG 
supplementation reduced (P < 0.01) the concentrations of TBARS in plasma from sows 
compared with control sows (Table A-31). Concentrations of TBARS in plasma from 
piglets were not affected by treatment or day of lactation.   
DISCUSSION 
Glutamate is a relatively abundant amino acid in typical corn- and soybean meal-
based diets for animals (Li et al., 2011).  However, 95% to 97% of glutamate in enteral 
diets is extensively catabolized in the small intestine to provide energy and synthesize 
nitrogenous substances with enormous physiological importanceincluding protein, 
glutathione, arginine and proline. In addition, there is growing evidence that glutamate 
inhibits the catabolism of glutamine and BCAA in enterocytes (Boutry et al., 2011; 
Reeds and Burrin, 2001) and possibly some amino acids (including nutritionally 
essential amino acids) by intestinal bacteria (Dai et al., 2013; Rezaei et al., 2013).  Thus, 
glutamate has multiple functions in regulating intestinal nitrogen metabolism to support 
integrity of the gut mucosa and spare dietary AA for utilization by extra-intestinal 
tissues.  In support of this view, dietary supplementation with MSG increased 
concentrations of some AA (including BCAA, glutamine, arginine, proline, and 
tryptophan) in plasma of lactating sows.  Although it had been a long-standing view that 
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animals have no requirements for dietary glutamate, compelling evidence from this 
study indicates that a sufficient supply of glutamate in diets is required to maximize 
lactational performance of sows. Thus, the present work represents a new paradigm shift 
in understanding of protein nutrition in animals. 
 Results of this study indicated that supplementing the diet of multiparous sows 
with up to 2% MSG during the entire 29 d period of lactation increased milk yield and 
concentrations of total AA and other nutrients in milk which improved growth 
performance of piglets. It is well known that insufficient milk production by sows limits 
maximal growth performance of neonatal pigs; however, it was not known whether a 
lack of all AA or certain AA was responsible for suboptimal milk production by sows 
fed conventional corn- and soybean meal-based diets.  Besides arginine (Wu et al., 
2004), glutamine (Haynes et al., 2009), and glycine (Wang et al., 2014), glutamate is the 
latest addition to the family of synthesizable AA that enhances milk production by sows. 
The mammary gland of lactating sows produce glutamate from BCAA and α-
ketoglutarate in mitochondria and cytoplasm and subsequently converts glutamate into 
glutamine by glutamine synthetase in the cytoplasm (Li et al., 2009). In contrast, the 
lactating gland does not hydrolyze glutamine into glutamate or form glutamate from 
proline due to the absence of glutaminase or proline oxidase, respectively (O’Quinn et 
al., 2002). Additionally, formation of glutamate from arginine in mammary tissue is very 
limited because of low activity of pyrroline-5-carboxylate dehydrogenase (O’Quinn et 
al., 2002). As a result, nutritionally significant quantities of glutamate in mammary 
epithelial cells are derived only from maternal blood and de novo synthesis from BCAA. 
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Because dietary BCAA in typical corn- and soybean meal-based diets are inadequate for 
maximizing milk production by lactating sows (Chapter II), increasing glutamate in 
maternal blood is likely an effective strategy to increase the availability of glutamate for 
protein synthesis in the lactating mammary gland.   
Whole colostrum and mature milk from sows contain 13.8 and 5.3 g/L glutamate, 
respectively (Wu et al., 2011).  Given daily milk yields of 4.7 and 7.7 L/sow on d 3 and 
15 of lactation, respectively, the lactating sow produces 65 and 41 g glutamate on d 3 
and 15 of gestation, respectively. Because accurate data on the extraction of arterial 
glutamate by the mammary gland of lactating sows are not available, it is unknown 
whether maternal blood supplies sufficient glutamate for synthesis of milk proteins.  
Uptake of AA by the lactating gland is positively correlated with their concentrations in 
the arterial blood (Manjarin et al., 2014). Thus, dietary supplementation with MSG, 
which increases concentrations of glutamate in maternal plasma increases the 
availability of glutamate for the synthesis of glutamine, alanine, aspartate, asparagine, 
and protein in mammary epithelial cells. This helps to explain how dietary 
supplementation with MSG enhanced concentrations of protein in sow’s milk in this 
study (Tables A-24 and A-28).       
 Besides protein, concentrations of lactose and fat in sow’s milk were increased 
by dietary supplementation with MSG (Table A-24).  Glutamate, glutamine, alanine, 
aspartate, proline and arginine are substrates for gluconeogenesis in pigs.  Increases in 
the concentrations of those AA in the maternal plasma contributed to the increase in 
circulating concentrations of glucose in lactating sows (Table A-29), which, in turn, 
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increased substrate for lactose synthesis by mammary tissue.  These AA may also be 
utilized to synthesize fatty acids by white adipose tissue (Jobgen et al., 2006), and uptake 
of fatty acids by the lactating gland promotes the formation of triacylglycerides in 
mammary epithelial cells. Furthermore, an increase in circulating levels of arginine in 
MSG-supplemented sows is expected to enhance blood flow to the mammary gland via 
increases in the production of nitric oxide (a major vasodilator), thereby increasing the 
provision of all nutrients for milk synthesis in mammary epithelial cells (Kim and Wu, 
2009).     
The weight gain of piglets is positively correlated with increased volume and 
nutrient composition of milk (Noblet and Etienne, 1989). Results of the present study 
indicate that piglets reared by MSG-supplemented sows have faster rates of growthand, 
therefore, heavier final BW at weaning (Tables A-21 and A-22). The increases in milk 
consumption and growth of piglets indicate greater production of milk by sows. 
Improved nutritional status of piglets improves their antioxidative capacity (Table A-31) 
as well as their digestive and immune functions (Wu et al., 2014), thereby reducing the 
rate of preweaning mortality (Table A-23). Because the voluntary feed intake of sows 
was not affected by treatment (Table A-20), increased concentrations of free and protein-
bound AA in milk likely result from increased efficiency of use of dietary nutrients for 
protein synthesis by MSG-supplemented sows. Indeed, arginine and glutamine activate 
the mechanistic target of rapamycin cell signaling pathway to stimulate protein synthesis 
and inhibit proteolysis in skeletal muscle and other tissues (Wu, 2013).  This mechanism 
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can explain our finding that dietary supplementation with MSG reduced the loss of body 
weight by lactating sows. 
Mateo et al. (2008) reported that dietary supplementation of lactating sows with 
arginine enhances its concentration in maternal plasma, milk production, and piglet 
growth. At present, the use of exogenous arginine in diets for lactating sows is limited by 
its relatively high costs.  MSG is a very cheap ingredient relative to arginine and, 
therefore, is expected to be cost-effective in promoting the growth of sucking piglets. An 
advantage of the use of MSG over arginine is that MSG increases concentrations of 
glutamine in maternal plasma and ameliorates loss of body weight, whereas arginine 
does not (Mateo et al., 2008). It is possible that glutamine and arginine, whose 
concentrations were increased in plasma of MSG-supplemented sows, have a synergetic 
effect to improve protein balance in skeletal muscle and reduce fat mobilization in white 
adipose tissue.  The underlying mechanisms remain to be elucidated in future 
investigations.   
 In summary, supplementing a typical corn- and soybean meal-based diet with 
MSG for lactating sows enhances milk synthesis and growth of their suckling piglets by 
increasing efficiency of milk protein synthesis and reducing oxidative stress. The 
increased litter weight gain results from increased provision of AA, including glutamine, 
arginine and poline, fat and lactose from sow’s milk. Given a plethora of beneficial 
effects of glutamate on lactation, MSG can be safely and effectively used to improve 
lactational performance of sows and, therefore, growth of suckling piglets. Thus, 
glutamate is truly a functional AA in lactating sows.
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CHAPTER IV 
BRANCHED-CHAIN AMINO ACIDS REGULATE 
INTRACELLULAR PROTEIN TURNOVER IN PORCINE 
MAMMARY EPITHELIAL CELLS 
SYNOPSIS 
Dietary supplementation with branched-chain amino acids (BCAA; leucine, 
isoleucine, and valine) enhances lactational performance in sows (Chapter II). This study 
tested the hypothesis that BCAA stimulate protein synthesis and inhibits protein 
degradation in mammary epithelial cells. Porcine mammary epithelial cells (PMEC) 
were cultured at 37°C in Dulbecco’s modified Eagle medium containing 5 mM D-
glucose, 1 mM phenylalanine, L-[ring-2,4-3H]phenylalanine, 0.1 (control), 0.25, 0.5, 1, 
or 2 mM L-leucine, L-isoleucine or L-valine or a mixture of the three BCAA. The 
culture medium also contained physiological concentrations of other amino acids found 
in plasma of lactating sows. Proliferation, protein synthesis, proteolysis, β-casein 
production, mechanic target of rapamycin (mTOR) signaling, and the ubiquitin-
proteasome pathway were determined for PMEC. Proliferation of cells and abundances 
of phoshporylated mTOR, 4E-BP1, and S6K1 proteins increased (P < 0.05), but the 
abundances of ubiquitinated protein and proteasome decreased (P < 0.05) when 
extracellular concentrations of leucine, isoleucine, valine, or a mixture of BCAA were 
increased from 0.1 to 2 mM. Compared with the control, 0.25, 0.5, 1 or 2 mM BCAA 
enhanced (P < 0.01) protein (including β-casein) synthesis, while decreasing (P < 0.05) 
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protein degradation in PMEC in a dose-dependent manner. Collectively, our results 
indicate that physiological concentrations of BCAA regulate protein turnover in 
mammary epithelial cells to favor net protein synthesis through stimulating the mTOR 
signaling pathway and inhibiting the ubiquitin-proteasome pathway. These findings 
advance basic understanding of molecular mechanisms in epithelial cells of the 
mammary gland whereby dietary BCAA supplementation enhances milk production by 
lactating sows.  
INTRODUCTION 
Lactation is essential for survival, growth and development of mammalian 
neonates. Milk protein synthesis occurs in mammary epithelial cells and depends on the 
availability of amino acids (Manjarin et al., 2014; Reynolds et al., 1994). In recent years, 
branched-chain amino acids (BCAA; L-leucine, L-isoleucine and L-valine) have 
received much attention as they can regulate cell cycle progression (Xu et al., 1998), cell 
differentiation (Kimura and Ogihara, 2005; Gonçalves and Gomes-Marcondes, 2010), 
and protein synthesis in muscle (Kimball et al., 1999; Escobar et al., 2006, 2010). BCAA 
are actively taken up by mammary epithelial cells (Lei et al., 2013), and activate the 
mechanic target of rapamycin (mTOR) cell signaling pathway (Suryawan and Davis, 
2011). Appuhamy et al. (2012) reported that, compared with Dulbecco’s modified 
Eagle’s F12 Ham medium (DMEM-F12) containing 17.5 mM glucose, 0.7 mM arginine, 
0.45 mM leucine, 0.42 mM isoleucine, and 0.45 mM valine (~ 3 to 5 times physiological 
concentrations of glucose and amino acids in the plasma of lactating cows and sows (Lei 
et al., 2012; Mateo et al., 2008), the omission of leucine or isoleucine reduced mTOR 
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phosphorylation and protein synthesis in incubated bovine mammary tissue.  Similar 
results were obtained for mouse CID and bovine L-1 cells (mammary epithelial cell 
lines) cultured in DMEM-F12 containing the same high concentrations of glucose and 
amino acids vs the DMEM-F12 without leucine (Moshel et al., 2006). In these studies 
(Appuhamy et al., 2012; Moshel et al., 2006), the investigators did not determine protein 
degradation in mammary tissue or cells. Comparison of results obtained from cell 
cultures in the presence of very high concentrations of amino acids (e.g., BCAA) and in 
their complete absence may not be nutritionally or physiologically relevant. 
 Net synthesis of milk proteins by mammary epithelial cells depends on the 
balance between intracellular protein synthesis and degradation (Xi et al., 2012; Kong et 
al., 2014; Tan et al., 2011). The mTOR pathway is a master regulator of protein 
synthesis and may also play a role in inhibiting protein degradation (Meijer et al., 2014).  
Among intracellular proteolytic systems, the ATP-ubiquitin-proteasome-dependent 
pathway plays a major role in degrading proteins in animal cells (Ciechanover, 2012). At 
present, no information is available about effects of individual or a mixture of BCAA 
within physiological concentrations on protein turnover (synthesis and degradation) in 
mammary epithelial cells cultured in the presence of the physiological concentration of 
glucose.  Based on our recent findings that dietary supplementation with BCAA 
enhances milk production by lactating sows (Chapter II), the present study was 
conducted with porcine mammary epithelial cells (PMEC) to test the hypothesis that 
BCAA stimulate protein synthesis and inhibit proteolysis to favor net synthesis of 
protein by these cells.  
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MATERIALS AND METHODS 
Reagents, antibodies, cell line 
L-[ring-2,4-
3
H]phenylalanine was purchased from American Radiolabel 
Chemicals. Dulbecco’s modified Eagle’s F12 Ham medium (DMEM-F12), sterile fetal 
bovine serum (FBS), and Gibco antibiotic-antimycotic liquid were purchased from 
Invitrogen. Insulin and amino acids were obtained from Sigma. Customized DMEM 
containing 5 mM D-glucose, 0.1 mM L-leucine, 0.1 mM L-isoleucine, 0.1 mM L-valine, 
and physiological concentrations of other amino acids found in plasma of lactating sows 
(Chapter II) was procured from Gibco. The BCA protein assay kit and SuperSignal West 
Dura Extended Duration Substrates were obtained from Pierce. Rabbit-derived primary 
antibodies against mTOR and phoshporylated mTOR (Ser2481), p70 S6K, 4E-BP1, 20S 
proteasome, and mouse primary antibodies against phoshporylated 4E-BP1 (Thr70), 
phoshporylated p70 S6K (Thr389), and ubiquitin were purchased from Cell Signaling. 
Mouse primary antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
was purchased from Chemicon. Secondary antibodies of peroxidase-labeled donkey anti-
rabbit or anti-mouse IgG were obtained from Jackson Immuno Research.  The ß-casein 
antibody was obtained from Santa Cruz (sc-30042) and prolactin from Sigma-Aldrich 
(Cat # 6520). PMEC were obtained as described in the following section. 
Preparation and culture of PMEC  
Aseptic techniques were used to isolate PMEC from three different mammary 
glands of a 9-month-old nonpregnant and nonlactating female pig. The gilt was 
sacrificed in a local slaughterhouse to obtain mammary glands. Mammary tissue was 
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disinfected by three cycles of quick dipping (2 seconds) in 75% ethanol and rinsing with 
1x phosphate-buffered saline (PBS). After visible fat tissue was removed from the 
disinfected mammary tissue, fat-free mammary tissue (10 g) was minced into small 
pieces (0.1 cm in diameter) using surgical scissors. The tissue pieces were placed in a 
50ml falcon tube followed by addition of 40 ml DMEM-F12 medium with 2 mM L-
glutamine (Sigma Cat. # D8437). The medium also contained 1 mg/ml collagenase A 
(Sigma Cat. # C9407, St. Louis, MO, USA), 0.05% hyaluronidase (Sigma Cat. # 
H3506), and 1X antifungal/anibiotics mixture (Gibco Cat. # 15240-062). The tissue 
pieces were dissociated at 37
o
C by gentle agitation (250 rpm on a rocker) for 14 h. The 
tissue digestion solution was transferred into 80-micron cell strainer meshes (80-mesh; 
BD Biosciences Cat. # 352360) to remove undissociated tissue, fat and debris. Cells that 
passed through the strainer meshes were collected into a 50ml conical tube. The tube 
was centrifuged at 800 x g for 3 min at 4
o
C, and the cells were washed three times with 




; Sigma Cat. # D1408) containing 1X 
antifungal/antibiotics mixture. The cell pellet (PMEC) was washed three times with 10 
ml DMEM-F12 (pH 7.4) containing 5% FBS and 1x antifungal/antibiotics mixture. The 
isolated PMEC were cultured in growth medium in four Petri dishes (Olympus Cat. # 
25-202). Each dish contained 10 ml DMEM-F12, 10% FBS, 5 µg/mL insulin (Gibco 
12585-014), 1 µg/mL hydrocortisone (Sigma Cat# H0888), 5 ng/mL epidermal growth 
factor (BD Cat # 354001), 50 µg/ml Gentamycin (Gibco Cat. # 15710-064), and 1x 
antifungal/antibiotics mixture. Every 24 h, medium was removed and the cells were 
washed three times with PBS containing 1x antifungal/antibiotics mixture. Thereafter, 
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fresh growth medium (10 ml) was added to the dish for continuous culturing. At 80% 
confluence, the cells were collected using 0.25% trypsin and 1 mM EDTA (Life 
Technology Cat. # 25300-054; diluted with PBS supplemented with 1x 
antifungal/antibiotics mixture).  The trypsinization step took ~ 5 min.  The cells were 
then stored in liquid nitrogen as passage 1. Some passage-1 cells continued to be 
cultured (1 × 10
6
 cells) in 10 ml fresh growth medium until 80% confluence as described 
above. This resulted in passage-2 cells. Cells at passage 5 were used for the current 
study. All cell cultures were carried out at 37
o
C in a 5% CO2/95% air incubator. 
To freeze PMEC in liquid nitrogen, culture medium was removed from the Petri 
dish and the cells were washed three times with 1x PBS through centrifugation. Then, 1 
mL of 0.25% trypsin and 1 mM EDTA (prepared in PBS supplemented with 1x 
antifungal/antibiotics mixture) was added to the cell pellet. The Petri dish was cultured 
for 5 min, and cell adhesion was monitored under an inverted phase-contrast 
microscope. Once cells were loosened, 5 mL complete growth DMEM-F12 medium was 
added to the Petri dish. The whole solution was transferred to a 50-ml conical tube, and 
the tube was centrifuged for 2 min at 600 x g. The supernatant fluid was removed, and 
the cells were gently re-suspended in 45 ml pre-warmed PBS. The cells were washed 
one more time with PBS, and the cell pellet was re-suspended in 1 mL solution 
consisting of 95% FCS and 5% DMSO (Sigma Cat. # D8418). The concentration of 
PMEC in this solution was 1x10
6
/ml.  An aliquot of the solution (1 mL) was transferred 
to a screw-top Cryovial (Corning Cat. # 25704). The Cryovials were quickly placed in a 
freezing chamber (Bel-Art-Product Cat. F18844) filled with isoproponol (Sigma Cat. # 
  103 
270490) and then transferred to a -80
o
C freezer. After 16 h, the Cryovials were removed 
from the freezer and immediately placed in a liquid nitrogen chamber for long-term 
storage. 
Determination of cell proliferation  
PMEC (1×10
6
 cells/well) were cultured for 3 days in 6-well plates containing 2 
mL DMEM-F12, 5% FBS, 0.2 μM prolactin, 5 µg/mL insulin, 1 µg/mL hydrocortisone, 
50 µg/mL Gentamycine, and 1x antifungal/antibiotics mixture (pH, 7.4), with the 
medium being changed every 24h. Cells were then used to determine effects of BCAA 





were seeded in 24-well culture plates containing 0.5 mL DMEM-F12/well. After 
overnight culture, the cells were maintained for 6 h in 0.5 ml customized DMEM 
containing 5 mM D-glucose, 0.1 mM L-leucine, 0.1 mM L-isoleucine, 0.1 mM L-valine, 
and physiological concentrations of other amino acids found in the plasma of lactating 
sows (Chapter II) . Thereafter, the cells were cultured in 0.5 ml of fresh customized 
DMEM containing 5% FBS, 0.2 μM prolactin, 5 µg/mL insulin, 1x antifungal/antibiotics 
mixture, 5 mM D-glucose, 0.1 (control), 0.25, 0.5, 1 or 2 mM Leu, Ile, or Val or a 
mixture of those three BCAA. We chose 0.1 mM for each of the three BCAA as the 
control, based on the concentrations of leucine (0.17 mM), isoleucine (0.09 mM) and 
valine (0.22 mM) in the plasma of sows at d 15 of lactation (Chapter II). Dietary 
supplementation with 1.64% leucine plus 0.64% isoleucine plus 0.79% valine increased 
the concentrations of leucine, isoleucine, and valine in the plasma of sows on Day 15 of 
lactation (2 h after feeding) to 0.40, 0.20, and 0.42 mM, respectively (Chapter II).  
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Culture medium was changed every 2 days. Cell numbers were determined on Days 2, 4 
and 6, as described by Wang et al. (2014). Briefly, at the end of the pre-specified time 
period, culture medium was aspirated and cells were washed three times with PBS. The 
cells were then fixed in 50% ethanol for 30 min, followed by staining with 0.2% solution 
of Janus Green B in PBS (pH 7.1-7.2) for 30 min at room temperature. Dye was 
aspirated off and plates were washed using cold PBS. After 0.5 ml of 0.5 N HCl was 
added to each well, the plates were gently shaken by hand for 5 min. Thereafter, 300 µl 
of each colored supernatant fluid was collected and transferred to a 96-well plate and 
read against blanks (0.5 N HCl) at 595 nm in a microplate reader (Molecular Device, 
Sunnyvale, CA).  
Determination of protein synthesis in PMEC 
The PMEC (1×10
5
 cells/well) were cultured for 3 days in 6-well plates 
containing 2 ml DMEM-F12, 5% FBS, 0.2 μM prolactin, 5 µg/mL insulin, 1 µg/mL 
hydrocortisone, 50 µg/ml Gentamycin, and 1x antifungal/antibiotics mixture (pH, 7.4), 
with the medium being changed every 24h. Cells were then used to determine effects of 
BCAA on protein synthesis, as described by Kong et al. (2014).  Briefly, the cells were 
maintained for 6 h in 2 ml customized DMEM, and then cultured for 4 days in the 
customized DMEM containing 5% FBS, 0.2 μM prolactin, 5 µg/mL insulin, 1x 
antifungal/antibiotics mixture, and 0.1, 0.25, 0.5, 1 or 2 mM Leu, Ile, Val or a mixture of 
the three BCAA. There were eight replicate sets of wells per a BCAA or a mixture of 
BCAA at each dose. After the 4-day culture, the medium was removed and the cells 
were washed once with 2 ml medium. Then, cells were cultured for 3 h in 2 ml 
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customized DMEM containing 5% FBS, 0.2 μM prolactin, 5 µg/mL insulin, and 1 mM 
L-phenylalanine, 0.8 µCi L-[ring-2,4-
3
H]phenylalanine (American Radiolabeled 
Chemicals). The medium also contained 0.1 (control), 0.25, 0.5, 1 or 2 mM Leu, Ile or 
Val or a mixture of these three BCAA. At the end of a 3h culture period, the medium 
was collected and cells were washed rapidly three times with 2 ml ice-cold PBS. The 
medium and the cell pellet were separately mixed with 2 ml of 10% trichloroacetic acid 
(TCA) (Wu and Thompson, 1990). Cells in each well were scraped and the whole 
solution was collected into a 15-ml tube and centrifuged at 3,000g for 5 min. The TCA-
treated culture medium and the TCA-treated cell extracts were combined and centrifuged 
at 600 x g for 10 min. The supernatant ﬂuid was removed and the protein pellet washed 
three times with 5 ml of 10% TCA, and then dried in air at 37°C. After the pellet was 
dissolved in 0.5 ml of 1 M NaOH, 0.4 ml of the solution was transferred to a 20-ml 
scintillation vial containing 19 ml of Hionic Fluor Scintillation cocktail (PerkinElmer, 
MA, USA). The 
3
H- phenylalanine generated radioactivity was determined by a liquid 
scintillation counting after overnight standing at room temperature. The specific 
radioactivity of 
3
H-phenylalanine in the medium was used to calculate the rate of protein 
synthesis in cells. 
Determination of protein degradation in PMEC 
PMEC were cultured as described for the measurement of protein synthesis, 
except that beginning on Day 4 of culture in the customized DMEM, cells were cultured 
for 24 h in 2 ml of DMEM containing 0.1 mM L-phenylalanine, L-[ring-2,4-
3
H]phenylalanine (0.8 µCi/well) and 0.1, 0.25, 0.5, 1 or 2 mM Leu, Ile, or Val or a 
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mixture of these three BCAA. After the 24 h culture to label cellular proteins, cells were 
washed three times with 2 ml DMEM medium containing 1 mM L-phenylalanine to 
deplete intracellular free [
3
H]phenylalanine (Wu and Thompson, 1990). The cells were 
then cultured for 3 h in 2 ml customized DMEM containing 1 mM L-phenylalanine. The 
customized medium also contained 0.1 (control), 0.25, 0.5, 1 or 2 mM Leu, Ile, or Val or 
a mixture of these three BCAA. At the end of a 3h culture period, the culture medium 
was collected into a new tube.  Then, 2 ml of 10% TCA was added separately to each 
culture medium and each well in the plates.  Cells were then scraped from the well 
thoroughly.  The whole TCA extract of the cells was collected into a 15-ml tube.  TCA-
treated culture medium and TCA-treated cell extract were centrifuged separately at 
3,000 x g for 5 min. The supernatant ﬂuid from the TCA-treated culture medium was 
used for the measurement of 
3
H-phenylalanine. The TCA-treated cell extract (protein 
pellet) was washed three times with 5 ml of 10% TCA and dried in air at 37°C. The 
protein pellet was then dissolved in 0.5 ml of 1 M NaOH and 0.4 ml of the solution 
transferred to a 20-ml scintillation vial containing 19 ml Hionic Fluor Scintillation 
cocktail for measurement of 
3
H-phenylalanine. For determining [
3
H]phenylalanine 
released from prelabeled proteins into culture medium, the collected medium was 
centrifuged at 3,000 x g for 2 min to remove any dead cells. An aliquot (1 ml) of the 
supernatant ﬂuid was transferred to a 15 ml tube containing 2 ml 10% TCA. After the 
tubes were centrifuged at 3,000 x g for 5 min, 1 ml of the supernatant ﬂuid was 
transferred to a 20ml scintillation vial containing 18 ml Hionic Fluor Scintillation 
cocktail for 
3
H measurement. The percentage of protein-bound [
3
H]phenylalanine 
  107 
released into culture medium (namely [
3
H]phenylalanine in medium ÷ [
3
H]phenylalanine 
in cell protein ×100) was calculated to indicate protein degradation in PMEC. 
Western blot analysis for the mTOR pathway, the ubiquitin-proteasome pathway, 
and ß-casein expression 
PMEC were cultured as described for the measurement of protein synthesis, 
except that the medium contained no [
3
H]phenylalanine. At the end of the 4-day culture 
in the presence of 0.1 (control), 0.25, 0.5, 1 or 2 mM Leu, Ile, Val or a mixture of the 
three BCAA, cells were lysed using 500 µl of lysis buffer to extract protein. Protein 
concentrations of cell homogenates were measured using the BCA method, with bovine 
serum albumin as the standard. All samples were adjusted to an equal concentration of 
protein. The supernatant ﬂuid (containing cell proteins) was diluted with 2× sodium 
dodecyl sulfate (SDS) sample buffer (0.63 ml of 0.5 M Tris–HCl pH 6.8, 0.42 ml 75% 
glycerol, 0.125 g SDS, 0.25 ml ß-mercaptoethanol, 0.2 ml 0.05% solution of bromphenol 
blue, and 1 ml water to a ﬁnal volume of 2.5 ml) and heated in boiling water for 5 min. 
The solution was cooled on ice and then used for western blot analysis. Aliquots of 
samples were loaded onto SDS polyacrylamide gels. After separation on 4% to 12% 
gels, proteins were transferred to a nitrocellulose membrane (BioRad, Hercules, CA, 
USA) under 12 V current overnight, using the Bio-Rad Transblot apparatus (Hercules, 
CA, USA). Membranes were blocked in 5% fat-free milk in Tris-Tween buffered saline 
(TTBS; 20 mM Tris/150 mM NaCl, pH 7.5, and 0.1% Tween-20) for 3 h and then 
incubated with one of the following primary antibodies overnight at 4°C with gentle 
rocking: mTOR (cell signaling, 1:1000), phosphorylated mTOR (Ser2448; cell signaling, 
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1:1000), 4EBP1 (cell signaling, 1:1000), phosphorylated 4EBP1 (Ser65; cell signaling, 
1:1000), S6K1 (cell signaling, 1:1000), phosphorylated S6K1 (Thr389; cell signaling, 
1:1000), ubiquitin (1 : 1000),  proteasome (1 : 10000), ß-casein (1:200) or GAPDH (cell 
signaling, 1:1000). After washing three times with TTBS, the membranes were 
incubated at room temperature for 3 h with secondary antibody at a dilution of 1:50,000 
(horseradish peroxidase-conjugated goat anti-rabbit IgG, cell signaling or peroxidase-
labeled rabbit anti-goat IgG, Kirkegaard & Perry Lab). Finally, the membranes were 
washed with TTBS, followed by development using Super signal West Dura Extended 
Duration Substrate according to the manufacturer’s instructions (Pierce, Rockford, IL, 
USA). The blot was scanned for detection of fluorescence using the BioRad Gel 
Detection system. All data were normalized as relative values of targeted protein 
abundance to GAPDH abundance. 
STATISTICAL ANALYSIS 
Results were expressed as means and pooled SEM. Data were statistically 
analyzed by one-way ANOVA (Assaad et al., 2014) and all tables were generated using 
the one-way ANOVA software available online at 
https://housseinassaad.shinyapps.io/TableReport/. The Duncan multiple comparisons test 
was used to identify effects of treatment. Values of P < 0.05 were taken to indicate 
statistical significance. All statistical analyses were run using the R 3.1.0 software for 
Linux (64-bit). 
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RESULTS 
Effects of Leu, Ile, or Val or a mixture of BCAA on cell proliferation and protein 
concentrations of PMEC 
The number of PMEC increased (P < 0.05) as the time of culture increased from 
2 to 6 days (Table A-32).  Cell numbers also increased (P < 0.05) on Days 2, 4 and 6 of 
culture as extra-cellular concentrations of Leu, Ile, or Val or a mixture of the three 
BCAA increased from 0.1 to 2 mM. Concentrations of proteins in PMEC treated with 
0.25, 0.5, 1 and 2 mM of Leu, Ile, or Val or a mixture of the three BCAA were greater (P 
< 0.05) than for the control, with values being greatest at 1 and 2 mM BCAA (Table A-
33). 
Effects of Leu, Ile, or Val or a mixture of BCAA on protein synthesis and protein 
degradation in PMEC 
Increasing the extracellular concentrations of Leu (Table A-34), Ile (Table A-35), 
or Val (Table A-36) or a mixture of BCAA (Table A-37) from 0.1 to 2 mM increased (P 
< 0.01) protein synthesis and reduced (P < 0.05) protein degradation in PMEC.  The 
rates of protein synthesis were 26%, 40%, 65%, and 77% higher (P < 0.05), while the 
rates of protein degradation were 18%, 30%, 53%, and 53% lower (P < 0.01) in cells 
treated with 0.25, 0.5, 1, 2 mM Leu, respectively, compared with the control. Treatment 
with 1 and 2 mM Ile increased (P < 0.05) protein synthesis by 23% and 43%, whereas Ile 
at 0.25 to 2 mM decreased (P < 0.05) protein degradation, as compared with the control. 
Val increased (P < 0.05) protein synthesis and decreased (P < 0.05) protein degradation 
at all doses. Of note, compared with 0.1 mM BCAA, 0.25 to 2 mM BCAA increased (P 
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< 0.05) protein synthesis and decreased (P < 0.05) proteolysis in PMEC in a dose-
dependent manner.  
Effects of Leu, Ile, or Val or a mixture of BCAA on the mTOR signaling pathway 
and β-casein expression in PMEC 
Figures B2-B5 illustrate effects of Leu, Ile, or Val or a mixture of BCAA on the 
abundance of total and phoshporylated mTOR, S6K1, and 4E-BP1 proteins, as well as 
the abundance of β-casein. Increasing extracellular concentrations of Leu, Ile, or Val 
from 0.1 to 2 mM did not affect (P > 0.05) total lmTOR, S6K1, or 4E-BP1 proteins in 
PMEC. However, in comparison the control, 0.25, 0.5, 1 or 2 mM Leu increased (P < 
0.05) the abundances of: 1) phosphorylated mTOR by 20%, 38%, 61%, and 63%; 2) 
phosphorylated 4E-BP1 by 20%, 36%, 51%, and 54%; 3) phosphorylated S6K1 by 29%, 
43%, 48%, and 57%; and 4) β-casein by 35%, 60%, 68%, and 89%, respectively (Fig B-
2). Addition of 1 and 2 mM Ile increased (P < 0.05) the abundance of phosphorylated 
mTOR, 4E-BP1 and S6K1, while 0.25 to 2 mM Ile increased (P < 0.05) β-casein, in 
comparison with the control (Fig B-3). Compared with the control, addition of 0.25 to 2 
mM Val to culture medium also increased (P < 0.05) the abundance of phosphorylated 
mTOR, 4E-BP1, S6K1, and β-casein (Fig B-4). Furthermore, compared with 0.1 mM 
BCAA, 0.25 to 2 mM BCAA increased (P < 0.05) the abundance of: 1) phosphorylated 
mTOR by 33%, 45%, 69%, and 73%; 2) phosphorylated 4E-BP1 by 23%, 28%, 51%, 
and 56%; 3) phosphorylated S6K1 by 43%, 46%, 58%, and 63%; and 4) β-casein by 
34%, 64%, 73%, and 93%, respectively (Fig B-5). A mixture of the three BCAA had a 
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greater (P < 0.05) effect on increasing the abundance of phosphorylated mTOR, S6K1, 
or 4E-BP1 proteins in PMEC than any individual BCAA.  
Effects of Leu, Ile, or Val or a mixture of BCAA on the ubiquitin-proteasome 
pathway in PMEC 
The effects of Leu, Ile, or Val or a mixture of BCAA on the abundance of 
ubiquitin, ubiquitinated proteins, and proteasome in PMEC are shown in Figures B6-B9 
respectively.  As indicated by its manufacturer, the ubiquitin antibody from Cell 
Signaling recognized both free and protein-conjugated ubiquitin. When compared with 
the control, addition of 0.25, 0.5, 1 or 2 mM Leu to culture medium reduced (P < 0.01) 
the abundance of: 1) ubiquitinated proteins by 19%, 34%, 44%, and 48%; and 2) 
proteasome by 21%, 34%, 42%, and 46%, respectively (Fig B-6). The abundance of free 
ubiquitin in PMEC was not affected by individual or the mixture of BCAA. Compared 
with the control, the three BCAA had a greater effect to reduce the abundance of both 
ubiquitinated protein and proteasome in PMEC than any individual BCAA. 
DISCUSSION 
The capacity of the lactating mammary gland to synthesize milk is greatly 
influenced by many factors, including the number and activity of functional mammary 
epithelial cells, mammary cell differentiation, degree of premature involution of the 
mammary gland, availability of adequate precursors (e.g. amino acids and energy), 
concentrations of lactogenic hormones, and inducers of key cell signaling pathways 
(Boyd et al., 1995; Kim and Wu, 2009). Lactogenic hormones (prolactin, growth 
hormone, insulin, and glucocorticoids) affect proliferation, functional differentiation, and 
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involution of mammary epithelial cells, as well as transcriptional and translational 
regulation of gene expression in these cells (Boyd et al., 1995; Rhoads and Grudzien-
Nogalska, 2007; Xu et al., 1998). In recent years, there has been growing interest in the 
regulation, by amino acids, of milk synthesis in mammary epithelial cells as BCAA are 
capable of stimulating cell cycle progression, cell differentiation (Xu et al., 1998; 
Kimura and Ogihara, 2005; Gonçalves and Gomes-Marcondes, 2010), and cell apoptosis 
(D’Anona et al., 2010; Toerien et al., 2010; Moshel et al., 2006). The present study 
focused on effects of BCAA on the mTOR cell signaling pathway, the ubiquitin-
proteasome pathway, and intracellular protein turnover in PMEC.  
L-Leucine stimulates protein synthesis and inhibits proteolytic degradation in 
skeletal muscle (Tischler et al.. 1982; Mitch and Clark, 1985), as well as protein 
synthesis in brain and heart (Swian et al., 1990).  Additionally, results of in vitro studies 
have shown that compared with 0.45 mM leucine (~ 3 to 4 times leucine concentration in 
the plasma of lactating cows and sows), the complete absence of leucine from culture 
medium containing 17.5 mM glucose reduced protein synthesis in bovine mammary 
tissue (Appuhamy et al., 2012), as well as bovine and mouse mammary epithelial cell 
lines (Moshel et al., 2006). The nutritional relevance of those findings is not known, 
because leucine is always present in the blood of animals. To date, no information is 
available about effects of physiological concentrations of BCAA on protein synthesis in 
mammary epithelial cells in the presence of the physiological concentration of glucose. 
Additionally, results of studies regarding effects of BCAA on rates of protein 
degradation or proteolytic systems in these cells are not available. Because accumulation 
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of protein in the cell is regulated by the balance between the rates of protein synthesis 
and degradation and it is necessary for cell growth and mitogenesis (Fingar et al., 2004 
and 2006), the present study determined whether BCAA regulate protein synthesis and 
protein degradation in mammary epithelial cells.  The findings were to increase 
understanding of cellular mechanisms whereby dietary BCAA supplementation enhances 
milk production by lactating sows and perhaps other mammals. As the ATP-ubiquitin-
proteasome-dependent pathway is responsible for bulk degradation of protein in cells 
(Ciechanover, 2012) and mTOR is the master regulator of protein synthesis (Suryawan 
and Davis, 2011), the present study was directed toward those pathways in PMEC 
treated with various physiological concentrations of BCAA. 
A novel and important observation from the current study is that individual or a 
mixture of BCAA reduced the abundance of ubiquitinated protein and proteasome, as 
well as the rate of protein degradation in PMEC. The ATP- and ubiquitin-dependent 
proteasome system is ubiquitous in animal cells (Tomko and Hochstrasser, 2013). The 
most common form of the proteasome is the 26S proteasome with a molecular mass of 
2,000 kDa, which contains one 20S proteasome and two 19S regulatory caps (Voges et 
al., 1999). Ubiquitin-dependent protein degradation involves: (a) activation of ubiquitin 
by a multienzyme system; (b) binding of multiple ubiquitin moieties to Lys residues of a 
protein substrate; and (c) hydrolysis of the protein substrate by 26S proteasome (Finley, 
2009). The ubiquitin antibody used in the present study detected both free and protein-
conjugated ubiquitin. Our findings that the abundance of ubiquitinated protein, but not 
free ubiquitin, was reduced by individual or a mixture of BCAA in PMEC suggests 
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inhibition of either ubiquitin activation or binding of multiple ubiquitin moieties to Lys 
residues of the target protein.  Nonetheless, the decrease in the abundances of 
ubiquitinated proteins and proteasome indicated that BCAA reduced degrade of 
intracellular proteins in PMEC to. This view is further supported by our actual 
measurement of hydrolysis of [
3
H]Phe-labeled proteins into TCA-soluble [
3
H]Phe 
fractions. Like any other proteins, the proteasome is subject to degradation by specific 
proteases whose expression may be enhanced by BCAA through an mTOR-dependent 
mechanism or whose enzymatic activity may be activated allosterically by BCAA as 
reported for glutamate dehydrogenase (Tomita et al., 2011).  Further studies are 
necessary to test those new hypotheses.  
As a serine/threonine (Ser/Thr) protein kinase, mTOR is a highly conserved 
signaling protein in eukaryotes that has a critical role in regulating protein synthesis, cell 
growth, metabolism, and proliferation by sensing and responding to a variety of 
nutritional and hormonal stimuli (Xu et al., 1998; Kim et al., 2002; Jankiewicz et al., 
2006; Debnath et al., 2003).  mTOR is a member of the phosphatidylinositol-3-kinase 
(PI3K)-related kinase family and phosphorylates its downstream effectors S6K1 and 4E-
BP1, which consequently control translation efficiency in cells (Suryawan and Davis, 
2011). Eukaryotic initiation factors (eIF) control mRNA translation by stimulating 
initiation of the translation process (Suryawan and Davis, 2011). Both L-isoleucine and 
L-leucine can increase mTOR, S6K1, and 4EBP1 phosphorylation (P < 0.05) in bovine 
mammary tissue, as compared with the complete absence of those amino acids from 
culture medium (Appuhamy et al., 2012).  The present study revealed that physiological 
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levels of BCAA activate the mTOR cell signaling pathway and stimulate protein 
(including casein) synthesis in PMEC, and demonstrated, for the first time to our 
knowledge, that L-valine had similar effects to those of L-leucine and L-isoleucine to 
enhance protein synthesis in PMEC.  Furthermore, a mixture of BCAA exerted a greater 
effect on activating the mTOR signaling pathway and protein synthesis in PMEC than 
any single BCAA. Whether BCAA exerts a direct or an indirect effect on mTOR 
phosphorylation is not known and warrants further investigation.  
In summary, individual or a mixture of BCAA at physiological concentrations 
activate the mTOR pathway and suppress the ubiquitin-proteasome pathway in PMEC, 
resulting in increased protein (including β-casein) synthesis, decreased protein 
degradation, and enhanced cell proliferation. These findings provide a molecular 
mechanism whereby dietary BCAA supplementation enhances milk production by 
lactating sows.  These results advance understanding of nutritional regulation of lactation 
and have important implications for improving milk protein synthesis in livestock, 
women, and other mammals. 
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CHAPTER V 
CONCLUSION AND SUMMARY 
Increasing efficiency and reducing costs of pork production are continually 
required to enhance the profitability of the global swine industry. Among livestock 
species, the pig exhibits the highest rate of neonatal mortality, which is currently 12% in 
the U.S.  This problem results from the lack of brown adipose tissue for thermogenesis 
in swine, very low to no fat depots at birth (only 1% of the body weight versus 10% in 
human newborns), and inadequate milk production by sows.   
Milk is the sole source of nutrients for neonatal mammals during the suckling 
period. Hodge (1974) and Boyd et al. (1995) demonstrated that artificially reared 
neonatal pigs grow at least 50% faster than sow-reared piglets.  Additionally, Harrell et 
al. (1993) have shown that a sow needs to produce at least 18 kg/d milk to supply piglets 
with enough energy to grow at a rate comparable to artificial-reared piglets of the same 
age. However, inadequate protein in sow's milk is another major factor limiting 
maximum growth of piglets (Wu et al., 2014). A heavier piglet in the first week after 
birth is more likely to survive to weaning. Thus, a major goal of rearing young pigs is to 
enhance their growth during the suckling period (Rezaei et al., 2013). 
The composition of sow’s colostrum and milk limits the potential for lean tissue 
growth of piglets (Wu et al., 1994). Based on the amino acid composition of sow’s milk, 
arginine requirements of piglets for growth, and metabolic studies, it is clear that a 
deficiency of arginine in milk is a major factor limiting maximum growth of young pigs 
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(Wu and Knabe, 1994; Wu and Knabe, 1995). Thus, arginine is a nutritionally essential 
amino acid for young mammals (Mateo et al., 2008).  Emerging evidence also shows 
that sufficient provision of glutamine, glutamate, and glycine in diets is required for 
maximum growth of milk-fed piglets (Wang et al., 2014; Wu et al., 2014).  Additionally, 
increasing the availability of amino acids (e.g., branched-chain amino acids; BCAA) that 
are not synthesized by animals is beneficial for promoting milk synthesis by lactating 
mammals and the growth of their offspring (Li et al., 2009; Lei et al., 2012a). 
The pre-weaning body weight of pigs is closely related to their post-weaning 
health and growth, and, therefore, the time from weaning to marketing. While piglets are 
exposed to many stressors immediately after birth, gastrointestinal problems are among 
the most severe. Milk-born amino acids are major sources of energy for the small 
intestine and are necessary for maintenance of anti-oxidative reactions in the intestine. 
The neonate instantly transits from primarily parenteral to enteral nutrition, which 
requires that the small intestine be the major organ for digestion and absorption of 
nutrients in the diet.  However, the gut of the neonatal pig is underdeveloped and highly 
susceptible to injury and oxidative stress.  Thus, the main losses in pig production occur 
between birth and weaning. Most pre-weaning mortality in piglets takes place during the 
first week after birth. In a study by Glastonbury (1976), mean total piglet mortality prior 
to weaning was 20% (n=10,000 piglets), and most losses occurred within the first 4 d 
after birth.  There is evidence that milk production by sows is inversely correlated with 
prewaning piglet mortality (Rezaei et al., 2011). This further underscores the importance 
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of developing strategies that insure sufficient milk production by sows for sustaining the 
swine industry in the U.S. and worldwide. 
As noted previously, the survival and growth of piglets are critically dependent 
on the availability of sufficient provision of nutrients in maternal milk. The synthetic 
capacity of the mammary gland for milk for all mammals is determined by coordinate 
actions of hormonal and nutritional factors, as well as functionality of mammary 
epithelial cells during gestation and lactation. In the current swine industry, dietary 
regimens for lactating sows are not adequate for efficient produce sufficient milk to 
support maximum survival or growth of preweaning piglets. As a result, a high rate of 
neonatal mortality and a suboptimal rate of growth remain two major problems in the 
swine industry worldwide (Wu et al., 2006).  These problems are particularly severe for 
low-birth-weight piglets in a litter. 
To date, few mechanism-based methods have been developed to improve 
lactation in mammals. Sows require tremendously high amounts of amino acids during 
lactation to support milk synthesis. Among the amino acids, BCAA are taken up in 
amounts in excess than their output in milk (Manjarin et al., 2014). The carbon skeleton 
and nitrogen of BCAA can be used to synthesize other amino acids (e.g., glutamate and 
glutamine) whose requirements by neonates to meet their physiological needs are 
particularly high. More importantly, BCAA take part in the regulation of metabolic 
pathways including DNA transcription, mRNA translation, and proteolysis which 
increase net protein synthesis and cell growth. Thus, dietary supplementation with valine 
to lactating sows enhances milk yield and piglet growth (Richert et al., 1997; Paulicks et 
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al., 2003). Similar results have been reported for supplementation of diets of lactating 
cows with leucine (Rulquin and Pisulewski, 2006). However, dietary supplements for 
sows with a single BCAA have yielded inconsistent results on milk production (Richert 
et al. 1997a,b; Moser et al., 2000) possibly due to dietary imbalances for the three BCAA 
(Wu et al., 2014). For example, dietary supplementation of diets for lactating sows with 
0.4% isoleucine could enhance growth of suckling piglets when the ratio of isoleucine to 
leucine in the complete diet was 0.88 (Richert et al. 1997a), but not at a ratio of 0.55 
(Moser et al., 2000).  Little is known about effects of dietary supplementation with 
leucine plus isoleucine plus valine on lactation performance in any mammal, including 
sows. 
In view of the foregoing published results, research for this dissertation was 
conducted to test the hypothesis that BCAA enhance milk protein synthesis and lactation 
performance in sows.  To achieve this goal, in vivo feeding (Chapters II and III) and in 
vitro cell culture (Chapter IV) experiments were performed. In the first feeding study, 
lactating sows fed a corn- and soybean meal-based diets supplemented with 0%, 1.535%, 
or 3.07% BCAA throughout a 29-d period of lactation had piglets that grew faster and 
had less neonatal mortality.  The sows fed the BCAA supplemented diet also lost less 
body weight which enhances subsequent reproductive performance. Concentrations of 
ree Arg, Gln, Glu, Asn, Asp and BCAA in plasma were also greater in BCAA sows and 
their piglets, as compared with control sows. Similarly, concentrations of most free and 
protein-bound amino acids were greater in milk from BCAA-supplemented sows. BCAA 
supplementation also increased concentrations of fats and lactose in sow's milk, while 
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reducing the plasma levels of TBARS which are indicative of oxidative stress. This 
finding may have important implications for lactation performance, as oxidative stress 
leads to lactation failure in mammals. 
Because glutamate is a predominant product of the extensive catabolism of 
BCAA in the lactating mammary gland (Li et al., 2009) and a major nutrient in milk of 
all mammals (Wu et al., 2014), we hypothesized that glutamate mediates, at least in part, 
the beneficial effect of BCAA supplementation to improve milk production in sows. 
Although glutamate has been traditionally regarded as a nutritionally nonessential amino 
acid for mammals, there is emerging evidence that a typical corn- and soybean meal-
based diet does not provide sufficient glutamate to support maximum protein synthesis 
in growing swine (Wu et al., 2014).  This view may also apply to diets for lactating 
sows. Thus, the second feeding trial was conducted with lactating sows fed corn- and 
soybean meal-based diets supplemented with 0, 1% or 2% MSG between d 0 and 29 of 
lactation, as described for the first feeding experiment.  Overall, the milk yield, body 
condition and antioxidative capacity, as well as the preweaning growth and survival of 
their piglets were improved for sows in response to dietary MSG supplementation in a 
dose-dependent manner. Collectively, these findings indicate important roles for BCAA 
and their metabolite glutamate in improving lactational performance in sows as well as 
growth and survival of their piglets. 
The cell culture experiments investigated biochemical pathways responsible for 
stimulatory effects of BCAA on milk synthesis in sows (Chapter IV). Mammary 
epithelial cells are secretory units of mammary glands. These cells synthesize milk and 
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secrete it upon stimulation by prolactin. We isolated these cells from a sexually mature 
gilt for biochemical studies and focused on regulatory effects of BCAA on mTOR cell 
signaling, the ubiquitin-proteasome pathway for degradation cellular proteins, and 
intracellular protein turnover in PMEC. mTOR has a critical role in regulating protein 
synthesis, rate of cell growth, metabolism, and proliferation by sensing and responding 
to a variety of nutritional and hormonal stimuli. (Xu et al., 1998; Kim et al., 2002; 
Jankiewicz et al., 2006; Debnath et al., 2003).  As a member of the phosphatidylinositol-
3-kinase (PI3K)-related kinase family, mTOR phosphorylates its downstream effectors 
S6K1 and 4E-BP1, which consequently control translation efficiency in cells (Suryawan 
and Davis, 2011). Eukaryotic initiation factors (eIF) controls mRNA translation by 
stimulating initiation of the translation process through the formation of the eIF4F 
complex (Suryawan and Davis, 2011). Compared with the control (0.1 mM BCAA), 
treatment of cells with 0.25 to 2 mM of individual or mixture of BCAA decreased the 
abundance of ubiqitinated proteins and proteasome, as well as the rate of protein 
degradation, while increasing phosphorylation of mTOR, 4EBP1 and S6K1 proteins, as 
well as the rate of protein (including β-casein) synthesis in PMEC.  Thus, increasing 
extracellular concentrations of BCAA from 0.1 to 2 mM increased the rate of 
proliferation of PMEC in a dose-dependent manner.  
Taken together, our results indicate that physiological levels of BCAA regulate 
protein synthesis and decrease protein degradation in PMEC through activating mTOR 
cell signaling and inhibiting the ubiquitin-proteasome pathway.  This proposed 
mechanism is illustrated in Figure B-10. Collectively, results of this dissertation research 
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provide compelling evidence that BCAA play important roles in enhancing milk 
production by lactating sows. The findings significantly advance understanding of 
nutritional regulation of lactation and provide a new strategy to improve milk protein 
synthesis in livestock, women, and other mammals.  
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Table A-2. Effects of dietary BCAA supplementation to lactating sows on growth of suckling piglets 
_______________________________________________________________________________________________________ 
BCAA, Lys and CP content  BCAA supplementation (%)       Total BCAA in  Milk Litter Ref. 
       in basal diet  (%)      supplemental diet (%) DM weigh 
____________________________ ________________________ ______________________ yield   gain of 
Leu Ile Val Lys CP Leu Ile Val Leu Ile Val  piglets      
_______________________________________________________________________________________________________ 
1.36 0.5 0.72 0.9 14.5 0 0.35-0.7 0 1.36 0.85-1.2 0.72 ↑ ↑ 1 
1.36 0.5 0.72 0.9 14.5 0 0 0.35-0.7 1.36 0.5 1.07-1.42 ↑ ↑ 1  
0.95 0.58 0.61 0.8 14.2 0 0 0.26-0.37 0.95 0.58 0.77-0.98 x NCa 2 
0.95 0.58 0.61 0.8 14.2 0 0 0.26-0.37 0.95 0.58 1.15 x NCb 2 
0.95 0.58 0.61 0.8 14.2 0 0 0.26-0.37 0.95 0.58 1.15 x ↑c 2 
0.95 0.58 0.94 1.2 20.5 0 0 0.23-43 0.95 0.58 1.17-1.37 x NCd 2 
0.95 0.58 0.94 1.2 20.5 0 0 0.23-43 0.95 0.58 1.17-1.37 x NCe 2 
0.95 0.58 0.94 1.2 20.5 0 0 0.23-43 0.95 0.58 1.17-1.37 x ↑f 2 
1.31 0.64 0.75 0.90 14.3 0 0 0.1-0.4 1.31 0.64 0.85-1.15 x ↑ 3 
1.57 0.68 0.8 0.9 15.5 0.4 0 0 1.97 0.68 0.8 NC NC 4 
1.57 0.68 0.8 0.9 15.5 0 0.4 0 1.97 1.08 0.8 NC NC 4 
1.57 0.68 0.8 0.9 15.5 0 0 0.4 1.97 0.68 1.2 NC ↑ 4 
1.18 0.65 0.45 1.01 15.5 0 0 0.1-1.0 1.18 0.65 0.55-1.45 ↑ ↑ 5 
____________________________________________________________________________________________________________________ 
a
All sows with the average total number of pigs weaned/litter being 9.8 to 10.0. 
b
Sows with the average total number of pigs weaned/litter being 8.61 to 8.91. 
c
Sows with the average total number of pigs weaned/litter being 10.4 to 10.6. 
d
All sows with the average total number of pigs weaned/litter being 9.95 to 10.0. 
e
All sows with the average total number of pigs weaned/litter being 8.7-8.91. 
f
All sows with the average total number of pigs weaned/litter being 10.5. 
 
NC = no effect 
The sign “x” denotes the lack of data. 
 
1
 Richert et al. (1997a);  
2
 Richert et al. (1997b); 
3
 Richert et al. (1996); 
4
 SA Moser et al. (2000);  
5
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Table A-3. Composition of the basal diet for lactating sows on an as-fed basis. 
 
 




 Corn grain         57.50  
 Soybean meal, 44.5% CP       27.00  
 Cornstarch       3.07 
 Sugarcane molasses      2.78 
 Potassium chloride        0.10  
 Salt          0.35  
 Vitamin-mineral premix
2
       3.00  
 Vegetable oil        3.00  
 Dicalcium phosphate       2.50  
 Limestone         0.70  
 
Chemical composition 
 DM, %         90.0  
 ME, Mcal/kg        3.32  
 CP
3
, %         17.5  
 Ca, %         1.04  
 Available P, %        0.54  
 Total P, %         0.79  
1 
This basal lactation diet was provided ad libitum from farrowing to d 29 of lactation. 
2
The vitamin premix provided the following per kilogram of complete diet (as-fed basis): 46.7 mg of Mn 
as manganous oxide; 75 mg of Fe as iron sulfate; 103.8 mg of Zn as zinc oxide; 9.5 mg of Cu as copper 
sulfate; 0.72 mg of I as ethylenediamine dihydroiodide; 0.23 mg of Se as sodium selenite; 7,556 IU of 
vitamin A as vitamin A acetate; 825 IU of vitamin D3; 61.9 IU of vitamin E; 4.4 IU of vitamin K as 
menadione sodium bisulfate; 54.9 µg of vitamin B12; 13.7 mg of riboflavin; 43.9 mg of D-pantothenic 
acid as calcium pantothenate; 54.9 mg of niacin; and 1,650 mg of choline as choline chloride. 
3
The basal diet provided the following amino acids (%, as-fed basis): alanine, 0.94; arginine, 1.09; 
asparagine, 0.79; aspartate, 1.12; cysteine, 0.30; glutamine, 1.68; glutamate, 1.56; glycine, 0.86; histidine, 
0.44; isoleucine, 0.74; leucine, 1.64; lysine, 0.90; methionine, 0.28; phenylalanine, 0.87; proline, 1.45; 
serine, 0.84; threonine, 0.65; tryptophan, 0.21; tyrosine, 0.71; and valine, 0.82. 
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Table A-4. Supplemental BCAA and L-alanine to the basal corn-soybean diet
1 
 
Treatment Supplemental amino acid (g/100 g diet)  Total  
 ______________________________________________ nitrogen  
 L-Isoleucine L-Leucine L-Valine L-Alanine (mmol N/100 g diet) 
Control 0.00 0.00                0.00             2.149        24.12 
1.535% BCAA   0.32 0.82  0.395 1.07                 24.12 
3.07% BCAA 0.64 1.64  0.79   0.00 24.12        
1
















  160 
Table A-5. Number of sows in each parity 
 
Treatment     Parity 2    Parity 3 
Control      4    6 
1.535 % BCAA     4    6 
3.07 % BCAA     4    6 
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Table A-6. Milk consumption of piglets and feed intake by sows during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 













D           
3 - 15 
d          
15 - 29 
d          
0 - 29 
d            
3 - 15 
d        
15 - 29 
d          
0 - 29 
d           
3 - 15 
d         
15 - 29 
d          
0 - 29 
 
29.7 34.2 32.0 29.9 33.7 31.8 29.7 34.0 31.9 3.1 0.997 0.069 0.996 
Values are means with pooled SEM, n = 10 sows/treatment group.  See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction.                                                                                                                                                                                 
2
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Table A-7. Body weights of sows and piglets during lactation 
 
Variable 









187 184 173 161 185 182 175 169 187 185 183 181 9.1 0.198 0.010 0.791 
Piglet 
BW, kg 
1.40 1.84 4.34 9.54 1.41 1.94 5.05 11.5 1.42 2.03 5.34 12.9 0.10 <0.001 <0.010 <0.010 
Values are means with pooled SEM, n = 10 sows/treatment group. See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction.
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Table A-8. Body-weight changes of sows and piglets during lactation 
 
Variable 




d     
0-3 
d     
3-15 
d      
15-29 
d     
0-29 
d     
0-3 
d    
3-15 
d   
15-29 
d     
0-29 
d    
 0-3 
d       
3-15 
d   
15-29 
d      




 ADG of 
piglets, 
g/d 
147 208 371 281 177 259 460 348 203 276 540 396 6.7 <0.001 <0.001 <0.010 
  BW loss 
of sows, 
kg 
3.4 11.1 11.7 26.2 3.3 7.4 6.0 16.7 1.3 2.5 2.2 6.0 0.98 <0.001 <0.001 <0.010 
Values are means with pooled SEM, n = 10 sows/treatment group. See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-9. Rates of survival and mortality of sow-reared piglets during lactation 
 
Group 
Number of piglets Rate of mortality (%) 








Control 90 78 77 76 0 13.3 14.4 15.6 
1.535% BCAA 90 84 84 84 0 6.7 6.7 6.7 
3.07% BCAA 90 86 86 86 0 4.4 4.4 4.4 
Values are the numbers of live piglets.  
Data were analyzed by X
2
-analysis, which revealed that BCAA supplementation reduced the rate of preweaning mortality (P = 0.021) as compared to 
control.   
1
Time of assignment to treatment groups. 
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Table A-10. Composition of milk in control and BCAA-supplemented sows during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
DM, % 20.8 19.6 19.4 22.4 20.7 20.5 22.8 21.1 21.0 0.478 <0.01 0.023 0.983 
CP, % 5.72 4.93 4.78 6.10 5.16 5.06 6.24 5.19 5.10 0.193 <0.01 0.011 0.985 
Fat, % 8.63 8.04 8.12 9.12 8.44 8.48 9.26 8.66 8.74 0.245 <0.01 0.002 0.952 
Lactose, 
% 
4.99 5.16 5.10 5.61 5.59 5.39 5.71 5.66 5.57 0.206 <0.01 0.329 0.996 
Carb, % 5.58 5.76 5.62 6.24 6.16 6.02 6.37 6.32 6.22 0.206 <0.01 0.329 0.981 
Ash, % 0.87 0.87 0.88 0.94 0.94 0.94 0.93 0.93 0.94 0.0251 <0.01 0.884 0.993 
Values are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
Carb = carbohydrate (including lactose); CP = N% x 6.25.
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Table A-11. Concentrations of free amino acids in the plasma of sows during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 369 492 517 482 600 607 596 640 649 42 <0.001 <0.001 0.485 
Arg 103 121 150 147 173 177 161 181 182 15 <0.001 0.001 0.632 
Asn 58 63 80 83 85 85 96 92 95 5.9 <0.001 0.052 0.037 
Asp 32 34 36 34 33 36 35 34 38 2.0 0.353 0.005 0.789 
b-Ala 17 18 19 18 18 19 18 19 19 0.59 0.021 0.038 0.056 
Cit 60 64 74 70 78 90 86 85 91 6.7 <0.001 0.004 0.597 
Cys 229 235 236 231 235 239 243 252 255 14 0.100 0.555 0.986 
Gln 564 567 572 620 628 632 654 664 670 26 <0.001 0.717 0.990 
Glu 84 72 80 113 121 125 132 140 143 18 <0.001 0.494 0.461 
Gly 947 964 1003 949 981 1018 1029 981 1023 54 0.429 0.343 0.822 
His 76 69 80 80 75 78 91 79 80 4.2 0.005 0.008 0.161 
Ile 70 91 114 130 139 146 169 195 219 14 <0.001 <0.001 0.545 
Leu 148 167 210 260 286 295 341 397 403 30 <0.001 0.011 0.831 
Lys 124 126 130 138 144 147 156 164 163 8.1 <0.001 0.265 0.984 
Met 37 35 34 41 41 41 41 42 50 3.0 <0.001 0.354 0.083 
Orn 69 76 102 76 77 101 78 77 105 6.1 0.465 <0.001 0.882 
Phe 72 77 96 73 73 95 79 73 97 4.7 0.684 <0.001 0.66 
Pro 237 246 247 300 306 320 358 376 385 17 <0.001 0.162 0.945 
Ser 136 137 147 138 141 151 139 142 154 9.1 0.675 0.030 0.997 
Tau 55 61 58 58 62 61 58 66 67 5.1 0.149 0.119 0.921 
Thr 101 102 127 108 101 132 109 119 132 9.4 0.151 <0.001 0.692 
Trp 49 49 52 53 51 57 54 60 64 3.8 <0.001 0.038 0.482 
Tyr 58 74 91 79 90 92 82 91 99 6.3 <0.001 <0.001 0.194 
Val 182 216 234 276 326 357 374 416 473 32 <0.001 <0.001 0.852 
Values, expressed as μmol/L, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction
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Table A-12. Concentrations of free amino acids in plasma of piglets during lactation 
  
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 





 238 171 173 272 179 183 12 <0.001 <0.001 0.881 
Asn 78 89 101 106 110 117 119 120 124 4.8 <0.001 <0.001 0.132 
Asp 14 19 20 18 21 22 19 23 25 1.2 <0.001 <0.001 0.754 
b-Ala 26 26 27 28 28 26 28 26 27 1.0 0.504 0.336 0.011 
Cit 132 76 81 164 82 90 178 107 109 5.4 <0.001 <0.001 0.149 
Cys 166 165 158 166 169 162 172 171 162 7.1 0.510 0.130 0.973 
Gln 709 542 538 748 605 602 809 646 688 32 <0.001 < 0.001 0.190 
Glu 83 83 85 101 107 103 112 116 118 10 <0.001 0.240 0.906 
Gly 1080 1091 1093 1152 1047 1060 1060 1160 1188 32 <0.001 0.647 0.968 
His 98 95 108 97 95 112 97 95 114 4.6 0.854 <0.001 0.885 
Ile 126 128 127 169 179 188 185 198 201 11 <0.001 0.132 0.732 
Leu 198 178 186 223 227 233 240 242 247 18 <0.001 0.674 0.596 
Lys 202 234 232 215 251 243 220 251 242 15 0.206 0.001 0.990 
Met 78 80 77 83 85 79 86 89 91 3.4 <0.001 0.413 0.485 
Orn 136 95 109 141 103 110 148 98 113 6.1 0.193 <0.001 0.613 
Phe 93 93 96 95 96 98 96 96 97 3.1 0.014 0.794 0.022 
Pro 500 509 510 526 534 540 541 568 573 14 <0.001 0.060 0.783 
Ser 251 294 301 269 294 299 269 291 302 12 0.703 <0.001 0.617 
Tau 113 128 123 141 137 157 143 170 167 8.0 <0.001 0.001 0.039 
Thr 261 241 243 273 249 253 296 260 269 14 0.004 <0.001 0.962 
Trp 42 46 48 43 48 59 44 51 59 2.2 0.029 <0.001 <0.001 
Tyr 128 136 135 141 139 136 146 143 140 6.8 <0.001 0.532 0.002 
Val 226 232 231 321 329 330 351 349 352 16 <0.001 0.787 0.547 
Values, expressed as μmol/L, are means with pooled SEM, n = 20 piglets/treatment group. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction  
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Table A-13. Composition of free amino acids in sow’s milk during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 235 511 635 279 597 730 301 609 663 50 0.025 <0.01 0.682 
Arg 36 64 72 52 73 91 54 87 109 6.7 <0.01 <0.01 0.220 
Asn 29 108 227 46 132 259 51 141 267 11 <0.01 <0.01 0.829 
Asp 158 462 480 192 526 593 313 546 639 30 <0.01 <0.01 0.075 
b-Ala 15 30 41 15 30 45 15 28 41 2.6 0.534 <0.01 0.634 
Cit 6.8 38 46 18 49 68 31 59 78 4.7 <0.01 <0.01 0.302 
Cys 116 192 362 120 199 358 123 204 370 19 0.706 <0.01 0.994 
Gln 326 1060 3517 439 1170 4025 472 1210 4196 112 <0.01 <0.01 0.024 
Glu 366 1010 991 419 1140 1070 447 1200 1190 43 <0.01 <0.01 0.261 
Gly 294 812 1180 307 830 1240 358 843 1300 57 0.096 <0.01 0.844 
His 787 682 436 769 689 465 824 688 486 35 0.269 <0.01 0.737 
Ile 5.2 17 21 14 31 38 29 43 52 3.7 <0.01 <0.01 0.546 
Leu 23 43 51 52 77 93 64 85 103 8.1 <0.01 <0.01 0.772 
Lys 32 52 68 35 66 86 50 66 85 4.5 <0.01 <0.01 0.063 
Met 2.9 20 23 4.2 21 28 4.2 22 28 2.2 0.059 <0.01 0.448 
Orn 29 45 64 30 48 67 30 52 58 3.9 0.548 <0.01 0.178 
Phe 20 35 38 25 36 39 27 38 40 2.8 0.040 <0.01 0.776 
Pro 34 82 114 46 115 147 49 123 168 12 <0.01 <0.01 0.195 
Ser 45 221 403 51 231 474 63 238 381 18 0.012 <0.01 <0.001 
Tau 1020 1280 1410 1110 1290 1430 1230 1290 1490 99 0.212 <0.01 0.722 
Thr 86 133 426 89 140 437 85 145 420 23 0.862 <0.01 0.962 
Trp 3.6 11 17 5.3 12 21 5.7 12 19 1.1 0.012 <0.01 0.378 
Tyr 35 63 75 42 63 76 49 66 79 5.7 0.114 <0.01 0.689 
Val 54 108 134 96 132 160 149 166 229 13 <0.01 <0.01 0.150 
Values, expressed as μmol/L of whole milk, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction 
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Table A-14. Composition of amino acids in proteins and peptides of sow’s milk during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 27.8 15.2 14.6 29.0 20.1 18.4 29.7 19.6 18.8 1.9 0.015 <0.001 0.690 
Arg 15.0 7.48 7.30 17.0 13.7 13.1 19.6 16.4 15.5 1.5 <0.001 <0.001 0.961 
Asp 16.2 10.1 9.72 17.5 13.0 11.8 18.2 14.8 13.9 1.1 <0.001 <0.001 0.157 
Asn 17.6 9.90 9.48 18.6 13.5 10.6 19.1 16.0 13.3 1.0 <0.001 <0.001 0.142 
Cys 6.82 3.22 3.08 7.02 3.48 3.35 7.56 3.89 3.73 0.50 0.030 <0.001 0.975 
Glu 41.1 23.5 21.8 44.3 26.2 24.7 46.8 29.7 28.5 2.4 <0.001 <0.001 0.341 
Gln 35.2 20.2 19.3 37.4 23.0 22.4 40.1 26.1 26.2 2.2 <0.001 <0.001 0.336 
Gly 19.3 9.48 9.21 20.7 9.85 9.64 21.5 10.2 9.73 1.2 <0.001 <0.001 0.892 
His 9.09 5.33 5.26 10.5 5.67 5.48 11.2 5.84 5.66 0.78 <0.001 <0.001 0.937 
Ile 19.6 11.8 11.0 21.1 13.0 12.6 23.6 14.8 13.9 1.8 <0.001 <0.001 0.975 
Leu 42.7 26.5 25.3 44.8 26.0 25.2 46.3 27.3 26.8 3.1 <0.001 <0.001 0.876 
Lys 36.3 24.1 23.2 39.5 26.6 24.8 40.7 28.1 25.1 2.3 <0.001 <0.001 0.997 
Met 9.90 6.18 5.97 10.6 6.77 6.34 11.3 6.98 6.56 0.70 <0.001 <0.001 0.413 
Phe 15.8 9.83 9.45 16.7 10.4 10.1 17.2 11.5 10.8 1.1 <0.001 <0.001 0.827 
Pro 42.1 32.8 31.2 44.6 35.6 34.5 46.8 37.2 36.0 3.7 <0.001 0.001 0.998 
Ser 31.6 16.8 15.3 33.0 18.2 16.1 33.8 19.7 18.3 2.5 <0.001 <0.001 0.947 
Thr 24.6 14.1 12.7 26.1 14.9 13.7 27.3 15.6 14.1 1.9 <0.001 <0.001 0.945 
Trp 6.01 3.32 3.18 6.57 3.58 3.39 6.65 3.79 3.54 0.26 <0.01 <0.001 0.702 
Tyr 18.7 11.9 10.6 19.2 12.4 11.4 20.7 13.5 12.0 1.5 <0.001 <0.001 0.946 
Val 27.8 15.2 14.4 30.3 16.8 16.0 32.5 17.4 16.1 2.1 <0.001 <0.001 0.296 
Values, expressed as mmol/L of whole milk, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction.
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Table A-15. Concentrations of metabolites in the plasma of sows and piglets and in milk during lactation 
 
Variable 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 




60 62 62 61 64 65 64 67 68 6.4 0.372 0.665 0.984 
Urea, mM 2.88 2.97 3.07 2.74 2.83 2.94 2.59 2.68 2.80 0.28 0.224 0.487 0.992 
Glucose, 
mM 
5.38 5.41 5.53 5.47 5.51 5.55 5.59 5.64 5.69 0.12 0.018 0.261 0.978 
Lactate, mM 1.27 1.49 1.69 1.28 1.52 1.76 1.25 147 1.66 0.21 0.979 <0.001 0.965 
Pyruvate, 
µM 




64 65 65 66 65 67 66 68 69 2.6 0.173 0.607 0.992 
Urea, mM 2.37 2.57 2.79 2.36 2.45 2.55 2.33 2.42 2.51 0.25 0.533 0.20 0.964 
Glucose, mM 5.32 5.34 5.44 5.41 5.64 5.73 5.65 5.84 5.84 0.13 <0.001 0.015 0.723 
Lactate, mM 2.37 2.38 2.40 2.44 2.44 2.45 2.52 2.49 2.51 0.15 0.367 0.987 0.981 
Pyruvate, 
µM 




1.59 1.64 1.66 1.65 1.71 1.72 1.70 1.78 1.81 0.17 0.383 0.677 0.986 
Urea, mM 7.23 4.79 5.26 7.04 4.65 5.09 6.92 4.67 5.14 0.58 0.832 <0.001 0.997 
Glucose, mM 0.54 0.589 0.592 0.577 0.62 0.629 0.574 0.633 0.64 0.06 0.384 0.163 0.972 
Lactate, mM 0.142 0.17 0.195 0.136 0.167 0.192 0.147 0.175 0.199 0.03 0.909 0.026 0.966 
Pyruvate, 
µM 
65 67 73 67 65 74 62 69 79 9.4 0.937 0.111 0.932 
Values are means with pooled SEM, n = 10 sows/treatment group for plasma and milk, n = 20 piglets/treatment group  
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction
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Control 1.535% BCAA 3.07% BCAA Pooled P-value 






2.28 2.24 2.27 2.21 2.23 2.25 2.20 2.24 2.20 0.29 0.742 0.894 0.997 
TG, mM 0.449 0.451 0.463 0.434 0.444 0.450 0.436 0.445 0.449 0.06 0.499 0.273 0.979 
FFA, mM 0.574 0.581 0.589 0.566 0.569 0.573 0.561 0.566 0.566 0.09 0.676 0.421 0.998 
Glycerol 
mM 




1.86 1.96 1.99 1.86 1.92 1.94 1.88 1.95 1.96 0.19 0.689 0.708 0.995 
TG, mM 0.421 0.429 0.433 0.427 0.434 0.439 0.429 0.437 0.443 0.07 0.234 0.279 0.667 
FFA, mM 0.323 0.329 0.332 0.328 0.330 0.335 0.326 0.334 0.337 0.05 0.341 0.456 0.976 
Glycerol 
mM 




1.11 1.09 1.07 1.16 1.13 1.10 1.20 1.16 1.12 0.14 0.297 0.521 0.995 
TG, mM 45.4 43.1 42.9 52.3 51.6 50.7 57.2 54.1 53.3 4.36 0.034 0.389 0.987 
FFA, mM 0.621 0.607 0.596 0.737 0.726 0.717 0.745 0.735 0.729 0.08 0.029 0.132 0.778 
Glycerol 
mM 
0.379 0.358 0.349 0.384 0.377 0.368 0.390 0.384 0.377 0.09 0.454 0.141 0.966 
Values are means with pooled SEM, n = 10/treatment group for sows, n = 20 piglets/treatment group, and n = 10 sows/treatment group for milk.   
Data were analyzed by two-way ANOVA.  
1
T × D = Treatment × Day interaction effect.
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Table A-17. Concentrations of TBARS in plasma of sows and piglets during lactation 
 
Animals 
Control 1.535% BCAA 3.07% BCAA Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Sows 1.99 2.37 2.84 1.76 2.17 2.59 1.70 2.02 2.41 0.18 0.004 <0.001 0.982 
Piglets 4.90 4.06 3.61 5.03 3.96 3.04 5.11 4.15 3.14 0.48 0.804 <0.001 0.829 
Values expressed as μmol/L are means with pooled SEM, n = 20 piglets/treatment group and n = 10 sows/treatment group.   
Data are analyzed by two-way ANOVA.  
1

















  173 





Treatment   MSG  NaCl  L-Alanine  Cornstarch 
kg/100 kg diet 
 
Control  0.00  0.271  1.054   0.675 
1 % MSG
1
  1.00  0.136  0.527   0.337 
2 % MSG
2
  2.00  0.00  0.00   0.00 
1
Equivalent to 0.87% of supplemental glutamate in the final diet or (55% of glutamate in the basal diet) 
2
Equivalent to 1.74% of supplemental glutamate in the final diet or (110% of glutamate in the basal diet) 
The molecular weight (MW) of glutamic acid = 147.1; The MW of MSG = 169.1; and the MW of Na = 
23.0 
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Table A-19. Number of sows in each parity 
 
Treatment     Parity 2    Parity 3 
Control      5    5 
1% MSG     5    5 
2% MSG     5    5 
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Table A-20. Milk consumption by piglets and feed intake by sows during lactation 
 
Variable 
Control 1% MSG 2% MSG Pooled 
SEM 
P-value 













d           
3-15 
d          
15-29 
d          
0-29 
d            
3-15 
d         
1-29 
d          
0-29 
d           
3-15 
d         
15-29 
d          
0-29 
 
30.3 33.9 32.8 30.9 34.5 32.1 30.5 34.6 32.8 4.1 0.998 0.144 0.995 
Values are means with pooled SEM, n = 10 sows/treatment group.  See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction.                                                                                                                                                                                
2
ADFI = Average daily feed intake          
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Table A-21. Body weights of sows and piglets during lactation 
 
Variable 









189 185 179 168 187
a
 184 179 170 185 182 176 172 11 0.226 0.010 0.865 
Piglet 
BW, kg 
1.37 1.79 4.23 9.64 1.37 1.88 5.37 11.8 1.38 2.01 5.91 13.3 0.21 <0.001 <0.001 <0.001 
Values are means with pooled SEM, n = 10 sows/treatment group. See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1





  177 
Table A-22. Changes in body weights of sows and piglets during lactation 
 
Variable 




d     
0-3 
d     
3-15 
d      
15-29 
d    
 0-29 
d    
 0-3 
d    
3-15 
d   
15-29 
d   
  0-29 
d   
  0-3 
d    
   3-15 
d   
15-29 







140 203 386 285 170 291 461 361 210 325 515 405 9.7 <0.001 <0.001 <0.001 
Sow   
BW loss, 
kg 
3.9 6.8 11.1 21.3 3.4 5.5 8.4 17.3 3.1 5.4 4.3 13.4 1.3 <0.001 <0.001 <0.001 
Values are means with pooled SEM, n = 10 sows/treatment group. See Table 6 for the number of piglets on d 3, 15 and 29 of lactation. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-23. Rates of mortality of sow-reared piglets during lactation 
 
Group 
Number of piglets Rate of mortality (%) 









Control 90 77 75 75 0 14.4 16.7 16.7 
1 % MSG 90 86 86 86 0 4.4 4.4 4.4 
2 % MSG 90 87 87 87 0 3.3 3.3 3.3 
Values are the numbers of live piglets 
Data were analyzed by X
2
-analysis, which revealed that MSG supplementation reduced the rate of preweaning mortality (P = 0.001)  
1
Time of assignment to treatment groups 
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Table A-24. Composition of milk from control and MSG-supplemented sows during a 29 d period of lactation 
 
Variable 
Control 1% MSG 2% MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
DM, % 20.7 19.5 19.3 22.6 20.4 20.2 23.0 20.7 20.4 0.54 <0.001 0.111 0.989 
CP, % 5.65 5.01 4.72 6.19 5.12 5.01 6.30 5.33 5.12 0.16 <0.001 0.027 0.990 
Fat, % 8.52 8.11 8.06 9.24 8.36 8.23 9.66 8.60 8.47 0.44 <0.001 0.001 0.960 
Lactose, 
% 
5.06 4.94 5.02 5.60 5.39 5.37 5.48 5.29 5.26 0.31 <0.001 0.355 0.997 
Carb, % 5.67 5.51 5.64 6.28 6.02 6.05 6.14 5.87 5.89 0.27 <0.001 0.284 0.985 
Ash, % 0.86 0.87 0.88 0.89 0.90 0.91 0.90 0.90 0.92 0.02 <0.01 0.903 0.992 
Values are means and pooled SEM. n = 10 per treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
Carb = carbohydrate (including lactose); CP = N% x 6.25.  
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Table  A-25. Concentrations of free amino acids in the plasma of sows during lactation 
 
Variable 
Control 1% MSG 2% MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 411 549 576 538 669 676 664 713 724 51 <0.001 <0.001 0.559 
Arg 115 135 168 164 193 198 180 202 209 19 <0.001 0.001 0.719 
Asn 65 71 91 93 96 96 109 104 107 6.7 <0.001 0.046 0.039 
Asp 37 39 42 39 39 42 40 39 45 3.4 0.418 0.004 0.822 
b-Ala 17 18 18 17 18 19 18 18 19 0.60 0.233 0.031 0.159 
Cit 67 72 83 78 88 101 96 95 101 8.2 <0.001 0.001 0.668 
Cys 230 227 231 236 239 248 239 246 248 18 0.299 0.681 0.991 
Gln 602 606 611 667 677 683 708 720 727 31 <0.001 0.669 0.984 
Glu 89 90 92 133 142 147 156 164 168 14 <0.001 0.519 0.722 
Gly 1078 1088 1110 1082 1102 1204 1134 1162 1196 52 0.523 0.394 0.909 
His 74 78 79 78 80 86 78 83 86 6.7 0.511 0.664 0.789 
Ile 74 81 89 78 87 93 85 90 97 6.4 <0.001 0.218 0.792 
Leu 140 145 153 154 158 171 160 168 176 8.1 <0.001 0.198 0.849 
Lys 116 121 123 122 130 138 127 136 145 12 0.169 0.362 0.989 
Met 36 38 39 37 40 41 36 42 43 5.2 0.266 0.421 0.844 
Orn 72 84 113 84 85 112 87 85 116 7.1 0.384 <0.001 0.831 
Phe 75 80 86 76 83 94 78 86 95 5.3 0.626 <0.001 0.692 
Pro 253 263 270 333 340 355 397 417 427 22 <0.001 0.209 0.956 
Ser 125 131 135 130 131 138 126 130 141 9.9 0.699 0.159 0.989 
Tau 54 60 56 57 60 60 57 66 65 5.0 0.122 0.136 0.949 
Thr 106 109 111 108 114 116 89.5 92.6 96.9 9.7 0.211 0.187 0.779 
Trp 47 48 52 53 55 61 55 61 68 4.2 <0.001 0.046 0.471 
Tyr 60 56 62 61 64 62 63 65 66 6.2 0.184 0.157 0.628 
Val 175
 
201 217 192 226 223 207 236 245 12 <0.001 <0.001 0.848 
Values, expressed as μmol/L, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-26. Concentrations of free amino acids in plasma of piglets during lactation 
 
Variable 
Control 1 % MSG 2 % MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 629 631 653 775 693 692 780 701 712 30 <0.001 0.002 0.031 
Arg 207 141 131 224 189 191 249 197 201 13 <0.001 <0.001 0.826 
Asn 86 98 111 117 121 129 131 132 136 5.3 <0.001 <0.001 0.187 
Asp 15 21 22 20 23 24 21 25 28 1.3 <0.001 <0.001 0.668 
b-Ala 27 27 30 32 31 28 31 28 30 1.1 0.504 0.323 0.035 
Cit 128 73 77 146 91 99 163 118 121 6.3 <0.001 <0.001 0.217 
Cys 173 168 164 166 170 162 172 171 162 8.1 0.449 0.165 0.988 
Gln 688 514 520 724 612 619 755 637 659 27 <0.001 <0.001 0.223 
Glu 87 85 90 110 117 119 124 128 130 5.8 <0.001 0.331 0.922 
Gly 1103 1024 1008 1066 1050 1058 1060 1073 1094 37 <0.001 0.725 0.979 
His 95 92 99 94 93 103 94 92 105 4.2 0.826 <0.001 0.898 
Ile 120 122 126 140 144 154 155 162 165 9.7 <0.001 0.187 0.789 
Leu 192 185 183 225 218 224 231 235 240 20 <0.001 0.566 0.652 
Lys 199 212 226 193 205 218 190 212 224 13 0.307 0.001 0.978 
Met 79 80 78 83 85 82 86 89 91 3.6 <0.001 0.368 0.549 
Orn 140 93 91 156 96 94 153 98 95 8.9 0.669 0.598 0.788 
Phe 98 104 106 96 107 103 96 102 103 3.4 0.157 0.614 0.293 
Pro 512 532 533 551 559 566 567 596 602 16 <0.001 0.079 0.799 
Ser 235 246 242 247 251 259 245 254 251 9.9 0.798 0.398 0.689 
Tau 98 113 109 125 121 139 137 163 160 6.2 <0.001 0.001 0.028 
Thr 243 266 270 253 275 283 278 287 296 16.6 <0.001 <0.001 0.898 
Trp 43 46 48 46 51 59 47 53 60 3.4 0.038 <0.001 <0.001 
Tyr 120 122 129 125 132 133 124 125 135 9.8 0.568 0.559 0.798 
Val 220 223 226 239 236 241 247 255 259 11 <0.001 0.801 0.679 
Values, expressed as μmol/L, are means with pooled SEM, n = 20 piglets/treatment group. 
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-27. Composition of free amino acids in sow’s milk during lactation 
 
Variable 
Control 1 % MSG 2 % MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 261 567 705 310 662 810 335 676 736 56 0.016 <0.001 0.723 
Arg 40 71 79 58 82 101 60 97 121 9.7 <0.001 <0.001 0.598 
Asn 32 120 252 51 146 287 57 156 297 15 <0.001 <0.001 0.778 
Asp 176 512 533 213 584 658 348 607 709 40 <0.001 <0.001 0.066 
b-Ala 16 34 45 16 33 49 17 35 46 2.8 0.625 <0.001 0.701 
Cit 7.5 42 51 20 54 76 35 65 87 7.2 <0.001 <0.001 0.556 
Cys 129 213 401 133 221 397 136 226 410 25.4 0.729 <0.001 0.986 
Gln 335 1180 3580 488 1300 3890 524 1350 4050 146 <0.001 <0.001 0.039 
Glu 406 1120 1100 465 1260 1180 496 1340 1320 59 <0.001 <0.001 0.338 
Gly 326 901 1310 340 921 1380 397 936 1440 71 0.125 <0.001 0.908 
His 802 707 484 844 765 516 856 764 539 44 0.321 <0.001 0.819 
Ile 5.8 19 23 6.1 21 27 6.4 27 27 4.1 0.279 <0.001 0.668 
Leu 25 49 58 37 55 67 41 54 69 9.2 0.044 <0.001 0.848 
Lys 35 57 75 39 73 95 55 74 95 5.1 <0.001 <0.001 0.133 
Met 3.2 22 25 4.6 23 32 4.6 24 31 3.3 0.069 <0.001 0.556 
Orn 31 50 71 33 54 74 34 58 65 5.6 0.487 <0.001 0.661 
Phe 22 38 42 27 40 44 30 42 45 3.1 0.036 <0.001 0.809 
Pro 37 91 126 51 128 164 54 136 187 15 <0.001 <0.001 0.195 
Ser 47 225 427 66 256 526 71 265 423 19 0.023 <0.001 <0.001 
Tau 1142 1420 1568 1229 1431 1590 1372 1435 1664 136 0.326 <0.001 0.819 
Thr 90 142 467 93 149 479 88 156 460 30 0.778 <0.001 0.996 
Trp 3.8 12 19 4.9 14 23 5.3 15 22 1.3 0.021 <0.001 0.456 
Tyr 37 66 80 46 70 82 54 73 81 7.8 0.235 <0.001 0.789 
Val 57 120 149 69 129 157 74 134 160 9.4 <0.001 <0.001 0.148 
Values, expressed as μmol/L of whole milk, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-28. Composition of amino acids of proteins and peptides in sow’s milk during lactation 
 
Variable 
Control 1 % MSG 2 % MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Ala 27.9 15.4 14.8 30.5 17.7 16.9 31.3 18.9 18.0 1.5 0.006 0.005 0.934 
Arg 14.7 7.53 7.26 16.3 8.03 7.81 18.0 9.24 8.86 0.86 <0.001 <0.001 0.924 
Asp 16.3 10.2 9.84 17.0 10.8 10.4 18.4 11.8 11.4 1.2 <0.001 <0.006 0.861 
Asn 17.2 10.4 9.66 18.1 11.0 10.8 19.2 11.2 11.0 1.0 <0.001 <0.005 0.848 
Cys 6.77 3.30 3.21 7.14 3.77 3.63 7.28 4.01 4.05 0.54 0.030 <0.001 0.975 
Glu 41.7 23.5 23.0 43.4 25.4 24.3 45.8 26.4 25.7 1.5 <0.001 0.026 0.964 
Gln 35.3 20.7 20.5 36.9 21.9 21.7 39.5 23.1 22.7 1.3 <0.001 0.024 0.952 
Gly 19.1 9.39 9.24 20.4 10.8 10.1 21.0 11.6 11.2 0.95 0.042 0.002 0.853 
His 9.13 5.40 5.22 9.66 5.89 5.63 10.5 6.34 6.20 0.62 0.006 <0.001 0.876 
Ile 19.3 12.1 11.7 20.4 14.0 13.6 21.5 16.2 14.8 1.3 <0.001 <0.001 0.702 
Leu 42.3 26.1 25.5 43.7 27.7 26.2 45.9 29.0 28.2 1.5 <0.001 <0.001 0.883 
Lys 36.8 24.0 23.6 37.4 27.9 26.1 39.2 28.6 27.2 1.7 0.005 0.001 0.991 
Met 10.1 6.23 6.09 10.8 6.65 6.27 12.6 7.18 6.84 0.51 0.038 <0.001 0.439 
Phe 16.1 10.3 9.28 17.3 10.8 9.61 18.7 11.3 9.93 0.65 0.030 <0.001 0.879 
Pro 42.8 33.2 32.0 45.2 37.3 36.5 47.3 38.5 37.4 2.9 <0.001 0.002 0.989 
Ser 32.1 17.0 16.4 33.8 18.2 17.5 35.2 19.3 18.7 1.6 0.024 0.004 0.995 
Thr 25.0 14.3 13.5 26.9 15.4 14.6 28.3 16.6 16.1 1.3 0.038 0.005 0.971 
Trp 6.07 3.40 3.26 6.48 3.73 3.55 6.91 3.87 3.72 0.24 <0.001 0.003 0.702 
Tyr 18.9 12.1 11.0 20.3 13.6 13.2 21.8 14.0 13.4 1.0 0.013 0.006 0.876 
Val 27.5 15.0 14.6 28.9 16.4 15.3 30.2 17.8 17.1 1.2 0.010 0.034 0.949 
Values, expressed as mmol/L of whole milk, are means with pooled SEM, n = 10 sows/treatment group.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction. 
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Table A-29. Concentrations of metabolites in the plasma of sows and piglets and in milk during lactation  
 
Variable 
Control 1 % MSG 2 % MSG Pooled 
SEM 
P-value 




61 63 63 60 61 64 65 65 66 7.2 0.399 0.689 0.982 
Urea, mM 2.73 2.81 2.94 2.79 2.90 2.98 2.82 2.89 2.90 0.31 0.287 0.501 0.975 
Glucose, 
mM 
5.15 5.23 5.36 5.39 5.44 5.45 5.49 5.50 5.52 0.14 0.033 0.308 0.990 
Lactate, mM 1.16 1.47 1.56 1.20 1.59 1.71 1.22 1.69 1.78 0.24 0.988 <0.001 0.988 
Pyruvate, 
µM 




61 62 63 62 64 64 63 65 67 3.1 0.221 0.715 0.991 
Urea, mM 2.19 2.26 2.44 2.25 2.35 2.51 2.29 2.48 2.59 0.29 0.566 0.280 0.977 
Glucose, 
mM 
5.36 5.34 5.39 5.31 5.41 5.45 5.40 5.45 5.50 0.188 0.514 0.161 0.997 
Lactate, mM 1.08 1.09 1.15 1.12 1.14 1.18 1.20 1.27 1.30 0.18 0.415 0.995 0.983 
Pyruvate, 
µM 




1.49 1.55 1.61 1.55 1.62 1.69 1.59 1.70 1.76 0.21 0.569 0.753 0.980 
Urea, mM 7.09 4.96 4.99 6.91 5.06 5.14 7.15 5.17 5.19 0.59 0.811 <0.001 0.992 
Glucose, 
mM 
0.52 0.57 0.58 0.58 0.60 0.61 0.59 0.61 0.62 0.06 0.426 0.196 0.984 
Lactate, mM 0.155 0.159 0.167 0.149 0.171 0.180 0.154 0.178 0.188 0.043 0.841 0.244 0.972 
Pyruvate, 
µM 
62 64 69 63 67 70 66 69 75 7.8 0.966 0.239 0.979 
Values are means with pooled SEM, n = 10/treatment group for sows, n = 20 piglets/treatment group, and n = 10 sows/treatment group for milk.   
Data were analyzed by two-way ANOVA.  
1
Treatment (T), Day (D) and T × D = Treatment × Day interaction.    
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Table A-30. Concentrations of lipids in the plasma of MSG-supplemented sows and their piglets and in milk during lactation 
 
Variable 
Control 1% MSG 2% MSG Pooled P-value 






2.33 2.29 2.24 2.27 2.20 2.20 2.26 2.19 2.23 0.33 0.599 0.871 0.996 
TG, mM 0.458 0.447 0.449 0.445 0.452 0.439 0.440 0.436 0.433 0.08 0.379 0.456 0.998 
FFA, mM 0.559 0.573 0.577 0.554 0.560 0.566 0.568 0.560 0.559 0.07 0.586 0.327 0.979 
Glycerol 
mM 




1.91 1.94 1.96 1.83 1.89 1.90 1.82 1.85 1.86 0.23 0.558 0.553 0.876 
TG, mM 0.417 0.422 0.427 0.423 0.429 0.428 0.425 0.430 0.436 0.09 0.421 0.385 0.998 
FFA, mM 0.314 0.321 0.322 0.321 0.326 0.329 0.321 0.324 0.327 0.08 0.546 0.477 0.981 
Glycerol 
mM 




1.18 1.12 1.11 1.19 1.17 1.13 1.21 1.17 1.14 0.18 0.388 0.229 0.988 
TG, mM 44.8 43.7 41.8 53.7 52.5 51.4 59.6 57.5 54.1 4.79 0.032 0.287 0.995 
FFA, mM 0.618 0.612 0.602 0.746 0.739 0.730 0.761 0.744 0.741 0.09 0.021 0.176 0.991 
Glycerol 
mM 
0.367 0.360 0.351 0.377 0.365 0.361 0.381 0.376 0.368 0.07 0.268 0.321 0.999 
Values are means with pooled SEM, n = 10/treatment group for sows, n = 20 piglets/treatment group, and n = 10 sows/treatment group for milk.   
Data were analyzed by two-way ANOVA.  
1
T × D = Treatment × Day interaction effect. 
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Table A-31. Concentrations of TBARS in plasma of sows and piglets during lactation 
 
Animals 
Control 1 % MSG 2 % MSG Pooled 
SEM 
P-value 
d 3 d 15 d 29 d 3 d 15 d 29 d 3 d 15 d 29 Treatment Day T×D
1
 
Sows 1.83 2.44 2.97 1.65 2.09 2.31 1.59 1.98 2.25 0.19 0.018 <0.001 0.979 
Piglets 5.15 4.15 3.54 5.09 3.89 2.95 5.13 3.84 2.94 0.61 0.544 <0.001 0.911 
Values, expressed as μmol/L, are means with pooled SEM, n = 20 piglets/treatment group and n = 10 sows/treatment group.   
Data are analyzed by two-way ANOVA.  
1
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Table A-32. Effects of L-leucine, L-isoleucine, or L-valine or a mixture of BCAA on 




L-Leucine concentrations in culture medium (mmol/L) Pooled 




































L-Isoleucine concentrations in culture medium (mmol/L) Pooled 




































L-Valine concentrations in culture medium (mmol/L) Pooled 




































Concentrations of a mixture of each of the three BCAA in 
culture medium (mmol/L) 
Pooled 
SEM 


































Values, expressed as %/day are means with pooled SEM, n = 8 per treatment group.  
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Table A-33. Effects of L-leucine, L-isoleucine, or L-valine or a mixture of BCAA on 
concentrations of protein in porcine mammary epithelial cells (PMEC)  
 
Leu in medium 
(mmol/L) 
0.1 0.25 0.5 1 2 
Pooled 
SEM 














Ile in medium 
(mmol/L) 
0.1 0.25 0.5 1 2 
Pooled 
SEM 














Val in medium 
(mmol/L) 
0.1 0.25 0.5 1 2 
Pooled 
SEM 














Mixture of three 
BCAA in medium 
(mmol/L) 
0.1 0.25 0.5 1 2 
Pooled 
SEM 













Values are means with pooled SEM, n = 8 per treatment group.  
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Table A-34. Effects of L-leucine on synthesis and degradation of proteins in primary 
mammary epithelial cells (PMEC) 
 
Variable 
Concentrations of L-leucine in culture medium 
(mmol/L) Pooled SEM 
0.1 0.25 0.5 1 2 
Protein synthesis 

























Values are means and pooled SEM, n = 8 per treatment group.  
Means in a row without a common superscript letter differ (P<0.05) 
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Table A-35. Effects of L-isoleucine on synthesis and degradation of proteins in primary 
mammary epithelial cells (PMEC) 
 
Variable 
Concentrations of L-isoleucine in culture 
medium (mmol/L) Pooled SEM 
0.1 0.25 0.5 1 2 
Protein synthesis 

























Values are means and pooled SEM, n = 8 per treatment group.  
Means in a row without a common superscript letter differ (P<0.05). 
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Table A-36. Effects of L-valine on synthesis and degradation of proteins in primary 
mammary epithelial cells (PMEC) 
 
Variable 
Concentrations of L-valine in culture 
medium (mmol/L) Pooled SEM 
0.1 0.25 0.5 1 2 
Protein synthesis 

























Values are means and pooled SEM, n = 8 per treatment group.  
Means in a row without a common superscript letter differ (P<0.05). 
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Table A-37. Effects of a mixture of three BCAA on synthesis and degradation of 
proteins in primary mammary epithelial cells (PMEC) 
 
Variable 
Concentrations of a mixture of each of the 
three BCAA in culture medium (mmol/L) Pooled SEM 
0.1 0.25 0.5 1 2 
Protein synthesis 

























Values are means and pooled SEM, n = 8 per treatment group.  
Means in a row without a common superscript letter differ (P<0.05). 
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APPENDIX B 
  194 
 
Figure B-1. Pathways for BCAA catabolism and amino acid synthesis in lactating 
porcine mammary tissue.  Enzymes that catalyze the indicated reactions are: 1) BCAT= 
branched-chain aminotransferase; 2) BCKAD = branched-chain alpha-keto acid 
dehydrogenase; 3) GS = glutamine synthetase; 4) GOT = glutamate-oxaloacetate 
transaminase; 5) GPT = glutamate-pyruvate transaminase; 6) AS = asparagine 
synthetase; 7) glucose metabolism via glycolysis and the Krebs cycle; 8) protein 
synthesis. The corresponding a-ketoacids of leucine, isoleucine and valine are a-
ketoisocaproate, a-keto-b-methylvalerate, and a-ketoisovalerate, respectively. Mammary 
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Figure B-2. Relative abundance of total and phosphorylated mTOR, S6K1, 4E-BP1, as 
well as β-casein in PMEC cultured in the presence of 0.1 to 2 mmol/L L-leucine. Values 
are mean ± SEM, n = 8. Different letters within each variable indicate statistical 
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Figure B-3. Relative abundance of total and phosphorylated mTOR, S6K1, 4E-BP1, as 
well as β-casein in PMEC cultured in the presence of 0.1 to 2 mmol/L L-isoleucine. 
Values are mean ± SEM, n = 8. Different letters within each variable indicate statistical 
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Figure B-4. Relative abundance of total and phosphorylated mTOR, S6K1, 4E-BP1, as 
well as β-casein in PMEC cultured in the presence of 0.1 to 2 mmol/L L-valine. Values 
are mean ± SEM, n = 8. Different letters within each variable indicate statistical 
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Figure B-5. Relative abundance of total and phosphorylated mTOR, S6K1, 4E-BP1, as 
well as β-casein in PMEC cultured in the presence of a mixture of the three BCAA 
(leucine, isoleucine and  valine) at 0.1 to 2 mmol/L. Values are mean ± SEM, n = 8. 
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Figure B-6. Relative abundance of ubiquitinated proteins (Ub-protein), free ubiquitin 
(Free-Ub) and proteasome in mammary epithelial cells treated with 0.1 to 2 mmol/L L-
leucine. Values are mean ± SEM, n = 8. Different letters within each variable indicate 
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Figure B-7. Relative abundance of ubiquitinated proteins (Ub-protein), free ubiquitin 
(Free-Ub) and proteasome in mammary epithelial cells treated with 0.1 to 2 mmol/L L-
isoleucine. Values are mean ± SEM, n = 8. Different letters within each variable indicate 
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Figure B-8. Relative abundance of ubiquitinated proteins (Ub-protein), free ubiquitin 
(Free-Ub) and proteasome in mammary epithelial cells treated with 0.1 to 2 mmol/L L-
valine. Values are mean ± SEM, n = 8. Different letters within each variable indicate 
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Figure B-9. Relative abundance of ubiquitinated proteins (Ub-protein), free ubiquitin 
(Free-Ub) and proteasome in PMEC cultured in the presence of a mixture of the three 
BCAA (leucine, isoleucine, valine) at 0.1 to 2 mmol/L. Values are mean ± SEM, n = 8. 
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Figure B-10. A proposed mechanism whereby BCAA increases milk synthesis in 
mammary epithelial cells.  BCAA increased phosphorylation of mTOR, 4EBP1 and 
S6K1 proteins which stimulated protein synthesis, while decreasing the abundance of 
ubiqitinated proteins and proteasome to inhibit protein degradation in PMEC.  Formation 
of glutamate, glutamine, alanine, aspartate and asparagine also contributes to enhanced 
protein synthesis in the cells. α-KG = α-ketoglutarate. mTOR = mechanistic target of 
rapamycin. The signs (+) and (-) denote activation and inhibition, respectively.  (1), 
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